var title_f26_31_27120="Lung ca I PI";
var content_f26_31_27120=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F53379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F53379&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Stage I lung cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts a stage I cancer. In stage I lung cancer, the tumor is small and has not spread to any of the lymph nodes or other structures in the chest.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27120=[""].join("\n");
var outline_f26_31_27120=null;
var title_f26_31_27121="Severe breathing trouble PI";
var content_f26_31_27121=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F59786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F59786&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Signs of severe trouble breathing (retractions)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 446px; height: 672px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When a child is having a lot of trouble breathing, the skin and muscles between the child's ribs or below the child's ribcage look like they are caving in.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27121=[""].join("\n");
var outline_f26_31_27121=null;
var title_f26_31_27122="Patient information: Salmonellosis (Salmonella) (The Basics)";
var content_f26_31_27122=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83760\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?0/34/557\">",
"         Tips for safe food handling",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/5/9299\">",
"         Patient information: Diarrhea in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?10/22/10595\">",
"         Patient information: Food poisoning (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?35/29/36308\">",
"         Patient information: Acute diarrhea in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?0/1/27\">",
"         Patient information: Acute diarrhea in children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?28/30/29156\">",
"         Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Salmonellosis (Salmonella) (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/salmonellosis-salmonella-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H14463103\">",
"      <span class=\"h1\">",
"       What is salmonellosis (salmonella infection)?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Salmonella infection is an illness that can cause nausea, vomiting, and diarrhea. &ldquo;Salmonella&rdquo; is a kind of bacteria. People get the infection from foods that contain the bacteria.",
"     </p>",
"     <p>",
"      Salmonella infection is common. It is not serious for most people. But sometimes the bacteria get into the bloodstream. If this happens, people with certain conditions could get very sick. These include people with:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        AIDS &ndash; This is an illness that makes the body&rsquo;s infection-fighting system, called the &ldquo;immune system,&rdquo; very weak.",
"       </li>",
"       <li>",
"        Cancer &ndash; People who recently had a treatment called &ldquo;chemotherapy&rdquo; have a higher risk of getting very sick.",
"       </li>",
"       <li>",
"        Sickle cell disease &ndash; This is an illness that affects the red blood cells.",
"       </li>",
"       <li>",
"        An organ transplant (such as a new heart, lung, or kidney)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Other people who can get very sick include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        People taking high doses of steroid medicines or other medicines that weaken the immune system &nbsp;",
"       </li>",
"       <li>",
"        Babies who were born too early or with immune system problems",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have heart disease or a man-made joint, there is a small chance that salmonella bacteria will attach to your blood vessels or the man-made joint. This could make you sicker than most people. &nbsp;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463118\">",
"      <span class=\"h1\">",
"       What are the symptoms of salmonella infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The symptoms include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Nausea or vomiting",
"       </li>",
"       <li>",
"        Fever &ndash; This usually lasts 2 or 3 days.",
"       </li>",
"       <li>",
"        Diarrhea that can be watery or bloody &ndash; This usually lasts 4 to 10 days. If you have diarrhea for more than 10 days, a different condition could be causing your symptoms.",
"       </li>",
"       <li>",
"        Belly pain",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463133\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;See your doctor or nurse if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Have severe belly pain",
"       </li>",
"       <li>",
"        Cannot eat or drink",
"       </li>",
"       <li>",
"        Vomit blood or have blood in your bowel movements",
"       </li>",
"       <li>",
"        Have a fever higher than 100.4&deg;F (38&deg;C)",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463148\">",
"      <span class=\"h1\">",
"       Is there a test for salmonella infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse can order tests on a sample of your bowel movement to check for salmonella bacteria. But it can take 2 or 3 days to get the test results. If you have a high risk of getting very sick from salmonella infection, your doctor or nurse might not wait for your test results before starting treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463163\">",
"      <span class=\"h1\">",
"       How is salmonella infection treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It usually goes away on its own, so most people do not need treatment. But if you get very sick, you might be treated in the hospital. Doctors can give antibiotics through an &ldquo;IV,&rdquo; a thin tube that goes into a vein.",
"     </p>",
"     <p>",
"      If you have a high risk of getting very sick from salmonella infection, your doctor might prescribe antibiotic pills. You might need them for 2 weeks or even several months. The antibiotics help get rid of the infection and keep it from coming back.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463178\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Drink plenty of liquids &ndash; This keeps your body from losing too much water when you have diarrhea or vomit.",
"       </li>",
"       <li>",
"        Eat small meals that don&rsquo;t have a lot of fat in them.",
"       </li>",
"       <li>",
"        Rest if you feel tired.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463193\">",
"      <span class=\"h1\">",
"       Can salmonella infection be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can lower the chances of getting or spreading the infection by:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Washing your hands after changing diapers, going to the bathroom, blowing your nose, touching animals, or taking out the trash.",
"       </li>",
"       <li>",
"        Staying home from work or school if you are sick",
"       </li>",
"       <li>",
"        Paying attention to food safety. Tips include:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Don&rsquo;t drink unpasteurized milk or eat foods made with it",
"       </li>",
"       <li>",
"        Wash fruits and vegetables well before eating them",
"       </li>",
"       <li>",
"        Keep the refrigerator colder than 40&deg;F (4.4&deg;C) and the freezer below 0&deg;F (-18&deg;C)",
"       </li>",
"       <li>",
"        Cook meat and seafood until well done",
"       </li>",
"       <li>",
"        Cook eggs until the yolk is firm",
"       </li>",
"       <li>",
"        Wash hands, knives, and cutting boards after they touch raw food",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      For more tips to on handling food safely, see the table (",
"      <a class=\"graphic graphic_table graphicRef60529 \" href=\"UTD.htm?0/34/557\">",
"       table 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463208\">",
"      <span class=\"h1\">",
"       What if I am pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you think you might have salmonella infection, talk to your doctor, nurse, or midwife. Most pregnant women do not need treatment. But you might need it if you get very sick and are near your due date.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H14463223\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=see_link\">",
"       Patient information: Diarrhea in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/22/10595?source=see_link\">",
"       Patient information: Food poisoning (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=see_link\">",
"       Patient information: Acute diarrhea in adults (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=see_link\">",
"       Patient information: Acute diarrhea in children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=see_link\">",
"       Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?26/31/27122?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83760 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27122=[""].join("\n");
var outline_f26_31_27122=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463103\">",
"      What is salmonellosis (salmonella infection)?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463118\">",
"      What are the symptoms of salmonella infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463133\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463148\">",
"      Is there a test for salmonella infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463163\">",
"      How is salmonella infection treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463178\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463193\">",
"      Can salmonella infection be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463208\">",
"      What if I am pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14463223\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83760\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/34/557\">",
"      Tips for safe food handling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/29/36308?source=related_link\">",
"      Patient information: Acute diarrhea in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/1/27?source=related_link\">",
"      Patient information: Acute diarrhea in children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/5/9299?source=related_link\">",
"      Patient information: Diarrhea in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/22/10595?source=related_link\">",
"      Patient information: Food poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?28/30/29156?source=related_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27123="Physical urticaria B";
var content_f26_31_27123=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F55636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F55636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Cold urticaria",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 300px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The \"ice cube test.\"",
"    <br>",
"     (A) Forearm before application of ice cube.",
"     <br>",
"      (B) Forearm 5 minutes after application of an ice cube. A large rectangular wheal and surrounding erythema have appeared.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: Goodheart HP, MD. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27123=[""].join("\n");
var outline_f26_31_27123=null;
var title_f26_31_27124="Denileukin diftitox: Patient drug information";
var content_f26_31_27124=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Denileukin diftitox: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/57/918?source=see_link\">",
"     see \"Denileukin diftitox: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F157513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ONTAK&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700515",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some patients have very bad side effects during the infusion. A sudden change in eyesight or in the way you see color may happen. Rapid weight gain, swelling, and low blood pressure may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2692073",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat skin cancer from lymphoma.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to denileukin diftitox or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029072\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697613",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before getting any vaccines. Use with this drug may either raise the chance of an infection or make the vaccine not work as well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029073\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698315",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may have more chance of getting an infection. Wash hands often. Stay away from people with infections, colds, or flu.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698085",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Flu-like signs. These include headache, weakness, fever, shakes, aches, pains, and sweating. Mild pain drugs may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698984",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not hungry.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698191",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Itching.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Rash.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F14790262\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain or loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699084",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight or in the way you see color.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029070\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695989",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein over a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11336 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-EFD95E538C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27124=[""].join("\n");
var outline_f26_31_27124=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F157513\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029066\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029068\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029067\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029072\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029073\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14790262\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029070\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029077\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/57/918?source=related_link\">",
"      Denileukin diftitox: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27125="Typhlitis (neutropenic enterocolitis)";
var content_f26_31_27125=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Typhlitis (neutropenic enterocolitis)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Louis-Michel Wong Kee Song, MD, FRCP(C)",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Norman E Marcon, MD, FRCP(C)",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Kieren A Marr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27125/contributors\">",
"     Anna R Thorner, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/31/27125/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typhlitis (from the Greek word \"typhlon,\" or cecum) is a life-threatening, necrotizing enterocolitis occurring primarily in neutropenic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/1\">",
"     1",
"    </a>",
"    ]. Other terms that have been used to describe this syndrome include \"necrotizing enterocolitis,\" \"neutropenic enterocolitis,\" and \"ileocecal syndrome.\" Typhlitis occurs most commonly in individuals with hematologic malignancies who are neutropenic and have breakdown of gut mucosal integrity as a result of cytotoxic chemotherapy. &ldquo;Typhlitis&rdquo; describes neutropenic enterocolitis of the ileocecal region; the more inclusive term, &ldquo;neutropenic enterocolitis,&rdquo; is appropriate when other parts of the small",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    large intestine are involved.",
"   </p>",
"   <p>",
"    The pathogenesis, clinical manifestations, diagnosis, management, and prognosis of typhlitis are reviewed here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of typhlitis is incompletely understood. It probably involves a combination of factors, including mucosal injury by cytotoxic drugs or other means, profound neutropenia, and impaired host defense to invasion by microorganisms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/2\">",
"     2",
"    </a>",
"    ]. The microbial infection leads to necrosis of various layers of the bowel wall. The cecum is almost always affected, and the process often extends into the ascending colon and terminal ileum [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/3\">",
"     3",
"    </a>",
"    ]. The predilection for the cecum is possibly related to its distensibility and its diminished vascularization relative to the rest of the colon.",
"   </p>",
"   <p>",
"    Gross and histologic examinations may reveal bowel wall thickening, discrete or confluent ulcers, mucosal loss, intramural edema, hemorrhage, and necrosis. Various bacterial",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fungal organisms, including gram-negative rods, gram-positive cocci, anaerobes (eg, Clostridium septicum), and Candida spp, are often seen infiltrating the bowel wall. Polymicrobial infection is frequent. Only rarely are inflammatory or leukemic infiltrates identified [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/3\">",
"     3",
"    </a>",
"    ]. Bacteremia or fungemia is also common, usually with enteric organisms such as Pseudomonas or yeasts such as Candida.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RISK FACTORS AND INCIDENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typhlitis was originally reported in children who underwent induction chemotherapy for acute leukemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/4\">",
"     4",
"    </a>",
"    ]. It has subsequently been described in children and adults with acute myeloid leukemia, multiple myeloma, myelodysplastic syndromes, aplastic anemia, acquired immunodeficiency syndrome, cyclic or drug-induced neutropenia, and after immunosuppressive therapy for solid malignancies and transplants [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/2,3,5-9\">",
"     2,3,5-9",
"    </a>",
"    ]. In one study, mucositis [odds ratio (OR) 31], stem cell transplantation (OR 59), and receipt of chemotherapy in the previous two weeks (OR 13) were significantly associated with the occurrence of typhlitis in pediatric patients with cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/53/14168?source=see_link\">",
"     \"Overview of the complications of acute myeloid leukemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rare reports have described it in otherwise healthy adults following ingestion of food contaminated with C. perfringens type A [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The true incidence of typhlitis is unknown. Typhlitis has been reported in up to 46 percent of childhood leukemia cases at autopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/3,12\">",
"     3,12",
"    </a>",
"    ]. It was diagnosed in 3.5 percent of 317 episodes of severe neutropenia among individuals &gt;16 years of age in another report [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42362?source=see_link&amp;anchor=H41#H41\">",
"     \"Enterotoxicity of chemotherapeutic agents\", section on 'Neutropenic enterocolitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typhlitis must be considered in the differential diagnosis of any profoundly neutropenic patient (absolute neutrophil count &lt;500",
"    <span class=\"nowrap\">",
"     cells/microL),",
"    </span>",
"    who presents with fever and abdominal pain, usually in the right lower quadrant. Symptoms often appear 10 to 14 days after cytotoxic chemotherapy, at a time when neutropenia is most profound and the patient is febrile [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/14\">",
"     14",
"    </a>",
"    ]. Additional symptoms may include abdominal distension, nausea, vomiting, and watery or bloody diarrhea [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/3,12\">",
"     3,12",
"    </a>",
"    ]. Peritoneal signs and shock suggest the possibility of bowel wall perforation. Stomatitis and pharyngitis, suggesting the presence of widespread mucositis, may be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typhlitis is usually diagnosed by characteristic computed tomography (CT) or ultrasound findings in high-risk patients. CT is the preferred diagnostic modality since it appears to have a lower false-negative rate of diagnosis (15 percent) than does ultrasound (23 percent) or plain x-rays of the abdomen (48 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/15\">",
"     15",
"    </a>",
"    ]. Findings include the presence of a fluid-filled, dilated, and distended cecum. Findings on CT may include diffuse cecal wall thickening; presence of intramural edema, air, or hemorrhage; localized perforation with free air; or soft tissue mass suggesting abscess formation.",
"   </p>",
"   <p>",
"    CT is usually helpful in the differentiation of typhlitis from appendicitis, appendiceal abscess, or even pseudomembranous colitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Typhlitis mimics acute appendicitis, and distinguishing between the two is important due to their different management [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/19\">",
"     19",
"    </a>",
"    ]. Acute lower gastrointestinal bleeding, which occurred in 35 percent of typhlitis cases in one series, should suggest typhlitis instead of appendicitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/3\">",
"     3",
"    </a>",
"    ]. Other diagnoses to consider include pseudomembranous colitis, ischemic colitis, and Ogilvie's syndrome (colonic pseudo-obstruction) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Blood and stool cultures and C. difficile toxin assays should be performed. Plain films of the abdomen are nonspecific but, occasionally, a fluid-filled, distended cecum with dilated adjacent small bowel loops, thumbprinting, or localized pneumatosis intestinalis is seen (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51214 \" href=\"UTD.htm?36/41/37520\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a stable patient with possible typhlitis without an indication for an emergency laparotomy, a diagnostic laparoscopy can be considered when the diagnosis remains in doubt despite cross-sectional CT imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"     Barium",
"    </a>",
"    enema is hazardous in the presence of potentially necrotic bowel, since it can cause perforation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/20\">",
"     20",
"    </a>",
"    ]. Similarly, colonoscopy is relatively contraindicated in the presence of neutropenia and thrombocytopenia, and air insufflation may precipitate cecal perforation. However, it may be reasonable to perform a flexible sigmoidoscopy with gentle manipulation and air insufflation if pseudomembranous colitis is suspected, although a sigmoidoscopy may be negative despite the presence of infection since pseudomembranes confined to the cecum have been described in neutropenic cancer patients with C. difficile infection. In those very few patients who underwent colonoscopic examination, mucosal irregularity with nodularity, ulcerations, and hemorrhagic friability, as well as a mass-like lesion mimicking carcinoma have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A general approach to patients with typhlitis can be suggested, although care should be individualized (",
"    <a class=\"graphic graphic_algorithm graphicRef70161 \" href=\"UTD.htm?42/32/43535\">",
"     algorithm 1",
"    </a>",
"    ). In patients without complicated typhlitis (ie, peritonitis, perforation, or severe bleeding), nonsurgical management with bowel rest, nasogastric suction, intravenous fluids, nutritional support, blood product support (packed red blood cells and fresh frozen plasma as needed), and broad-spectrum antibiotics is a reasonable initial approach [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/15,20,23\">",
"     15,20,23",
"    </a>",
"    ]. Examples of appropriate antimicrobial regimens include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"     piperacillin-tazobactam",
"    </a>",
"    as monotherapy or combination therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/33/16919?source=see_link\">",
"     cefepime",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/0/17415?source=see_link\">",
"     ceftazidime",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/24\">",
"     24",
"    </a>",
"    ]. Antibiotic coverage for C. difficile should be added if pseudomembranous colitis has not been excluded.",
"   </p>",
"   <p>",
"    Fungemia and fungal invasion of the bowel can occur. As a result, an antifungal agent should be started in neutropenic patients with protracted fever (&gt;72 hours) despite broad-spectrum antibiotics. We favor an antifungal agent with activity against fluconazole-resistant Candida spp as well as Aspergillus spp. Examples of appropriate antifungal agents include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/38/17002?source=see_link\">",
"     voriconazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/53/43863?source=see_link\">",
"     amphotericin B",
"    </a>",
"    formulations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=see_link\">",
"     \"Treatment of candidemia and invasive candidiasis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28970?source=see_link\">",
"     \"Treatment and prevention of invasive aspergillosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anticholinergic, antidiarrheal, and opioid agents should be avoided since they may aggravate ileus.",
"   </p>",
"   <p>",
"    An attempt to accelerate leukocyte recovery with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/13/23767?source=see_link\">",
"     granulocyte colony-stimulating factor",
"    </a>",
"    (G-CSF) is reasonable, since normalization of the leukocyte count may permit containment and healing of bowel lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/5,12,25\">",
"     5,12,25",
"    </a>",
"    ]. Other possible treatments such as selective decontamination of the digestive tract, enteral nutrition (for maintaining structural and functional integrity of the gut), glutamine (for maintaining gut integrity and local and systemic immune function), and granulocyte transfusions as a means of reducing the incidence or duration of typhlitis are of unproven benefit but deserve further study [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/2,26\">",
"     2,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical intervention is recommended for those with peritonitis, free perforation, persistent gastrointestinal bleeding despite correction of coagulopathy and cytopenias, or clinical deterioration during close observation and serial examinations [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/12\">",
"     12",
"    </a>",
"    ]. If surgery is performed, a two-stage right hemicolectomy is the preferred approach, and further chemotherapy should be delayed until recovery. A surgeon may be tempted not to resect edematous bowel without apparent severe inflammation or gangrene. The caveat is that diffuse mucosal necrosis may be present underneath unimpressive serosal inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27125/abstract/2\">",
"     2",
"    </a>",
"    ]; incomplete removal of all necrotic tissue uniformly results in death.",
"   </p>",
"   <p>",
"    Patients developing typhlitis during chemotherapy are prone to develop this complication again during subsequent treatments. Sufficient time should be allowed for complete healing. In addition, bowel decontamination has been suggested before resumption of chemotherapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial reports of patients with typhlitis described mortality rates between 40 to 50 percent, with most deaths attributed to transmural bowel necrosis, perforation, and sepsis. More recently, early recognition and progress in management have probably reduced mortality, although no large series have been published.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H469422553\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Typhlitis (from the Greek word \"typhlon,\" or cecum) is a life-threatening, necrotizing enterocolitis occurring primarily in neutropenic patients. Other terms that have been used to describe this syndrome include \"necrotizing enterocolitis,\" \"neutropenic enterocolitis,\" and \"ileocecal syndrome.\" (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pathogenesis of typhlitis is incompletely understood. It probably involves a combination of factors, including mucosal injury by cytotoxic drugs or other means, profound neutropenia, and impaired host defense to invasion by microorganisms. The microbial infection leads to necrosis of various layers of the bowel wall. The cecum is almost always affected, and the process often extends into the ascending colon and terminal ileum. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Typhlitis was originally reported in children who underwent induction chemotherapy for acute leukemia. It has subsequently been described in children and adults with acute myeloid leukemia, multiple myeloma, myelodysplastic syndromes, aplastic anemia, acquired immunodeficiency syndrome, cyclic or drug-induced neutropenia, and after immunosuppressive therapy for solid malignancies and transplants. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Risk factors and incidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Typhlitis must be considered in the differential diagnosis of any severely neutropenic patient (absolute neutrophil count &lt;500",
"      <span class=\"nowrap\">",
"       cells/microL),",
"      </span>",
"      who presents with fever and abdominal pain, usually in the right lower quadrant. Symptoms often appear 10 to 14 days after cytotoxic chemotherapy, at a time when neutropenia is most profound and the patient is febrile. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Typhlitis is usually diagnosed by characteristic computed tomography (CT) or ultrasound findings in high-risk patients. CT is the preferred diagnostic modality. Both modalities indicate the presence of a fluid-filled, dilated, and distended cecum. Findings on CT may include diffuse cecal wall thickening; presence of intramural edema, air, or hemorrhage; localized perforation with free air; or soft tissue mass suggesting abscess formation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients without complicated typhlitis (ie, peritonitis, perforation, or severe bleeding), we recommend nonsurgical management with bowel rest, nasogastric suction, intravenous fluids, nutritional support, blood product support (packed red blood cells and fresh frozen plasma as needed), and broad-spectrum antimicrobials (",
"      <a class=\"graphic graphic_algorithm graphicRef70161 \" href=\"UTD.htm?42/32/43535\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/1\">",
"      Rolston KV, Bodey GP, Safdar A. Polymicrobial infection in patients with cancer: an underappreciated and underreported entity. Clin Infect Dis 2007; 45:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/2\">",
"      Urbach DR, Rotstein OD. Typhlitis. Can J Surg 1999; 42:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/3\">",
"      Katz JA, Wagner ML, Gresik MV, et al. Typhlitis. An 18-year experience and postmortem review. Cancer 1990; 65:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/4\">",
"      Wagner ML, Rosenberg HS, Fernbach DJ, Singleton EB. Typhlitis: a complication of leukemia in childhood. Am J Roentgenol Radium Ther Nucl Med 1970; 109:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/5\">",
"      Pestalozzi BC, Sotos GA, Choyke PL, et al. Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer. Cancer 1993; 71:1797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/6\">",
"      Quigley MM, Bethel K, Nowacki M, et al. Neutropenic enterocolitis: a rare presenting complication of acute leukemia. Am J Hematol 2001; 66:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/7\">",
"      Cunningham SC, Fakhry K, Bass BL, Napolitano LM. Neutropenic enterocolitis in adults: case series and review of the literature. Dig Dis Sci 2005; 50:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/8\">",
"      Bremer CT, Monahan BP. Necrotizing enterocolitis in neutropenia and chemotherapy: a clinical update and old lessons relearned. Curr Gastroenterol Rep 2006; 8:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/9\">",
"      Davila ML. Neutropenic enterocolitis. Curr Opin Gastroenterol 2006; 22:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/10\">",
"      Moran H, Yaniv I, Ashkenazi S, et al. Risk factors for typhlitis in pediatric patients with cancer. J Pediatr Hematol Oncol 2009; 31:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/11\">",
"      Sobel J, Mixter CG, Kolhe P, et al. Necrotizing enterocolitis associated with clostridium perfringens type A in previously healthy north american adults. J Am Coll Surg 2005; 201:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/12\">",
"      Wade DS, Nava HR, Douglass HO Jr. Neutropenic enterocolitis. Clinical diagnosis and treatment. Cancer 1992; 69:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/13\">",
"      Aksoy DY, Tanriover MD, Uzun O, et al. Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis. Ann Oncol 2007; 18:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/14\">",
"      Schnoll-Sussman F, Kurtz RC. Gastrointestinal emergencies in the critically ill cancer patient. Semin Oncol 2000; 27:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/15\">",
"      Sloas MM, Flynn PM, Kaste SC, Patrick CC. Typhlitis in children with cancer: a 30-year experience. Clin Infect Dis 1993; 17:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/16\">",
"      de Brito D, Barton E, Spears KL, et al. Acute right lower quadrant pain in a patient with leukemia. Ann Emerg Med 1998; 32:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/17\">",
"      Kirkpatrick ID, Greenberg HM. Gastrointestinal complications in the neutropenic patient: characterization and differentiation with abdominal CT. Radiology 2003; 226:668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/18\">",
"      Cronin CG, O'Connor M, Lohan DG, et al. Imaging of the gastrointestinal complications of systemic chemotherapy. Clin Radiol 2009; 64:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/19\">",
"      Wallace J, Schwaitzberg S, Miller K. Sometimes it really is appendicitis: case of a CML patient with acute appendicitis. Ann Hematol 1998; 77:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/20\">",
"      Kaste SC, Flynn PM, Furman WL. Acute lymphoblastic leukemia presenting with typhlitis. Med Pediatr Oncol 1997; 28:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/21\">",
"      Dworkin B, Winawer SJ, Lightdale CJ. Typhlitis. Report of a case with long-term survival and a review of the recent literature. Dig Dis Sci 1981; 26:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/22\">",
"      Musher DR, Amorosi EL, Gouge T, et al. Neutropenic typhlitis simulating carcinoma of the cecum. Gastrointest Endosc 1989; 35:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/23\">",
"      Mullassery D, Bader A, Battersby AJ, et al. Diagnosis, incidence, and outcomes of suspected typhlitis in oncology patients--experience in a tertiary pediatric surgical center in the United Kingdom. J Pediatr Surg 2009; 44:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/24\">",
"      Cloutier RL. Neutropenic enterocolitis. Hematol Oncol Clin North Am 2010; 24:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/25\">",
"      Kouroussis C, Samonis G, Androulakis N, et al. Successful conservative treatment of neutropenic enterocolitis complicating taxane-based chemotherapy: a report of five cases. Am J Clin Oncol 2000; 23:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27125/abstract/26\">",
"      O'Brien S, Kantarjian HM, Anaissie E, et al. Successful medical management of neutropenic enterocolitis in adults with acute leukemia. South Med J 1987; 80:1233.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2690 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-95F309B6B5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27125=[""].join("\n");
var outline_f26_31_27125=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H469422553\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RISK FACTORS AND INCIDENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H469422553\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/2690\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2690|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?42/32/43535\" title=\"algorithm 1\">",
"      Typhlitis management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/2690|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/41/37520\" title=\"diagnostic image 1\">",
"      Typhlitis pneumatosis KUB",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/23/42362?source=related_link\">",
"      Enterotoxicity of chemotherapeutic agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/53/14168?source=related_link\">",
"      Overview of the complications of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/18/28970?source=related_link\">",
"      Treatment and prevention of invasive aspergillosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/13/29914?source=related_link\">",
"      Treatment of candidemia and invasive candidiasis in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27126="Flexible bronchoscopy balloon dilation";
var content_f26_31_27126=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Flexible bronchoscopy balloon dilation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27126/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27126/contributors\">",
"     Henri G Colt, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27126/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27126/contributors\">",
"     Praveen N Mathur, MB, BS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27126/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27126/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/31/27126/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Benign tracheobronchial stenosis of the proximal airways can result from a variety of conditions and can cause dyspnea, cough, wheeze, stridor, or recurrent pulmonary infections. A variety of modalities may be used to manage benign airway strictures, but none is documented to be uniformly effective [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. The technique of flexible balloon dilation for treating benign airway strictures (bronchoplasty) will be reviewed here. Other techniques for treating these lesions are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The successful use of a balloon to dilate a benign airway stricture was first reported in an 18-week infant with a post-surgical stricture [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/6\">",
"     6",
"    </a>",
"    ]. Several uses of the technique were reported in the following years for strictures related to prolonged intubation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/7\">",
"     7",
"    </a>",
"    ], sleeve resection with bronchial reimplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/8\">",
"     8",
"    </a>",
"    ], endobronchial granuloma due to an aspirated pill fragment, and recurrent squamous cell carcinoma following radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These initial reports utilized fluoroscopy or rigid bronchoscopy to guide the dilation procedure. Flexible bronchoscopy with balloon dilation was not described until 1991 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/10\">",
"     10",
"    </a>",
"    ], and since that time relatively few reports with small numbers of patients have been published [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/11-19\">",
"     11-19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY OF STRICTURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subacute airway compromise results most commonly as a complication of bronchogenic carcinoma, but balloon dilation provides only limited palliation in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/20\">",
"     20",
"    </a>",
"    ]. However, the technique is useful in the treatment of benign strictures due to a number of conditions, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sequelae of long-term endotracheal intubation or tracheotomy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Bronchial reimplantation after sleeve lobectomy for lung cancer",
"     </li>",
"     <li>",
"      Anastomosis of transplanted lungs (with and without prior dehiscence [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/15\">",
"       15",
"      </a>",
"      ])",
"     </li>",
"     <li>",
"      Granulomatous disease (eg, tuberculosis, sarcoidosis, berylliosis, granulomatosis with polyangiitis [formerly called Wegener's granulomatosis])",
"     </li>",
"     <li>",
"      Trauma",
"     </li>",
"     <li>",
"      Smoke inhalation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In infants, prolonged intubation, tracheotomy, and congenital lesions are the primary causes for stenosis and result most commonly in subglottic or tracheal lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/21\">",
"     21",
"    </a>",
"    ]. In contrast, the etiologies in adults are more variable, and the mainstem or lobar bronchi are most commonly involved [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/9,18,20\">",
"     9,18,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathophysiology of stricture formation is best appreciated in the case of tuberculosis. Pathologically, the process progresses through three stages: submucosal infiltration by granulomas and lymphocytes; ulceration and growth of submucosal granulation tissue; and development of a fibrous scar as healing occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/22-27\">",
"     22-27",
"    </a>",
"    ]. Other causes of stricture also result ultimately in fibrotic scarification of the airways but may be due to other inciting mechanisms. As an example, fibrotic anastomotic airway stenosis may occur in lung transplant recipients from either airway rejection or ischemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no prospective controlled studies comparing the various treatment modalities for tracheobronchial stenosis; thus, the clinician's experience with and preference for a particular modality have guided selection. Several factors must be present if bronchoscopic balloon dilation is to be performed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient should have symptomatic airway stenosis.",
"     </li>",
"     <li>",
"      The patient should be able to tolerate flexible bronchoscopy (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"       \"Flexible bronchoscopy: Indications and contraindications\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The bronchoscopist should be familiar with the technique of bronchoscopic balloon dilation and also should be capable of using other modalities, if necessary, in combination with or instead of bronchoscopic balloon dilation.",
"     </li>",
"     <li>",
"      The stenosis should be amenable to balloon dilation. Tracheal stenoses generally are treated by alternative means, or by a combination of therapies, which may include balloon dilation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The suitability of a lesion for balloon dilation is influenced by the underlying process causing the stenosis. The procedure is more successful in fibrotic lesions than those secondary to malacia, inflammation, calcification, or carcinoma. Dumon has classified acquired benign stenosis into either concentric or bottleneck types; the latter is accompanied by \"hourglass\" collapse of the bronchial wall due to the loss of supporting cartilage and is less responsive to dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/28\">",
"     28",
"    </a>",
"    ]. The presence of pale nonedematous mucosa at the stricture is more typical of a noninflammatory fibrotic lesion and is predictive of greater response to dilation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Medical treatment of the underlying cause of the stricture (if available) should be maximized prior to attempts at dilation. As examples, local treatment of patients with strictures secondary to tuberculosis should not be attempted until adequate antimicrobial treatment is documented, and patients with sarcoidosis should first be treated with appropriate doses of immunosuppressive medications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Absolute contraindications to flexible bronchoscopic balloon dilation are similar to those for flexible bronchoscopy (",
"    <a class=\"graphic graphic_table graphicRef79205 \" href=\"UTD.htm?18/7/18555\">",
"     table 1",
"    </a>",
"    ). However, because the procedure requires the passage of a guidewire beyond the stenosis, balloon dilation also is contraindicated when there is nonvisualization beyond the lesion or an absence of a usable channel through the narrowed airway segment. Intubation and mechanical ventilation do not contraindicate the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/15,21,29\">",
"     15,21,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bronchoscopic balloon dilation is a simple, nontraumatic, rapid method to dilate a stenosis and restore adequate airflow. It may be used in combination with other techniques such as surgery, laser resection, bougie dilation, cryotherapy, or electrocautery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Balloon dilation is performed via the flexible bronchoscope with topical anesthesia and conscious sedation. Preoperative patient evaluation and monitoring considerations are identical to those utilized for diagnostic bronchoscopy. However, balloon dilation is a longer procedure than routine diagnostic bronchoscopy, and maintenance of the proper levels of sedation and topical anesthesia may require repetitive administration of medications until dilation is completed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After adequate topical anesthesia and conscious sedation are obtained, a bronchoscope with a 2.0 mm or 2.2 mm channel is passed orally or nasally. A thorough inspection of the airways is undertaken and the stenosis is identified. If the stenosis appears amenable to balloon dilation, a 0.89 mm diameter guidewire (Cook Incorporated, Bloomington, IN) is passed through the working channel of the bronchoscope and advanced beyond the stenosis. This procedure should be monitored fluoroscopically to avoid creating coils or sharp bends or extending the wire into the lung periphery. After adequate guidewire positioning is obtained, the bronchoscope is removed and the guidewire is left in place.",
"   </p>",
"   <p>",
"    Next, a balloon catheter (Rigiflex OTW, Boston Scientific Corporation, Watertown, MA) is selected based upon the length and diameter of the stenosis and the desired post-procedure dimensions. Visualization of the stenosis, along with analysis of prior radiographic studies, allows one to approximate the length and diameter of the stenosis and to choose an appropriate balloon size:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The balloon should protrude enough beyond each end of the stenosis so that dilation of the entire lesion will occur upon balloon inflation. Damage to uninvolved airways may result if the balloon extends too far distally, but if the balloon does not extend distally enough it tends to slip out of the stenosis upon inflation. A 2.5 to 4.0 cm long balloon is usually adequate.",
"     </li>",
"     <li>",
"      The diameter of the inflated balloon needs to be larger than the lesion for dilation to occur, but should not be so large that excessive airway injury results. Because an ineffective balloon can always be replaced by a larger one, one should start with a relatively small diameter balloon (eg, 1.0 to 1.5 cm) and substitute progressively larger balloons as needed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When a balloon has been selected, it is passed over the guidewire (which is no longer within the bronchoscope) under fluoroscopic guidance. Some balloons have radiopaque markers at the proximal and distal ends so that they can be properly located with respect to the stenosis. The bronchoscope is then reinserted (preferably through a different route than the guidewire) to allow direct visualization of the balloon during inflation. The balloon is inflated with water to pressures between 45 psi and 131 psi, based on the characteristics of the particular balloon, using a basic inflation syringe (Merit Medical Systems, Inc., Salt Lake City, UT). The balloon is kept inflated for approximately one to two minutes depending upon patient tolerance. Inflation times may need to be kept short initially, but usually can be increased as progressive dilation occurs (",
"    <a class=\"graphic graphic_picture graphicRef70533 \" href=\"UTD.htm?15/2/15407\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Repeated inflations can be performed with the same balloon if the result is inadequate, or a longer or wider balloon may be exchanged over the guidewire. Since the catheter is not placed through the working channel of the bronchoscope, it is not limited in size by the diameter of the channel. More than one stenosis may be dilated during a single session, and adjunctive treatment, such as with lasers, electrocautery, cryotherapy, or stents, may follow or precede balloon dilation.",
"   </p>",
"   <p>",
"    Immediate success is defined based upon an increased airway diameter after balloon deflation. We perform a follow-up flexible bronchoscopy approximately two weeks after the procedure only if the patient's signs and symptoms are suggestive of a significant residual stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general complications associated with flexible bronchoscopy are detailed elsewhere (",
"    <a class=\"graphic graphic_table graphicRef50348 \" href=\"UTD.htm?17/19/17724\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=see_link\">",
"     \"Flexible bronchoscopy: Indications and contraindications\"",
"    </a>",
"    .) In addition, chest pain during balloon inflation and periprocedural bronchospasm or atelectasis have been described by several authors [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/21,29,30\">",
"     21,29,30",
"    </a>",
"    ]. Excessive balloon inflation may lacerate or rupture the airway, theoretically producing hemorrhage, pneumothorax, pneumomediastinum, or mediastinitis, but these complications have not been reported. Similarly, no reported deaths have been attributed to balloon dilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several case series of bronchoscopic balloon dilation in adults have been reported, but these have been small and have had inconsistent lengths of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/8-10,13,15-18,31\">",
"     8-10,13,15-18,31",
"    </a>",
"    ]. The largest series involved 19 stenoses in 16 patients with varying conditions: 10 patients were lung transplant recipients, four underwent bronchial reimplantation, one received radiation therapy, and one suffered from granulomatosis with polyangiitis (formerly called Wegener's granulomatosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/18\">",
"     18",
"    </a>",
"    ]. Initial clinical success was achieved in 13 of 19 bronchial stenoses; six dilations were unsuccessful because stenoses were caused by localized bronchomalacia. Of the initial 13 successes, seven stenoses recurred but were redilated with success in four cases. Improvement in both respiratory status and appearance by bronchoscopy was seen in 9 of 13 patients with fibrous stenoses at a mean follow-up of 22 months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMPARISON WITH OTHER DILATIONAL TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Flexible bronchoscopic balloon dilation is effective in some cases of benign fibrotic bronchial stenosis. The procedure is minimally invasive, safe, rapid, and does not require general anesthesia. However, multiple dilations may need to be performed in order to maintain a satisfactory result, and only fibrous stenoses can be reliably improved with balloon dilation alone.",
"   </p>",
"   <p>",
"    Other options for the treatment of tracheobronchial stenoses include:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Surgical resection or repair of the stenotic segment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical treatment of the stenotic segment is technically feasible in most patients, but is controversial due to the risk of the procedure and the high rate of recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=see_link\">",
"     \"Diagnosis and management of central airway obstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Mechanical dilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical dilation of a stenosis can be performed using rigid bronchoscopy and a series of metal bougies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/33/37394?source=see_link\">",
"     \"Rigid bronchoscopy: Instrumentation\"",
"    </a>",
"    .) This approach is not commonly used because general anesthesia is required and a high recurrence rate has been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Laser bronchoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nd:YAG laser photocoagulation has been used alone or with balloon dilation. Laser resections are technically difficult and, when used for benign strictures, present a risk of bronchial perforation",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/9,35\">",
"     9,35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/47/38645?source=see_link\">",
"     \"Bronchoscopic laser resection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Airway stents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway stents generally are more effective than balloon dilation when tracheo- or bronchomalacia is present. However, their use in the treatment of fibrotic strictures is less well defined. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34823?source=see_link\">",
"     \"Airway stents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Endobronchial cryotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endobronchial cryotherapy in conjunction with balloon dilation has been used in two cases of benign airway stenoses with success [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/31,36\">",
"     31,36",
"    </a>",
"    ]. However, an airway stent is usually needed to support the airway if there is damage to cartilage in the trachea or bronchi resulting in bronchomalacia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27126/abstract/16,31\">",
"     16,31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/13/10453?source=see_link\">",
"     \"Bronchoscopic cryosurgery: Principles and technique\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Flexible bronchoscopic balloon dilation (bronchoplasty) is a useful therapeutic modality for patients with benign fibrotic bronchial stenosis, such as those caused by long-term endotracheal intubation or tracheotomy, bronchial reimplantation after sleeve lobectomy for lung cancer, anastomosis of transplanted lungs, granulomatous disease, trauma, and smoke inhalation. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology of strictures'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Several factors must be present if bronchoscopic balloon dilation is to be performed: the patient should have symptomatic airway stenosis, the stenosis should be amenable to balloon dilation, the patient should be able to tolerate flexible bronchoscopy, and the bronchoscopist should be familiar with the technique of bronchoscopic balloon dilation and should be capable of using other modalities in combination with or instead of bronchoscopic balloon dilation if necessary. Medical treatment of the underlying cause of the stricture should be maximized prior to attempts at dilation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Contraindications to flexible bronchoscopic balloon dilation are similar to those for flexible bronchoscopy. However, because the procedure requires the passage of a guidewire beyond the stenosis, balloon dilation is also contraindicated when there is nonvisualization beyond the lesion or an absence of a usable channel through the narrowed airway segment. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The procedure is minimally invasive, safe, rapid, and does not require general anesthesia. Multiple dilations may need to be performed in order to maintain a satisfactory result, and only fibrous, web-like stenoses can be reliably improved with balloon dilation alone. If the cartilage has been compromised, a stent is needed to support the airway. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The complications of flexible bronchoscopic balloon dilation are similar to those for flexible bronchoscopy. In addition, chest pain during balloon inflation, periprocedural bronchospasm, and periprocedural atelectasis have been described. Excessive balloon inflation may lacerate or rupture the airway. No deaths have been attributed to balloon dilation. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Other options for the treatment of tracheobronchial stenoses include surgical resection or repair, mechanical dilation, laser bronchoscopy, stenting, and cryotherapy. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Comparison with other dilational techniques'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/1\">",
"      Bolliger CT, Mathur PN, Beamis JF, et al. ERS/ATS statement on interventional pulmonology. European Respiratory Society/American Thoracic Society. Eur Respir J 2002; 19:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/2\">",
"      Ernst A, Silvestri GA, Johnstone D, American College of Chest Physicians. Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians. Chest 2003; 123:1693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/3\">",
"      Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care Med 2004; 169:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/4\">",
"      Mehta AC, Harris RJ, De Boer GE. Endoscopic management of benign airway stenosis. Clin Chest Med 1995; 16:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/5\">",
"      Prakash UB. Advances in bronchoscopic procedures. Chest 1999; 116:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/6\">",
"      Cohen MD, Weber TR, Rao CC. Balloon dilatation of tracheal and bronchial stenosis. AJR Am J Roentgenol 1984; 142:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/7\">",
"      Groff DB, Allen JK. Gruentzig balloon catheter dilation for acquired bronchial stenosis in an infant. Ann Thorac Surg 1985; 39:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/8\">",
"      Fowler CL, Aaland MO, Harris FL. Dilatation of bronchial stenosis with Gruentzig balloon. J Thorac Cardiovasc Surg 1987; 93:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/9\">",
"      Carlin, BW, Harrell, II JH, Moser, KM. The treatment of endobronchial stenosis using balloon catheter dilation. Chest 1988; 93:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/10\">",
"      Nakamura K, Terada N, Ohi M, et al. Tuberculous bronchial stenosis: treatment with balloon bronchoplasty. AJR Am J Roentgenol 1991; 157:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/11\">",
"      Hautmann H, Gamarra F, Pfeifer KJ, Huber RM. Fiberoptic bronchoscopic balloon dilatation in malignant tracheobronchial disease: indications and results. Chest 2001; 120:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/12\">",
"      Noppen M, Schlesser M, Meysman M, et al. Bronchoscopic balloon dilatation in the combined management of postintubation stenosis of the trachea in adults. Chest 1997; 112:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/13\">",
"      Girard P, Baldeyrou P, Lemoine G, Grunewald D. Left main-stem bronchial stenosis complicating bronchial artery embolization. Chest 1990; 97:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/14\">",
"      Ball JB, Delaney JC, Evans CC, et al. Endoscopic bougie and balloon dilatation of multiple bronchial stenoses: 10 year follow up. Thorax 1991; 46:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/15\">",
"      Keller C, Frost A. Fiberoptic bronchoplasty. Description of a simple adjunct technique for the management of bronchial stenosis following lung transplantation. Chest 1992; 102:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/16\">",
"      Carr&eacute; P, Rousseau H, Lombart L, et al. Balloon dilatation and self-expanding metal Wallstent insertion. For management of bronchostenosis following lung transplantation. The Toulouse Lung Transplantation Group. Chest 1994; 105:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/17\">",
"      Fouty BW, Pomeranz M, Thigpen TP, Martin RJ. Dilatation of bronchial stenoses due to sarcoidosis using a flexible fiberoptic bronchoscope. Chest 1994; 106:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/18\">",
"      Ferretti G, Jouvan FB, Thony F, et al. Benign noninflammatory bronchial stenosis: treatment with balloon dilation. Radiology 1995; 196:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/19\">",
"      Mayse ML, Greenheck J, Friedman M, Kovitz KL. Successful bronchoscopic balloon dilation of nonmalignant tracheobronchial obstruction without fluoroscopy. Chest 2004; 126:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/20\">",
"      Vansteenkiste JF, Lacquet LM. Possibilities and indications for Nd-YAG laser and dilation therapy in the management of tracheal stenosis. Acta Otorhinolaryngol Belg 1995; 49:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/21\">",
"      Brown SB, Hedlund GL, Glasier CM, et al. Tracheobronchial stenosis in infants: successful balloon dilation therapy. Radiology 1987; 164:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/22\">",
"      Wilson, NJ. Bronchoscopic observations in tuberculous tracheobronchitis: Clinical and pathological correlation. Dis Chest 1945; 11:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/23\">",
"      Bugher, JC, Littig, J, Culp, J. Tuberculous tracheobronchitis: Its pathogenesis. Am J Med Sci 1937; 193:515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/24\">",
"      AUERBACH O. Tuberculosis of the trachea and major bronchi. Am Rev Tuberc 1949; 60:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/25\">",
"      Eloesser, L. Bronchial stenosis in pulmonary tuberculosis with some notes on tuberculous stenosis of the trachea and the bronchioles. Am Rev Tuberc 1934; 30:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/26\">",
"      Salkin, D Cadden, AV, Edson, RC. The natural history of tuberculous tracheobronchitis. Am Rev Tuberc 1943; 47:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/27\">",
"      JUDD AR. Tuberculous tracheobronchitis; a study of 500 consecutive cases. J Thorac Surg 1947; 16:512.",
"     </a>",
"    </li>",
"    <li>",
"     Dumon JF. YAG Laser bronchoscopy, Praeger Publishers, New York 1985. p.117.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/29\">",
"      Elkerbout SC, van Lingen RA, Gerritsen J, Roorda RJ. Endoscopic balloon dilatation of acquired airway stenosis in newborn infants: a promising treatment. Arch Dis Child 1993; 68:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/30\">",
"      Hebra A, Powell DD, Smith CD, Othersen HB Jr. Balloon tracheoplasty in children: results of a 15-year experience. J Pediatr Surg 1991; 26:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/31\">",
"      Sheski FD, Mathur PN. Long-term results of fiberoptic bronchoscopic balloon dilation in the management of benign tracheobronchial stenosis. Chest 1998; 114:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/32\">",
"      Grillo HC, Mathisen DJ. Surgical management of tracheal strictures. Surg Clin North Am 1988; 68:511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/33\">",
"      Iles PB. Multiple bronchial stenoses: treatment by mechanical dilatation. Thorax 1981; 36:784.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/34\">",
"      Mehta AC, Lee FY, Cordasco EM, et al. Concentric tracheal and subglottic stenosis. Management using the Nd-YAG laser for mucosal sparing followed by gentle dilatation. Chest 1993; 104:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/35\">",
"      Dumon JF, Reboud E, Garbe L, et al. Treatment of tracheobronchial lesions by laser photoresection. Chest 1982; 81:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27126/abstract/36\">",
"      Mathur PN, Wolf KM, Busk MF, et al. Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction. Chest 1996; 110:718.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4402 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-FA3CAE7412-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27126=[""].join("\n");
var outline_f26_31_27126=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY OF STRICTURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMPARISON WITH OTHER DILATIONAL TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Surgical resection or repair of the stenotic segment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Mechanical dilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Laser bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Airway stents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Endobronchial cryotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/4402\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4402|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/2/15407\" title=\"picture 1\">",
"      Balloon dilation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/4402|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/7/18555\" title=\"table 1\">",
"      Contraindications bronchoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/19/17724\" title=\"table 2\">",
"      Complications of bronchoscopy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/0/34823?source=related_link\">",
"      Airway stents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/13/10453?source=related_link\">",
"      Bronchoscopic cryosurgery: Principles and technique",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/47/38645?source=related_link\">",
"      Bronchoscopic laser resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37351?source=related_link\">",
"      Diagnosis and management of central airway obstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=related_link\">",
"      Flexible bronchoscopy: Equipment, procedure, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/15/38135?source=related_link\">",
"      Flexible bronchoscopy: Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/33/37394?source=related_link\">",
"      Rigid bronchoscopy: Instrumentation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27127="Permissive hypercapnia";
var content_f26_31_27127=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Permissive hypercapnia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Robert C Hyzy, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Jorge Hidalgo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27127/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/31/27127/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 30, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mechanical ventilation was traditionally applied with the aim of normalizing blood gas values, particularly the arterial carbon dioxide tension (PaCO",
"    <sub>",
"     2",
"    </sub>",
"    ). However, this is no longer the primary goal of mechanical ventilation. The emphasis is now on maintaining adequate gas exchange while minimizing the risks of mechanical ventilation.",
"   </p>",
"   <p>",
"    Examples of strategies to reduce the risk of mechanical ventilation include (1) low tidal volume ventilation to protect the lung from ventilator-associated lung injury in patients with acute lung injury and (2) reduction of the tidal volume, respiratory rate, or both to minimize intrinsic positive end-expiratory pressure (ie, auto-PEEP) in patients with obstructive lung disease, thereby protecting the lung from barotrauma. Both strategies may result in hypercapnia. Acceptance of the hypercapnia and continuation of the ventilation strategy is called permissive hypercapnia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/1\">",
"     1",
"    </a>",
"    ]. Permissive hypercapnia is supported by the observation that hypercapnia is well tolerated and may be advantageous to patients with pulmonary disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Typical clinical situations in which permissive hypercapnia may be used are reviewed here, as well as the contraindications, technique, benefits, and potential harms. The use of permissive hypercapnia in patients with acute respiratory distress syndrome and asthma is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=see_link\">",
"     \"Mechanical ventilation in acute respiratory distress syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10535?source=see_link\">",
"     \"Invasive mechanical ventilation in adults with acute exacerbations of asthma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30730058\">",
"    <span class=\"h1\">",
"     CLINICAL SCENARIOS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are certain clinical settings in which hypercapnia is likely to occur as a consequence of the ventilation strategy and, therefore, the decision about whether to adopt permissive hypercapnia must be made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ALI or ARDS &ndash; Low tidal volume ventilation improves important clinical outcomes in patients with ARDS. The respiratory rate is routinely increased during low tidal volume ventilation in an effort to maintain adequate minute ventilation. However, the increased respiratory rate may be insufficient to compensate for the low tidal volumes and hypercapnia may develop. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=see_link&amp;anchor=H2#H2\">",
"       \"Mechanical ventilation in acute respiratory distress syndrome\", section on 'Low tidal volume ventilation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Asthma or COPD &ndash; Widespread bronchoconstriction reduces expiratory airflow during an asthma or COPD exacerbation. This increases the likelihood that inspiration will be initiated prior to the completion of expiration, creating intrinsic positive end-expiratory pressure (ie, auto-PEEP). In this situation, the ventilator should be adjusted to facilitate the completion of expiration. This may be accomplished by increasing the inspiratory flow rate, decreasing the tidal volume, or decreasing the respiratory rate. Reduction of the tidal volume or respiratory rate may result in hypercapnia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10535?source=see_link\">",
"       \"Invasive mechanical ventilation in adults with acute exacerbations of asthma\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30663?source=see_link&amp;anchor=H9#H9\">",
"       \"Positive end-expiratory pressure (PEEP)\", section on 'Auto (intrinsic) PEEP'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30730070\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Permissive hypercapnia is safe for most patients. However, there are some patients in whom hypercapnia is potentially harmful and, therefore, permissive hypercapnia is contraindicated.",
"   </p>",
"   <p>",
"    Hypercapnia is contraindicated in some patients who have cerebral disease (eg, mass lesions, trauma, and cerebral edema) or a seizure disorder for several reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"     3",
"    </a>",
"    ]. First, hypercapnia is associated with cerebral vasodilatation, which increases cerebral blood flow and may cause an increase in the intracranial pressure. In patients with significant neurological injuries, a high intracranial pressure may cause a prohibitive reduction in cerebral perfusion pressure. Second, intraventricular hemorrhages have been associated with hypercapnia in neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Finally, it is believed that hypercapnia may lower the seizure threshold.",
"   </p>",
"   <p>",
"    The cerebral risks associated with hypercapnia are largely theoretical, with a paucity of supportive empirical evidence. In a prospective cohort study that followed low birth weight infants (a population at high risk for brain injury and cerebral hemorrhage) managed with permissive hypercapnia, there was no evidence of increased brain impairment when assessed two to three years later [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are additional circumstances in which hypercapnia may be harmful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with coronary artery disease, heart failure, cardiac arrhythmias, or pulmonary hypertension with right ventricular dysfunction &ndash; Hypercapnia increases sympathomimetic output, which leads to short-lived physiological alterations that may be poorly tolerated by patients who have cardiac disease. These effects are discussed in greater detail below. (See",
"      <a class=\"local\" href=\"#H9738426\">",
"       'Cardiovascular'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Patients taking beta blockers &ndash; Hypercapnia has negative inotropic effects and, theoretically, beta blockers could impair compensation for these effects [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Hypovolemia &ndash; Hypercapnia can induce systemic vasodilation, predisposing patients to hypotension (especially those who are hypovolemic) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/5\">",
"       5",
"      </a>",
"      ]. Hypovolemia should be corrected prior to the initiation of ventilatory strategies that may cause hypercapnia.",
"     </li>",
"     <li>",
"      Gastrointestinal bleeding &ndash; Hypercapnia increased gastric hydrogen ion secretion in animal studies, suggesting that the incidence or severity of gastrointestinal bleeding could increase during PHV [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30730169\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The arterial carbon dioxide tension (PaCO",
"    <sub>",
"     2",
"    </sub>",
"    ) should rise gradually during mechanical ventilation rather than rapidly, preferably at a rate of &lt;10 mmHg per hour [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"     3",
"    </a>",
"    ]. The rise should be even slower if the PaCO",
"    <sub>",
"     2",
"    </sub>",
"    exceeds 80 mmHg.",
"   </p>",
"   <p>",
"    There is no consensus about whether the acidemia that accompanies hypercapnia should be corrected.",
"   </p>",
"   <p>",
"    Arguing for correction, most of the trials that found clinical benefits associated with low tidal volume ventilation corrected acidemia using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Arguing against correction, (1) hypercapnic acidosis may have beneficial effects that are independent of the low tidal volume or respiratory rate that caused them [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/7-10\">",
"     7-10",
"    </a>",
"    ], (2) the carbon dioxide that is generated by the buffering of protons can worsen the hypercapnia and transiently worsen intracellular acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"     3",
"    </a>",
"    ], and (3) a large elevation in the plasma bicarbonate concentration is required to produce a modest improvement in the acidemia. As an example, the plasma bicarbonate concentration has to increase from 29 to 41",
"    <span class=\"nowrap\">",
"     mEq/L",
"    </span>",
"    in order to change the arterial pH from 7.00 to 7.15, assuming a PaCO",
"    <sub>",
"     2",
"    </sub>",
"    of 120 mmHg. These pitfalls may be avoided by using Carbicarb (an equimolar mixture of sodium carbonate and bicarbonate) or THAM (tris-hydroxymethyl aminomethane,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/29/43475?source=see_link\">",
"     tromethamine",
"    </a>",
"    , trometamol) because these buffers improve acidemia without producing carbon dioxide [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    Given the opposing arguments about whether to correct the acidemia, it seems reasonable to administer",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    , Carbicarb, or THAM as needed to maintain an arterial pH in the range of 7.15 to 7.20 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3,13\">",
"     3,13",
"    </a>",
"    ]. In the case of sodium bicarbonate, 100 mEq of sodium bicarbonate solution in 1 L of D5W at a rate of 75 to 100",
"    <span class=\"nowrap\">",
"     mL/hour",
"    </span>",
"    is generally sufficient to maintain an arterial pH of approximately 7.20. The pH should not be normalized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     BENEFITS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are data that suggest that permissive hypercapnia is associated with better patient-important outcomes:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A post hoc analysis of data from the ARDS Network's low tidal volume ventilation trial (ie, ARMA trial) found that hypercapnic acidosis was associated with reduced 28-day mortality in the control group, but not the low tidal volume group [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/10\">",
"       10",
"      </a>",
"      ]. These results are consistent with a protective effect of hypercapnic acidosis against ventilator-associated lung injury, although there are other reasonable interpretations of these data [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=see_link&amp;anchor=H2#H2\">",
"       \"Mechanical ventilation in acute respiratory distress syndrome\", section on 'Low tidal volume ventilation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A trial that randomly assigned surfactant-treated preterm infants to a ventilatory strategy that included permissive hypercapnia or a ventilatory strategy targeting normocapnia found that infants who received permissive hypercapnia had a shorter duration of mechanical ventilation, although there was no difference in mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In humans, it is difficult to determine whether the potential benefits associated with permissive hypercapnia are due to the low minute ventilation or the resulting hypercapnic acidosis because they generally occur together. However, in vitro cell studies and in vivo animal models suggest that hypercapnic acidosis itself may have a beneficial impact that is independent of the effect of low minute ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/7-9,16-19\">",
"     7-9,16-19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When cell cultures are subjected to hypercapnic acidic conditions, or animals develop hypercapnic acidosis by inhaling carbon dioxide, there is less hypoxemia and fewer histologic abnormalities that suggest ventilator-associated lung injury. In addition, there is decreased free protein in the bronchoalveolar fluid, less lung edema, improved pulmonary compliance, decreased inflammation, diminished free radical production, and less histologic evidence of diffuse alveolar damage [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/20-27\">",
"       20-27",
"      </a>",
"      ]. It is unknown whether these effects of hypercapnic acidosis are due primarily to the hypercapnia or the acidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/18\">",
"       18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a dog model, progressive lowering of the minute ventilation with resultant hypercapnic acidosis was associated with a significant increase in splanchnic oxygenation [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/28\">",
"       28",
"      </a>",
"      ]. A rabbit model similarly demonstrated a reduction in lipopolysaccharide-mediated gut permeability during ventilation-induced hypercapnic acidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     POTENTIAL HARMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypercapnia is usually well tolerated if the arterial carbon dioxide tension (PaCO",
"    <sub>",
"     2",
"    </sub>",
"    ) rises slowly. Acute hypercapnia should be avoided because it is more likely to lead to the potential adverse consequences described below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9738426\">",
"    <span class=\"h2\">",
"     Cardiovascular",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several potential adverse cardiovascular consequences of hypercapnia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/5\">",
"     5",
"    </a>",
"    ]. These consequences are mediated by hyperactivity of the indirect sympathetic nervous system (ie, elevated levels of circulating epinephrine and norepinephrine derived from efferent sympathetic nerve fibers and the adrenal gland) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased heart rate and blood pressure &ndash; Significant increases in the heart rate and stroke volume elevate the cardiac output. The result is an increase in the blood pressure, which is attenuated by a simultaneous decrease in the systemic vascular resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/32\">",
"       32",
"      </a>",
"      ]. Remarkably, the increased stroke volume occurs despite the direct myocardial depressant effects of hypercapnia and intracellular acidosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/33-36\">",
"       33-36",
"      </a>",
"      ], which interfere with myofilament response to calcium [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/37\">",
"       37",
"      </a>",
"      ] and increase the oxygen cost of myocardial contraction [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Exacerbation of right heart dysfunction &ndash; Respiratory acidosis can cause pulmonary vasoconstriction, which increases the pulmonary vascular resistance. The elevated right ventricular afterload may lead to circulatory instability in patients with right heart dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/39,40\">",
"       39,40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cardiac arrhythmias &ndash; There is a theoretical potential to induce cardiac arrhythmias given the sympathetic hyperactivity [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Possible coronary artery steal &ndash; Hypercapnia results in coronary vasodilation in the normal heart, but this effect appears to be blunted in heart disease (eg, ischemic left ventricular failure [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/41\">",
"       41",
"      </a>",
"      ]). In theory, then, hypercapnia-induced coronary vasodilation may induce preferential perfusion through nondiseased coronary arteries, causing a steal phenomenon. This effect has not been confirmed in humans, but a similar response has been noted among patients with coronary artery disease following exposure to certain anesthetic agents [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/42\">",
"       42",
"      </a>",
"      ]. The clinical impact of the coronary artery steal due to anesthetic agents appears to be minimal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12583396\">",
"    <span class=\"h2\">",
"     Neurological",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute hypercapnia may also have adverse effects on the central nervous system:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased intracranial pressure &ndash; Cerebral arterioles dilate in response to hypercapnia, a response largely mediated by extracellular pH [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/43,44\">",
"       43,44",
"      </a>",
"      ]. The increased cerebral blood flow leads to an increase in the cerebral blood volume, resulting in an increase in the intracranial pressure. This response is usually transient, with cerebral blood flow returning to baseline after approximately 48 hours of continued hypercapnia.",
"     </li>",
"     <li>",
"      Agitation or depressed consciousness &ndash; The effect of hypercapnia on a patient&rsquo;s mental status is variable. Most patients with acute hypercapnia are agitated, which often requires increased pharmacological sedation. Others experience depressed consciousness, which is frequently referred to as CO",
"      <sub>",
"       2",
"      </sub>",
"      narcosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/45-47\">",
"       45-47",
"      </a>",
"      ]. Some patients are only minimally affected, remaining fully alert despite PaCO",
"      <sub>",
"       2",
"      </sub>",
"      levels that exceed 100 mm Hg [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/48,49\">",
"       48,49",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decreased seizure threshold &ndash; Seizure activity may occur at extreme levels of hypercapnia [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/50,51\">",
"       50,51",
"      </a>",
"      ], but it is unknown whether less severe acute hypercapnia may lead to seizures in those with a preexisting seizure disorder or another type of brain injury.",
"     </li>",
"     <li>",
"      Cerebral artery steal &ndash; A cerebral steal phenomenon, similar to the coronary artery steal described above, may occur in some settings [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/52\">",
"       52",
"      </a>",
"      ], although its clinical importance is unknown.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Pulmonary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adverse pulmonary consequences of hypercapnia include hypoxemia and exacerbation of lung injury:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Alveolar hypoventilation can induce hypoxemia or worsen the hypoxemia caused by the underlying lung disease [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/53,54\">",
"       53,54",
"      </a>",
"      ]. Intrinsic compensatory mechanisms exist that mitigate the impact of the hypoxemia; most importantly, hypercapnia increases the cardiac output and shifts the oxyhemoglobin dissociation curve to the right. The former keeps the oxygen delivery stable, while the latter promotes oxygen release to the tissues [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/54,55\">",
"       54,55",
"      </a>",
"      ]. The hypoxemia is managed by administering supplemental oxygen and extrinsic positive end-expiratory pressure (ie, applied PEEP) (",
"      <a class=\"graphic graphic_figure graphicRef68240 \" href=\"UTD.htm?8/16/8462\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/13,53\">",
"       13,53",
"      </a>",
"      ]. Applied PEEP recruits collapsed alveoli, which improves ventilation-perfusion",
"      <span class=\"nowrap\">",
"       (V/Q)",
"      </span>",
"      matching. It is most effective among patients with increased intrapulmonary shunting (eg, patients with ARDS) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/56\">",
"       56",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30663?source=see_link\">",
"       \"Positive end-expiratory pressure (PEEP)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=see_link\">",
"       \"Mechanical ventilation in acute respiratory distress syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypercapnia may worsen lung injury by reducing wound repair and increasing inflammation in injured lungs, according to animal studies [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/57,58\">",
"       57,58",
"      </a>",
"      ]. This was demonstrated using a model of E. coli pneumonia, in which hypercapnic acidosis resulted in increased bacterial numbers, impaired neutrophil phagocytic response, and increased physiologic and pathologic lung damage [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/29\">",
"       29",
"      </a>",
"      ]. The detrimental effects of hypercapnic acidosis were abrogated by the administration of antibiotics at the time of E. coli inoculation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9739213\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypercapnia causes intracellular acidosis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"     3",
"    </a>",
"    ], which inhibits contractility via actin-myosin interaction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/37\">",
"     37",
"    </a>",
"    ], interferes with neuronal electrical activity [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/59\">",
"     59",
"    </a>",
"    ], inhibits cellular division [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/60\">",
"     60",
"    </a>",
"    ], decreases glycolysis, and increases oxidative deamination (which results in amino acid depletion). Intracellular adenosine triphosphate (ATP) concentrations are less affected [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/61\">",
"     61",
"    </a>",
"    ]. The clinical importance of these responses to intracellular acidosis remains to be fully determined, but the importance is likely minor due to a variety of counter-regulatory mechanisms that are initiated in response to a decrease in intracellular pH (pHi). These mechanisms include physicochemical buffering by intracellular proteins and phosphates [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/62\">",
"     62",
"    </a>",
"    ], modifications of cellular metabolism to reduce intracellular production of hydrogen ions, and modifications of H",
"    <sup>",
"     +",
"    </sup>",
"    and HCO",
"    <sub>",
"     3",
"    </sub>",
"    <sup>",
"     -",
"    </sup>",
"    flux across the cell membrane [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/63\">",
"     63",
"    </a>",
"    ]. Physicochemical buffering is instantaneous, but the other mechanisms are delayed 1 to 3 hours after the onset of hypercapnia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. The compensatory mechanisms are very efficient, with numerous animal studies demonstrating only modest increases in pHi, even in the presence of profound respiratory acidemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27127/abstract/66,67\">",
"     66,67",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ventilatory strategies that aim to reduce the risks of mechanical ventilation frequently result in hypercapnia. Acceptance of the hypercapnia and continuation of the ventilation strategy is called permissive hypercapnia. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are certain clinical settings in which hypercapnia is likely to occur as a consequence of the ventilation strategy and, therefore, permissive hypercapnia is likely to be adopted. These include acute lung",
"      <span class=\"nowrap\">",
"       injury/acute",
"      </span>",
"      respiratory distress syndrome managed with low tidal volume ventilation and obstructive lung disease managed with a low tidal volume",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a low respiratory rate to minimize intrinsic positive end-expiratory pressure (ie, auto-PEEP). (See",
"      <a class=\"local\" href=\"#H30730058\">",
"       'Clinical scenarios'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypercapnia is contraindicated in some patients who have cerebral disease (eg, mass lesions, trauma, or cerebral edema) or a seizure disorder. In addition, there are circumstances in which hypercapnia should be avoided in light of theoretical risks. (See",
"      <a class=\"local\" href=\"#H30730070\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypercapnic acidosis should develop gradually during mechanical ventilation, rather than rapidly. Acute hypercapnia is more likely to lead to cardiovascular dysfunction, neurologic dysfunction, hypoxemia, and death. (See",
"      <a class=\"local\" href=\"#H30730169\">",
"       'Technique'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Potential harms'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who develop severe hypercapnic acidosis during permissive hypercapnia, we suggest administering a buffer to increase the pH into the range of 7.15 to 7.20 (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/52/840?source=see_link\">",
"       Sodium bicarbonate",
"      </a>",
"      , Carbicarb, and THAM are all reasonable options. (See",
"      <a class=\"local\" href=\"#H30730169\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No randomized trial has unequivocally demonstrated that permissive hypercapnia is associated with improved clinical outcomes in adults; however, there are observational data that suggest that hypercapnia may be beneficial. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Benefits'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/1\">",
"      Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150:870.",
"     </a>",
"    </li>",
"    <li>",
"     Core Topics in Mechanical Ventilation, Mackenzie I.  (Ed), Cambridge University Press, 2008. p.153.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/3\">",
"      Feihl F, Perret C. Permissive hypercapnia. How permissive should we be? Am J Respir Crit Care Med 1994; 150:1722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/4\">",
"      Hagen EW, Sadek-Badawi M, Carlton DP, Palta M. Permissive hypercapnia and risk for brain injury and developmental impairment. Pediatrics 2008; 122:e583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/5\">",
"      Kavanagh BP, Laffey JG. Hypercapnia: permissive and therapeutic. Minerva Anestesiol 2006; 72:567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/6\">",
"      Tobin MJ. Culmination of an era in research on the acute respiratory distress syndrome. N Engl J Med 2000; 342:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/7\">",
"      Laffey JG, Engelberts D, Kavanagh BP. Buffering hypercapnic acidosis worsens acute lung injury. Am J Respir Crit Care Med 2000; 161:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/8\">",
"      Laffey JG, Tanaka M, Engelberts D, et al. Therapeutic hypercapnia reduces pulmonary and systemic injury following in vivo lung reperfusion. Am J Respir Crit Care Med 2000; 162:2287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/9\">",
"      Laffey JG, Kavanagh BP. Carbon dioxide and the critically ill--too little of a good thing? Lancet 1999; 354:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/10\">",
"      Kregenow DA, Rubenfeld GD, Hudson LD, Swenson ER. Hypercapnic acidosis and mortality in acute lung injury. Crit Care Med 2006; 34:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/11\">",
"      Shapiro JI, Elkins N, Logan J, et al. Effects of sodium bicarbonate, disodium carbonate, and a sodium bicarbonate/carbonate mixture on the PCO2 of blood in a closed system. J Lab Clin Med 1995; 126:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/12\">",
"      Nahas GG, Sutin KM, Fermon C, et al. Guidelines for the treatment of acidaemia with THAM. Drugs 1998; 55:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/13\">",
"      Bidani A, Tzouanakis AE, Cardenas VJ Jr, Zwischenberger JB. Permissive hypercapnia in acute respiratory failure. JAMA 1994; 272:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/14\">",
"      Broccard AF. Respiratory acidosis and acute respiratory distress syndrome: time to trade in a bull market? Crit Care Med 2006; 34:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/15\">",
"      Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants. Pediatrics 1999; 104:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/16\">",
"      Broccard AF, Hotchkiss JR, Vannay C, et al. Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med 2001; 164:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/17\">",
"      Sinclair SE, Kregenow DA, Lamm WJ, et al. Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury. Am J Respir Crit Care Med 2002; 166:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/18\">",
"      Laffey JG, O'Croinin D, McLoughlin P, Kavanagh BP. Permissive hypercapnia--role in protective lung ventilatory strategies. Intensive Care Med 2004; 30:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/19\">",
"      Peltekova V, Engelberts D, Otulakowski G, et al. Hypercapnic acidosis in ventilator-induced lung injury. Intensive Care Med 2010; 36:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/20\">",
"      Takeshita K, Suzuki Y, Nishio K, et al. Hypercapnic acidosis attenuates endotoxin-induced nuclear factor-[kappa]B activation. Am J Respir Cell Mol Biol 2003; 29:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/21\">",
"      Laffey JG, Honan D, Hopkins N, et al. Hypercapnic acidosis attenuates endotoxin-induced acute lung injury. Am J Respir Crit Care Med 2004; 169:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/22\">",
"      Bidani A, Wang CZ, Saggi SJ, Heming TA. Evidence for pH sensitivity of tumor necrosis factor-alpha release by alveolar macrophages. Lung 1998; 176:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/23\">",
"      Serrano CV Jr, Fraticelli A, Paniccia R, et al. pH dependence of neutrophil-endothelial cell adhesion and adhesion molecule expression. Am J Physiol 1996; 271:C962.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/24\">",
"      Shibata K, Cregg N, Engelberts D, et al. Hypercapnic acidosis may attenuate acute lung injury by inhibition of endogenous xanthine oxidase. Am J Respir Crit Care Med 1998; 158:1578.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/25\">",
"      Coakley RJ, Taggart C, Greene C, et al. Ambient pCO2 modulates intracellular pH, intracellular oxidant generation, and interleukin-8 secretion in human neutrophils. J Leukoc Biol 2002; 71:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/26\">",
"      Adding LC, Agvald P, Persson MG, Gustafsson LE. Regulation of pulmonary nitric oxide by carbon dioxide is intrinsic to the lung. Acta Physiol Scand 1999; 167:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/27\">",
"      De Smet HR, Bersten AD, Barr HA, Doyle IR. Hypercapnic acidosis modulates inflammation, lung mechanics, and edema in the isolated perfused lung. J Crit Care 2007; 22:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/28\">",
"      Schwartges I, Schwarte LA, Fournell A, et al. Hypercapnia induces a concentration-dependent increase in gastric mucosal oxygenation in dogs. Intensive Care Med 2008; 34:1898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/29\">",
"      Morisaki H, Yajima S, Watanabe Y, et al. Hypercapnic acidosis minimizes endotoxin-induced gut mucosal injury in rabbits. Intensive Care Med 2009; 35:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/30\">",
"      Brofman JD, Leff AR, Munoz NM, et al. Sympathetic secretory response to hypercapnic acidosis in swine. J Appl Physiol 1990; 69:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/31\">",
"      Hoka S, Arimura H, Bosnjak ZJ, Kampine JP. Regional venous outflow, blood volume, and sympathetic nerve activity during hypercapnia and hypoxic hypercapnia. Can J Physiol Pharmacol 1992; 70:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/32\">",
"      Carvalho CR, Barbas CS, Medeiros DM, et al. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med 1997; 156:1458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/33\">",
"      Weber T, Tschernich H, Sitzwohl C, et al. Tromethamine buffer modifies the depressant effect of permissive hypercapnia on myocardial contractility in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 162:1361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/34\">",
"      Fo&euml;x P, Fordham RM. Intrinsic myocardial recovery from the negative inotropic effects of acute hypercapnia. Cardiovasc Res 1972; 6:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/35\">",
"      Tang WC, Weil MH, Gazmuri RJ, et al. Reversible impairment of myocardial contractility due to hypercarbic acidosis in the isolated perfused rat heart. Crit Care Med 1991; 19:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/36\">",
"      Walley KR, Lewis TH, Wood LD. Acute respiratory acidosis decreases left ventricular contractility but increases cardiac output in dogs. Circ Res 1990; 67:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/37\">",
"      Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990; 258:C967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/38\">",
"      Hata K, Goto Y, Kawaguchi O, et al. Hypercapnic acidosis increases oxygen cost of contractility in the dog left ventricle. Am J Physiol 1994; 266:H730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/39\">",
"      Nahurn, A, Marini, JJ. Alternatives to conventional mechanical ventilation in acute respiratory failure. Curr Pulmonol 1994; 15:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/40\">",
"      Viitanen A, Salmenper&auml; M, Heinonen J. Right ventricular response to hypercarbia after cardiac surgery. Anesthesiology 1990; 73:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/41\">",
"      Wexels JC, Mj&oslash;s OD. Effects of carbon dioxide and pH on myocardial function in dogs with acute left ventricular failure. Crit Care Med 1987; 15:1116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/42\">",
"      Pulley DD, Kirvassilis GV, Kelermenos N, et al. Regional and global myocardial circulatory and metabolic effects of isoflurane and halothane in patients with steal-prone coronary anatomy. Anesthesiology 1991; 75:756.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/43\">",
"      Lassen NA. Brain extracellular pH: the main factor controlling cerebral blood flow. Scand J Clin Lab Invest 1968; 22:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/44\">",
"      Kontos HA, Raper AJ, Patterson JL. Analysis of vasoactivity of local pH, PCO2 and bicarbonate on pial vessels. Stroke 1977; 8:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/45\">",
"      Eisele JH, Eger EI 2nd, Muallem M. Narcotic properties of carbon dioxide in the dog. Anesthesiology 1967; 28:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/46\">",
"      SIEKER HO, HICKAM JB. Carbon dioxide intoxication: the clinical syndrome, its etiology and management with particular reference to the use of mechanical respirators. Medicine (Baltimore) 1956; 35:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/47\">",
"      WESTLAKE EK, SIMPSON T, KAYE M. Carbon dioxide narcosis in emphysema. Q J Med 1955; 24:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/48\">",
"      Meissner HH, Franklin C. Extreme hypercapnia in a fully alert patient. Chest 1992; 102:1298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/49\">",
"      Caroll GC, Rothenberg DM. Carbon dioxide narcosis. Pathological or \"pathillogical\"? Chest 1992; 102:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/50\">",
"      Kacmarek R, Hickling KG. Permissive hypercapnia. Respir Care 1993; 38:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/51\">",
"      Murray JF, Matthay MA, Luce JM, Flick MR. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988; 138:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/52\">",
"      Loftus CM, Silvidi JA, Bernstein DD, Kosier T. Effects of hypercapnia on cerebral blood flow following prophylactic and delayed experimental superficial temporal artery-middle cerebral artery bypass. Surg Neurol 1989; 31:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/53\">",
"      Feihl F, Eckert P, Brimioulle S, et al. Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome. Am J Respir Crit Care Med 2000; 162:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/54\">",
"      Pfeiffer B, Hachenberg T, Wendt M, Marshall B. Mechanical ventilation with permissive hypercapnia increases intrapulmonary shunt in septic and nonseptic patients with acute respiratory distress syndrome. Crit Care Med 2002; 30:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/55\">",
"      Hassett P, Laffey JG. Permissive hypercapnia: Balancing risks and benefits in the peripheral microcirculation. Crit Care Med 2007; 35:2229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/56\">",
"      Mancini M, Zavala E, Mancebo J, et al. Mechanisms of pulmonary gas exchange improvement during a protective ventilatory strategy in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164:1448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/57\">",
"      Doerr CH, Gajic O, Berrios JC, et al. Hypercapnic acidosis impairs plasma membrane wound resealing in ventilator-injured lungs. Am J Respir Crit Care Med 2005; 171:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/58\">",
"      Lang JD, Figueroa M, Sanders KD, et al. Hypercapnia via reduced rate and tidal volume contributes to lipopolysaccharide-induced lung injury. Am J Respir Crit Care Med 2005; 171:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/59\">",
"      Moody W Jr. Effects of intracellular H+ on the electrical properties of excitable cells. Annu Rev Neurosci 1984; 7:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/60\">",
"      Madshus IH. Regulation of intracellular pH in eukaryotic cells. Biochem J 1988; 250:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/61\">",
"      Cohen Y, Chang LH, Litt L, et al. Stability of brain intracellular lactate and 31P-metabolite levels at reduced intracellular pH during prolonged hypercapnia in rats. J Cereb Blood Flow Metab 1990; 10:277.",
"     </a>",
"    </li>",
"    <li>",
"     Gennari FJ, Cohen JJ. Intracellular acid-base physiology. In: Acid/Base, Cohen JJ, Kassirer JP.  (Eds), Little, Brown, Boston 1982. p.25.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/63\">",
"      Siesj&ouml; BK, Folbergrov&aacute; J, MacMillan V. The effect of hypercapnia upon intracellular pH in the brain, evaluated by the bicarbonate-carbonic acid method and from the creatine phosphokinase equilibrium. J Neurochem 1972; 19:2483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/64\">",
"      Siesj&ouml; BK. Quantification of pH regulation in hypercapnia and hypocapnia. Scand J Clin Lab Invest 1971; 28:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/65\">",
"      Cingolani HE, Koretsune Y, Marban E. Recovery of contractility and pHi during respiratory acidosis in ferret hearts: role of Na(+)-H+ exchange. Am J Physiol 1990; 259:H843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/66\">",
"      Portman MA, Lassen NA, Cooper TG, et al. Intra- and extracellular pH of the brain in vivo studied by 31P-NMR during hyper- and hypocapnia. J Appl Physiol 1991; 71:2168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27127/abstract/67\">",
"      Barrere B, Meric P, Borredon J, et al. Cerebral intracellular pH regulation during hypercapnia in unanesthetized rats: a 31P nuclear magnetic resonance spectroscopy study. Brain Res 1990; 516:215.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1645 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-C55D250E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27127=[""].join("\n");
var outline_f26_31_27127=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30730058\">",
"      CLINICAL SCENARIOS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30730070\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30730169\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      BENEFITS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      POTENTIAL HARMS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9738426\">",
"      Cardiovascular",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12583396\">",
"      Neurological",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Pulmonary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9739213\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1645\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1645|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/16/8462\" title=\"figure 1\">",
"      Oxygen allows less ventilation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/18/10535?source=related_link\">",
"      Invasive mechanical ventilation in adults with acute exacerbations of asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/42/2730?source=related_link\">",
"      Mechanical ventilation in acute respiratory distress syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/60/30663?source=related_link\">",
"      Positive end-expiratory pressure (PEEP)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27128="Pulmonary artery catheterization: Indications and complications";
var content_f26_31_27128=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pulmonary artery catheterization: Indications and complications",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27128/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27128/contributors\">",
"     Gerald L Weinhouse, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27128/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27128/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27128/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27128/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/31/27128/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical use of invasive hemodynamic monitoring has both changed and defined the modern practice of cardiology and critical care medicine. Flow-directed pulmonary artery catheters, also called Swan-Ganz catheters, were developed in the 1970s and initially used to guide therapy following acute myocardial infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/1\">",
"     1",
"    </a>",
"    ]. Today, pulmonary artery catheterization is used in both diagnosis and management of a range of conditions in critically ill patients worldwide (",
"    <a class=\"graphic graphic_table graphicRef68139 \" href=\"UTD.htm?30/49/31516\">",
"     table 1",
"    </a>",
"    ). Despite the popularity of pulmonary artery catheterization, the effect of invasive hemodynamic monitoring on patient outcome remains controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/2-5\">",
"     2-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The generally accepted uses and most frequent complications of pulmonary artery catheters will be reviewed here. The technique of catheter insertion and interpretation of hemodynamic data are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25221?source=see_link\">",
"     \"Insertion of pulmonary artery catheters\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44199?source=see_link\">",
"     \"Pulmonary artery catheterization: Interpretation of tracings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RATIONALE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemodynamic data and other information obtained from pulmonary artery catheterization may provide diagnostic clues, guide management, and inform prognosis. Accurate placement of the catheter can be expected to yield direct measurements of central venous, right-sided intracardiac, pulmonary arterial, and pulmonary artery wedge (pulmonary capillary wedge) pressures (",
"    <a class=\"graphic graphic_figure graphicRef75601 \" href=\"UTD.htm?8/48/8965\">",
"     figure 1",
"    </a>",
"    ). Automated thermodilution techniques can be used to estimate cardiac output; other hemodynamic parameters, including systemic and pulmonary vascular resistance, can be calculated on the basis of vascular pressures and cardiac output. In addition, samples of mixed venous blood can be used to quantify oxygen utilization. Much less frequently, aspirates from a wedged catheter can be used to diagnose lymphangitic carcinomatosis, and may lend support to the diagnosis of fat embolism syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Studies supporting the use of pulmonary artery catheters emphasize the inaccuracy of clinical parameters in the hemodynamic assessment of the critically ill patient. In several reports, clinicians correctly predicted the pulmonary artery wedge pressure and the cardiac index in only 30 to 70 percent of patients in a general ICU population [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/8-11\">",
"     8-11",
"    </a>",
"    ] and 60 to 85 percent of patients in coronary care units [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/8,12,13\">",
"     8,12,13",
"    </a>",
"    ]. It has been argued that more rapid and accurate diagnosis of treatable conditions should result in improved patient outcome. This advantage should be greatest for patients in whom chronic lung disease, dilated cardiomyopathy, tricuspid valve disease, or pulmonary hypertension prevent accurate assessment of left ventricular preload on the basis of central venous pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EFFECT ON SURVIVAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of pulmonary artery catheterization on patient outcome have never been convincingly demonstrated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/3-5,14-18\">",
"     3-5,14-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Intensive care unit",
"    </span>",
"    &nbsp;&mdash;&nbsp;A widely-cited observational study published in 1996 evaluated the effect of pulmonary artery catheterization within the first 24 hours of admission to the ICU on patient survival [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/3\">",
"     3",
"    </a>",
"    ]. A statistical tool, called a propensity score, was used to adjust for treatment selection bias. Patients who underwent right heart catheterization had an increased 30-day mortality (odds ratio 1.24) compared to those who did not undergo the procedure. Subgroup analysis did not reveal any group in which right heart catheterization was associated with an improved outcome. Several possible explanations for these findings have been suggested:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The study might not have adequately adjusted for an important confounding variable, such as vasopressor use [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Use of the catheter might have been a marker for a more aggressive or invasive style of care, which could be associated with higher mortality.",
"     </li>",
"     <li>",
"      Placement of a pulmonary artery catheter might have led to worse patient outcomes because of complications or misinterpretation of the data obtained. There is a wide interobserver variability in the interpretation of hemodynamic data, even among intensive care unit clinicians and anesthesiologists [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/20-22\">",
"       20-22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other limitations included the observational design and the focus on the use of the pulmonary artery catheter during the first 24 hours, rather than later in the ICU stay. However, this study reignited a long-standing debate about the risk-to-benefit ratio of pulmonary artery catheterization and issued a renewed call for a prospective, randomized, controlled trials to examine the most appropriate use of this device [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/3,23,24\">",
"     3,23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unfortunately, attempts to perform randomized trials in the ICU setting have been hindered by the perception of ethical constraints, as many patients were excluded because the attending clinician perceived it unethical to not place the catheter [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/25\">",
"     25",
"    </a>",
"    ]. Nevertheless, randomized trials that were performed, a meta-analysis and Cochrane review found that use of a pulmonary artery catheter was not associated with any benefit in critically ill patients, did not increase overall mortality, and did not increase days in hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/14,26,27\">",
"     14,26,27",
"    </a>",
"    ]. As a result, there has been a trend toward decreased use of pulmonary artery catheters in critically ill patients in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Heart failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of pulmonary artery catheterization to guide tailored therapy in heart failure patients is an area of controversy. The randomized ESCAPE trial showed no benefit on a primary end point of the number of days alive and out of the hospital at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4743?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of refractory heart failure\", section on 'Hemodynamic monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Perioperative",
"    </span>",
"    &nbsp;&mdash;&nbsp;The routine use of pulmonary artery catheters in high-risk patients undergoing elective or emergent surgery also is controversial and of unclear benefit. A large, well-executed multicenter trial randomly assigned nearly 2000 high-risk (ASA class III or IV) patients ages 60 years or older undergoing cardiac, vascular, or orthopedic surgery to perioperative management with or without a pulmonary artery catheter (",
"    <a class=\"graphic graphic_table graphicRef78084 \" href=\"UTD.htm?9/5/9307\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients in the control group could be managed on the basis of directly measured central venous pressure and other clinical parameters.",
"   </p>",
"   <p>",
"    There were no significant differences in in-hospital mortality (7.8 versus 7.7 percent) or in one-year mortality (17 versus 16 percent) between the two groups (",
"    <a class=\"graphic graphic_figure graphicRef78324 \" href=\"UTD.htm?17/34/17965\">",
"     figure 2",
"    </a>",
"    ). The only significant difference was a higher rate of pulmonary embolism in the PAC group (0.9 versus 0 percent).",
"   </p>",
"   <p>",
"    One possible reason for these findings is the clinical value of directly measured central venous pressure as a surrogate for left ventricular filling pressures among the control group. In the absence of pulmonary hypertension or profound right ventricular dysfunction, central venous pressure provides a reasonable estimation of left ventricular filling characteristics, and can be used to rule out hypovolemia in most patients. It is also possible that this group of patients was not sick enough to benefit from routine PAC placement, based on the low overall mortality noted in this trial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the widespread use of pulmonary artery catheters in hemodynamically unstable patients, no study has definitively demonstrated improved outcome in critically ill patients managed using pulmonary artery catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/14\">",
"     14",
"    </a>",
"    ]. As a result, use of pulmonary artery catheters has decreased [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/30\">",
"     30",
"    </a>",
"    ]. Observational studies suggest that placement of a pulmonary artery catheter is more likely if the patient is severely ill, hemodynamically unstable (eg, cardiogenic shock, septic shock, use of vasoactive medications), post abdominal aortic aneurysm repair, or mechanically ventilated. Nonmedical factors (eg, insurance reimbursement, the presence of trainees, the physician&rsquo;s specialty) also appear to influence decisions regarding catheter placement [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/15-17,30-32\">",
"     15-17,30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Accepted indications for pulmonary artery catheterization have been generated largely on the basis of clinical experience [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/23\">",
"     23",
"    </a>",
"    ]. Fundamentally speaking, the decision to place a pulmonary artery catheter should be based upon a specific question regarding a patient's hemodynamic status that cannot be satisfactorily answered by clinical or noninvasive assessment. If the answer could change management, then placement of the catheter is indicated. Common indications are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef68139 \" href=\"UTD.htm?30/49/31516\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6120?source=see_link\">",
"     \"Shock in adults: Types, presentation, and diagnostic approach\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    To address the complex issues surrounding the rational use of pulmonary artery catheters, the American Thoracic Society, the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, the American College of Chest Physicians, the American Association of Critical Care Nurses, and the American College of Critical Care Medicine jointly issued recommendations in 1997 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/33\">",
"     33",
"    </a>",
"    ]. On the basis of these findings and the results of the subsequent randomized controlled trial, the following recommendations can be made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is no indication at the present time for a moratorium on the use of the pulmonary artery catheter in the ICU, and clinicians should carefully consider the clinical risks and benefits of right heart catheterization in the ICU on a patient-by-patient basis. However, there is strong evidence that the routine use of pulmonary artery catheters in older patients undergoing high-risk surgery is not associated with improved mortality [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/4\">",
"       4",
"      </a>",
"      ]. Similarly, prospective studies of medical ICU patients managed with or without PAC placement have not demonstrated any clear improvements in outcome associated with the use of this device [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/14,15,18\">",
"       14,15,18",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The decision to insert a pulmonary artery catheter should continue to be based upon the specific clinical circumstances of a given patient, and a weighing of the risks versus benefits. In the absence of severe lung disease, pulmonary hypertension, tricuspid regurgitation, or profoundly impaired right ventricular performance, monitoring central venous pressure may be adequate to rule out hypovolemia and guide fluid management.",
"     </li>",
"     <li>",
"      Clinicians overseeing catheter placement and collection of hemodynamic data should be able to assess the quality of the data and reproducibly interpret the results. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44199?source=see_link\">",
"       \"Pulmonary artery catheterization: Interpretation of tracings\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pulmonary artery catheterization should be avoided in patients with Eisenmenger Syndrome because there is a high potential for hemorrhagic or other complications. If cardiac catheterization is deemed necessary, it should be performed in a center with expertise managing pulmonary arterial hypertension related to congenital heart disease. These issues are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/20/7496?source=see_link&amp;anchor=H18#H18\">",
"     \"Medical management of Eisenmenger syndrome\", section on 'Noncardiac surgery'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6007?source=see_link\">",
"     \"Evaluation and prognosis of Eisenmenger syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three categories of complications related to the use of pulmonary artery catheters:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Those related to insertion of the introducer or the pulmonary artery catheter",
"     </li>",
"     <li>",
"      Those related to maintenance and use of the catheter",
"     </li>",
"     <li>",
"      Those related to the interpretation of hemodynamic data",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    General complications of central venous cannulation include hemorrhage, pneumothorax, and infection, and are discussed elsewhere (",
"    <a class=\"graphic graphic_table graphicRef77376 \" href=\"UTD.htm?11/30/11755\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/1/29?source=see_link\">",
"     \"Complications of central venous catheters and their prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37464?source=see_link\">",
"     \"Epidemiology, pathogenesis, and microbiology of intravascular catheter infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Insertion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Problems associated with passage of the pulmonary artery catheter are caused by trauma to the vessels and heart, potentially leading to vascular inflammation or rupture, valvular damage, and arrhythmia. These complications can be minimized by ensuring that the balloon at the tip of the catheter is fully inflated after the catheter tip enters the right atrium, so that the catheter tip does not protrude beyond the balloon (",
"    <a class=\"graphic graphic_figure graphicRef59475 \" href=\"UTD.htm?32/1/32799\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25221?source=see_link\">",
"     \"Insertion of pulmonary artery catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Nevertheless, some complications are inevitable. Atrial and ventricular arrhythmias, for example, commonly occur during passage of the catheter through the cardiac chambers. Most of these rhythm disturbances are self-limited [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/34\">",
"     34",
"    </a>",
"    ]. However, potentially serious rhythm disorders can be seen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sustained ventricular arrhythmias (&gt;30 consecutive ventricular contractions) occur in up to 3 percent of patients [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/34\">",
"       34",
"      </a>",
"      ]. Prophylactic use of intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      is not recommended prior to pulmonary artery catheter placement [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/35-37\">",
"       35-37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Right bundle branch block develops during approximately 5 percent of catheter insertions, placing patients with preexisting left bundle branch block at risk for complete heart block [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/38,39\">",
"       38,39",
"      </a>",
"      ]. Although the risk is low and complete heart block is usually transient, catheter insertion should not be undertaken in such patients without the ability to institute immediate cardiac pacing [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/40\">",
"       40",
"      </a>",
"      ]. This can be accomplished by placement of a transthoracic or transvenous pacer, or by using a PA catheter with an intraluminal pacing electrode. In many centers, pulmonary artery catheterization in the setting of a left bundle branch block is performed under fluoroscopic guidance to expedite passage of the catheter tip through the right ventricle and decrease the risk of inducing complete heart block.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Knotting of the catheter can occur during insertion if loops are allowed to form within one of the cardiac chambers. This can generally be avoided if the individual passing the catheter is careful not to exceed the expected distance from the insertion point to the right ventricle or pulmonary artery (",
"    <a class=\"graphic graphic_figure graphicRef50235 \" href=\"UTD.htm?24/62/25569\">",
"     figure 4",
"    </a>",
"    ). When knotting occurs, the catheter can usually be removed transvenously. However, some patients require placement of a guidewire, venotomy, or even surgical extraction [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Use and maintenance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications associated with use and maintenance of the catheter can often be avoided by careful attention to catheter position. Included in this group of complications are pulmonary artery rupture, pulmonary infarction, thromboembolic events, and misinterpretation of the data [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/20,21,35\">",
"     20,21,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most feared complication is pulmonary artery perforation, which has a mortality in excess of 30 percent and usually requires emergent thoracotomy for management [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/42\">",
"     42",
"    </a>",
"    ]. This complication may occur during insertion, but often is due to balloon inflation in a catheter that has inadvertently migrated into a distal position in the pulmonary artery. Self-limited pulmonary hemorrhage following perforation can result in the formation of a pulmonary artery pseudoaneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/43-45\">",
"     43-45",
"    </a>",
"    ]. The lesions are at risk of subsequent hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/35,45,46\">",
"     35,45,46",
"    </a>",
"    ]. The diagnosis of pulmonary artery pseudoaneurysm usually is made on the basis of a contrast-enhanced computed tomographic scan of the thorax (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef59974 \" href=\"UTD.htm?14/16/14594\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/43\">",
"     43",
"    </a>",
"    ]. Pulmonary angiography can be used to confirm the diagnosis, and may permit direct coil embolization of the lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/43,45,46\">",
"     43,45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for pulmonary artery rupture include pulmonary hypertension, advanced age, mitral valve disease, hypothermia, and anticoagulant therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/47\">",
"     47",
"    </a>",
"    ]. For patients at increased risk, it may be advisable to use the pulmonary artery diastolic pressure to approximate the wedge pressure, if possible, rather than repeatedly inflate the balloon. Conditions in which the pulmonary artery diastolic pressure does not approximate the wedge pressure are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44199?source=see_link\">",
"     \"Pulmonary artery catheterization: Interpretation of tracings\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Migration of the catheter tip or a balloon left inflated in the wedge position for an extended time may result in pulmonary infarction, a potentially avoidable complication. When small, these infarcts may be asymptomatic and diagnosed only by chest radiography.",
"   </p>",
"   <p>",
"    Thromboembolic events may occur with catheters acting as a nidus for thrombus formation. This complication is now seen less frequently because of the common use of heparin-bonded catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/48\">",
"     48",
"    </a>",
"    ]. Patients at increased risk should be considered for systemic anticoagulation. Included in this high-risk group are those with hypercoagulable states, traumatic insertions, or prolonged need for monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other complications seen with pulmonary artery catheters include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mural thrombi induced by inflammation or infection of a vessel wall are present up to 30 percent of the time [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/49\">",
"       49",
"      </a>",
"      ]. These clots can propagate (and cause vessel occlusion), embolize, or act as a nidus for infection.",
"     </li>",
"     <li>",
"      Sterile cardiac valve vegetations are seen in up to 30 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Endocarditis, especially of the pulmonic valve, occurs in less than 2 percent of cases [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Venous air embolism, caused by open infusion ports or catheter hubs, can lead to entrainment of room air through the monitoring system and into the venous circulation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38664?source=see_link\">",
"       \"Air embolism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Catheter-related infections, with possible bloodstream infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37464?source=see_link\">",
"       \"Epidemiology, pathogenesis, and microbiology of intravascular catheter infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/23/375?source=see_link\">",
"       \"Diagnosis of intravascular catheter-related infections\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31578?source=see_link\">",
"       \"Prevention of intravascular catheter-related infections\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Data interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another important limitation related to the use of pulmonary artery catheters is misinterpretation of the hemodynamic data. Under ideal conditions, the tip of the catheter sits in zone 3 of the lung, where the arterial pressure exceeds the venous pressure and the venous pressure exceeds the alveolar pressure, thereby creating a continuous column of blood from the catheter tip to the left atrium when the balloon is inflated (",
"    <a class=\"graphic graphic_figure graphicRef50235 \" href=\"UTD.htm?24/62/25569\">",
"     figure 4",
"    </a>",
"    ). In addition, under ideal conditions, the left atrial (LA) pressure is similar to left ventricular end-diastolic pressure (LVEDP), which reflects left ventricular end-diastolic volume (LVEDV).",
"   </p>",
"   <p>",
"    These conditions may not necessarily apply in a variety of settings, and can result in inaccurate data and potential mismanagement of the patient. Sources of error include improperly calibrated or leveled pressure monitors, transduction of airway pressures under non-zone 3 conditions, and overestimation of PCWP because of incomplete pulmonary artery branch occlusion [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/51\">",
"     51",
"    </a>",
"    ]. In addition, there is wide interobserver variability in the interpretation of hemodynamic data, even among intensive care unit clinicians and anesthesiologists [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/20-22,52\">",
"     20-22,52",
"    </a>",
"    ]. For these reasons, misinterpretation of accurately measured data is generally accepted to be common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44199?source=see_link\">",
"     \"Pulmonary artery catheterization: Interpretation of tracings\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In light of the data suggesting decreased use of the PA catheter, data misinterpretation can reasonably be expected to increase in frequency as clinicians lose valuable experience using the PA catheter and interpreting its data.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     FUTURE DIRECTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some experts have advocated continued, judicious use of the device, but recommend directing resources toward improving and testing less invasive technology, such as transnasal transesophageal echo-Doppler, which is able to assess cardiac preload indirectly [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/53,54\">",
"     53,54",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18054?source=see_link\">",
"     \"Hemodynamics derived from transesophageal echocardiography\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other less invasive approaches under active development allow estimation of cardiac output, but not preload; these include thoracic or whole body electrical bioimpedance (also called impedance cardiography),",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     lithium",
"    </a>",
"    dilution techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/55\">",
"     55",
"    </a>",
"    ], and inert gas rebreathing [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/56\">",
"     56",
"    </a>",
"    ]. Electrical bioimpedance systems measure subtle changes in electrical conduction through the body over the course of the cardiac cycle to determine stroke volume using pulse contour analysis algorithms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/57-59\">",
"     57-59",
"    </a>",
"    ]. Similarly, lithium dilution techniques analyze changes in lithium concentration over time following a bolus injection to estimate cardiac output [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although some systems based on these techniques have shown good correlation with cardiac output measured via PA catheter thermodilution [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/58,60\">",
"     58,60",
"    </a>",
"    ], clinical experience is limited and further study will be needed before any of these approaches can be recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27128/abstract/61,62\">",
"     61,62",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pulmonary artery (PA) catheters obtain direct measurements of central venous, right-sided intracardiac, pulmonary arterial, and pulmonary artery wedge (ie, pulmonary capillary wedge) pressures. In addition, they can estimate cardiac output, systemic vascular resistance, and pulmonary vascular resistance. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Rationale'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      No study has demonstrated improved outcome due to a PA catheter, and it remains controversial whether PA catheters are associated with poorer outcomes in critically ill patients. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Effect on survival'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The decision to place a PA catheter should be made on a case-by-case basis after carefully weighing the potential benefits versus risks for the individual patient. Hemodynamic data provided by PA catheters may be a useful adjunct to clinical parameters in patients whose central venous pressures may not accurately reflect left ventricular preload including severe lung disease, pulmonary hypertension, severe tricuspid valve regurgitation, or profoundly impaired right ventricular dysfunction. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Rationale'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H7\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PA catheters should not be used routinely for elderly patients undergoing high risk surgery. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Indications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of PA catheters can be associated with insertion of the catheter, use and maintenance of the catheter, or incorrect interpretation of the hemodynamic data. These complications may, rarely, be catastrophic. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Placement of a PA catheter in a patient with a pre-existing left bundle branch block should only be undertaken if the patient could have immediate cardiac pacing instituted in the event that complete heart block is induced. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Insertion'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/1\">",
"      Swan HJ, Ganz W, Forrester J, et al. Catheterization of the heart in man with use of a flow-directed balloon-tipped catheter. N Engl J Med 1970; 283:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/2\">",
"      Ivanov R, Allen J, Calvin JE. The incidence of major morbidity in critically ill patients managed with pulmonary artery catheters: a meta-analysis. Crit Care Med 2000; 28:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/3\">",
"      Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 1996; 276:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/4\">",
"      Sandham JD, Hull RD, Brant RF, et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 2003; 348:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/5\">",
"      Yu DT, Platt R, Lanken PN, et al. Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis. Crit Care Med 2003; 31:2734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/6\">",
"      Masson RG, Krikorian J, Lukl P, et al. Pulmonary microvascular cytology in the diagnosis of lymphangitic carcinomatosis. N Engl J Med 1989; 321:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/7\">",
"      Castella X, Vall&eacute;s J, Cabezuelo MA, et al. Fat embolism syndrome and pulmonary microvascular cytology. Chest 1992; 101:1710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/8\">",
"      Matthay MA, Chatterjee K. Bedside catheterization of the pulmonary artery: risks compared with benefits. Ann Intern Med 1988; 109:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/9\">",
"      Connors AF Jr, McCaffree DR, Gray BA. Evaluation of right-heart catheterization in the critically ill patient without acute myocardial infarction. N Engl J Med 1983; 308:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/10\">",
"      Eisenberg PR, Jaffe AS, Schuster DP. Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med 1984; 12:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/11\">",
"      Fein AM, Goldberg SK, Walkenstein MD, et al. Is pulmonary artery catheterization necessary for the diagnosis of pulmonary edema? Am Rev Respir Dis 1984; 129:1006.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/12\">",
"      Forrester JS, Diamond GA, Swan HJ. Correlative classification of clinical and hemodynamic function after acute myocardial infarction. Am J Cardiol 1977; 39:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/13\">",
"      Bayliss J, Norell M, Ryan A, et al. Bedside haemodynamic monitoring: experience in a general hospital. Br Med J (Clin Res Ed) 1983; 287:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/14\">",
"      Shah MR, Hasselblad V, Stevenson LW, et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 2005; 294:1664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/15\">",
"      Richard C, Warszawski J, Anguel N, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2003; 290:2713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/16\">",
"      Chittock DR, Dhingra VK, Ronco JJ, et al. Severity of illness and risk of death associated with pulmonary artery catheter use. Crit Care Med 2004; 32:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/17\">",
"      Cohen MG, Kelly RV, Kong DF, et al. Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials. Am J Med 2005; 118:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/18\">",
"      Harvey S, Harrison DA, Singer M, et al. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial. Lancet 2005; 366:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/19\">",
"      Vieillard-Baron A, Girou E, Valente E, et al. Predictors of mortality in acute respiratory distress syndrome. Focus On the role of right heart catheterization. Am J Respir Crit Care Med 2000; 161:1597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/20\">",
"      Jacka MJ, Cohen MM, To T, et al. Pulmonary artery occlusion pressure estimation: how confident are anesthesiologists? Crit Care Med 2002; 30:1197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/21\">",
"      Komadina KH, Schenk DA, LaVeau P, et al. Interobserver variability in the interpretation of pulmonary artery catheter pressure tracings. Chest 1991; 100:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/22\">",
"      Squara P, Bennett D, Perret C. Pulmonary artery catheter: does the problem lie in the users? Chest 2002; 121:2009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/23\">",
"      Mueller HS, Chatterjee K, Davis KB, et al. ACC expert consensus document. Present use of bedside right heart catheterization in patients with cardiac disease. American College of Cardiology. J Am Coll Cardiol 1998; 32:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/24\">",
"      Dalen JE, Bone RC. Is it time to pull the pulmonary artery catheter? JAMA 1996; 276:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/25\">",
"      Guyatt G. A randomized control trial of right-heart catheterization in critically ill patients. Ontario Intensive Care Study Group. J Intensive Care Med 1991; 6:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/26\">",
"      National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network, Wheeler AP, Bernard GR, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006; 354:2213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/27\">",
"      Rajaram SS, Desai NK, Kalra A, et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev 2013; 2:CD003408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/28\">",
"      Wiener RS, Welch HG. Trends in the use of the pulmonary artery catheter in the United States, 1993-2004. JAMA 2007; 298:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/29\">",
"      Binanay C, Califf RM, Hasselblad V, et al. Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 2005; 294:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/30\">",
"      Koo KK, Sun JC, Zhou Q, et al. Pulmonary artery catheters: evolving rates and reasons for use. Crit Care Med 2011; 39:1613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/31\">",
"      Rapoport J, Teres D, Steingrub J, et al. Patient characteristics and ICU organizational factors that influence frequency of pulmonary artery catheterization. JAMA 2000; 283:2559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/32\">",
"      Afessa B, Spencer S, Khan W, et al. Association of pulmonary artery catheter use with in-hospital mortality. Crit Care Med 2001; 29:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/33\">",
"      Pulmonary Artery Catheter Consensus conference: consensus statement. Crit Care Med 1997; 25:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/34\">",
"      Sprung CL, Pozen RG, Rozanski JJ, et al. Advanced ventricular arrhythmias during bedside pulmonary artery catheterization. Am J Med 1982; 72:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/35\">",
"      Coulter TD, Wiedemann HP. Complications of hemodynamic monitoring. Clin Chest Med 1999; 20:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/36\">",
"      Salmenper&auml; M, Peltola K, Rosenberg P. Does prophylactic lidocaine control cardiac arrhythmias associated with pulmonary artery catheterization? Anesthesiology 1982; 56:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/37\">",
"      Sprung CL, Marcial EH, Garcia AA, et al. Prophylactic use of lidocaine to prevent advanced ventricular arrhythmias during pulmonary artery catheterization. Prospective double-blind study. Am J Med 1983; 75:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/38\">",
"      Sprung CL, Elser B, Schein RM, et al. Risk of right bundle-branch block and complete heart block during pulmonary artery catheterization. Crit Care Med 1989; 17:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/39\">",
"      Thomson IR, Dalton BC, Lappas DG, Lowenstein E. Right bundle-branch block and complete heart block caused by the Swan-Ganz catheter. Anesthesiology 1979; 51:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/40\">",
"      Morris D, Mulvihill D, Lew WY. Risk of developing complete heart block during bedside pulmonary artery catheterization in patients with left bundle-branch block. Arch Intern Med 1987; 147:2005.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/41\">",
"      Mond HG, Clark DW, Nesbitt SJ, Schlant RC. A technique for unknotting an intracardiac flow-directed balloon catheter. Chest 1975; 67:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/42\">",
"      Kearney TJ, Shabot MM. Pulmonary artery rupture associated with the Swan-Ganz catheter. Chest 1995; 108:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/43\">",
"      Utsumi T, Kido T, Ohata T, et al. Swan-Ganz catheter-induced pseudoaneurysm of the pulmonary artery. Jpn J Thorac Cardiovasc Surg 2002; 50:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/44\">",
"      Poplausky MR, Rozenblit G, Rundback JH, et al. Swan-Ganz catheter-induced pulmonary artery pseudoaneurysm formation: three case reports and a review of the literature. Chest 2001; 120:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/45\">",
"      Ferretti GR, Thony F, Link KM, et al. False aneurysm of the pulmonary artery induced by a Swan-Ganz catheter: clinical presentation and radiologic management. AJR Am J Roentgenol 1996; 167:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/46\">",
"      Abreu AR, Campos MA, Krieger BP. Pulmonary artery rupture induced by a pulmonary artery catheter: a case report and review of the literature. J Intensive Care Med 2004; 19:291.",
"     </a>",
"    </li>",
"    <li>",
"     Voyce SJ, Urbach D, Rippe JM. Pulmonary artery catheters. In: Intensive Care Medicine, Rippe JM, Irwin RS, Alpert JS, Fink MP (Eds), Little Brown, Boston 1991. p.66.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/48\">",
"      Hoar PF, Wilson RM, Mangano DT, et al. Heparin bonding reduces thrombogenicity of pulmonary-artery catheters. N Engl J Med 1981; 305:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/49\">",
"      Ducatman BS, McMichan JC, Edwards WD. Catheter-induced lesions of the right side of the heart. A one-year prospective study of 141 autopsies. JAMA 1985; 253:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/50\">",
"      Mermel LA, Maki DG. Infectious complications of Swan-Ganz pulmonary artery catheters. Pathogenesis, epidemiology, prevention, and management. Am J Respir Crit Care Med 1994; 149:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/51\">",
"      Leatherman JW, Shapiro RS. Overestimation of pulmonary artery occlusion pressure in pulmonary hypertension due to partial occlusion. Crit Care Med 2003; 31:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/52\">",
"      Rizvi K, Deboisblanc BP, Truwit JD, et al. Effect of airway pressure display on interobserver agreement in the assessment of vascular pressures in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med 2005; 33:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/53\">",
"      Dark PM, Singer M. The validity of trans-esophageal Doppler ultrasonography as a measure of cardiac output in critically ill adults. Intensive Care Med 2004; 30:2060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/54\">",
"      Weil MH. The assault on the Swan-Ganz catheter: a case history of constrained technology, constrained bedside clinicians, and constrained monetary expenditures. Chest 1998; 113:1379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/55\">",
"      Chaney JC, Derdak S. Minimally invasive hemodynamic monitoring for the intensivist: current and emerging technology. Crit Care Med 2002; 30:2338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/56\">",
"      Lang CC, Karlin P, Haythe J, et al. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 2007; 99:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/57\">",
"      Moshkovitz Y, Kaluski E, Milo O, et al. Recent developments in cardiac output determination by bioimpedance: comparison with invasive cardiac output and potential cardiovascular applications. Curr Opin Cardiol 2004; 19:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/58\">",
"      Cotter G, Moshkovitz Y, Kaluski E, et al. Accurate, noninvasive continuous monitoring of cardiac output by whole-body electrical bioimpedance. Chest 2004; 125:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/59\">",
"      Summers RL, Shoemaker WC, Peacock WF, et al. Bench to bedside: electrophysiologic and clinical principles of noninvasive hemodynamic monitoring using impedance cardiography. Acad Emerg Med 2003; 10:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/60\">",
"      Hamilton TT, Huber LM, Jessen ME. PulseCO: a less-invasive method to monitor cardiac output from arterial pressure after cardiac surgery. Ann Thorac Surg 2002; 74:S1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/61\">",
"      Bellomo R, Uchino S. Cardiovascular monitoring tools: use and misuse. Curr Opin Crit Care 2003; 9:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27128/abstract/62\">",
"      Rhodes A, Grounds RM. New technologies for measuring cardiac output: the future? Curr Opin Crit Care 2005; 11:224.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1593 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-61.234.146.186-043A92644E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27128=[""].join("\n");
var outline_f26_31_27128=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RATIONALE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EFFECT ON SURVIVAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Intensive care unit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Perioperative",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Insertion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Use and maintenance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Data interpretation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      FUTURE DIRECTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/1593\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1593|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/16/14594\" title=\"diagnostic image 1\">",
"      PA pseudoaneurysm CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1593|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/48/8965\" title=\"figure 1\">",
"      Waveforms Swan Ganz tip",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/34/17965\" title=\"figure 2\">",
"      PA catheter and survival",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/1/32799\" title=\"figure 3\">",
"      Swan Ganz balloon inflation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/62/25569\" title=\"figure 4\">",
"      Swan Ganz lung zones",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/1593|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/49/31516\" title=\"table 1\">",
"      Indications for catheterization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/5/9307\" title=\"table 2\">",
"      ASA physical status scale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?11/30/11755\" title=\"table 3\">",
"      Complications of central venous catheterization",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/48/38664?source=related_link\">",
"      Air embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/1/29?source=related_link\">",
"      Complications of central venous catheters and their prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/23/375?source=related_link\">",
"      Diagnosis of intravascular catheter-related infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/37/37464?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of intravascular catheter infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/55/6007?source=related_link\">",
"      Evaluation and prognosis of Eisenmenger syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/40/18054?source=related_link\">",
"      Hemodynamics derived from transesophageal echocardiography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/40/25221?source=related_link\">",
"      Insertion of pulmonary artery catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4743?source=related_link\">",
"      Management of refractory heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/20/7496?source=related_link\">",
"      Medical management of Eisenmenger syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31578?source=related_link\">",
"      Prevention of intravascular catheter-related infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/10/44199?source=related_link\">",
"      Pulmonary artery catheterization: Interpretation of tracings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/62/6120?source=related_link\">",
"      Shock in adults: Types, presentation, and diagnostic approach",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27129="Bipolar disorder in postpartum women: Epidemiology, clinical features, assessment, and diagnosis";
var content_f26_31_27129=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bipolar disorder in postpartum women: Epidemiology, clinical features, assessment, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27129/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27129/contributors\">",
"     Victoria Hendrick, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27129/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27129/contributors\">",
"     Paul Keck, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27129/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27129/contributors\">",
"     David Solomon, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/31/27129/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 16, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H50297302\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A large, nationally representative survey of the United States general population estimated that among postpartum women, the 12-month prevalence of bipolar disorder was 2.9 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/1\">",
"     1",
"    </a>",
"    ]. Many postpartum bipolar patients suffer acute mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/2-4\">",
"     2-4",
"    </a>",
"    ], and the risk of episodes in female bipolar patients may be greater during the puerperium than at other times [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/2,5\">",
"     2,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews the epidemiology, pathogenesis, clinical features, assessment, and diagnosis of postpartum bipolar mood episodes. Treatment of postpartum bipolar disorder, postpartum psychosis, and postpartum unipolar major depression are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5146?source=see_link\">",
"     \"Bipolar disorder in postpartum women: Treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link\">",
"     \"Treatment of postpartum psychosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=see_link\">",
"     \"Postpartum blues and depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H50297310\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar disorder is a mood disorder that is characterized by episodes of mania (",
"    <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"     table 1",
"    </a>",
"    ), hypomania (",
"    <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"     table 2",
"    </a>",
"    ), and major depression (",
"    <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"     table 3",
"    </a>",
"    ), as well as mixed episodes (major depression concurrent with mania) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6\">",
"     6",
"    </a>",
"    ]. The subtypes of bipolar disorder include bipolar I and bipolar II. Patients with bipolar I disorder experience manic and mixed episodes, and nearly always experience major depressive and hypomanic episodes. Bipolar II disorder is marked by at least one hypomanic episode, at least one major depressive episode, and the absence of manic and mixed episodes. Additional information about the clinical features and diagnosis of bipolar disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H4#H4\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Clinical manifestations and diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Onset of postpartum bipolar mood episodes occurs within a limited time period following birth of a live child. However, there is no established cut-off that separates postpartum-onset episodes from subsequent nonpostpartum episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/7\">",
"     7",
"    </a>",
"    ]; definitions of the puerperium include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For episodes &ldquo;with postpartum onset,&rdquo; the American Psychiatric Association's Diagnostic and Statistical Manual, Fourth Edition, Text Revision (DSM-IV-TR) requires onset of the episode within four weeks of childbirth [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6\">",
"       6",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      For &ldquo;episodes that are associated with the puerperium,&rdquo; the World Health Organization's International Classification of Diseases-10th Revision (ICD-10) requires onset of the episode within six weeks of delivery [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/8\">",
"       8",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Other definitions of the puerperium range from the first 3 to 12 months following a live birth [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/2,7,9\">",
"       2,7,9",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postpartum bipolar mood episodes are often referred to as &ldquo;postpartum psychosis&rdquo; or &ldquo;puerperal psychosis,&rdquo; although neither term is a formal diagnosis in DSM-IV-TR or ICD-10 [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6,8\">",
"     6,8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13183269\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of acute bipolar mood episodes may be greater in the puerperium than at other times. A retrospective study of 621 bipolar patients found that mood episodes occurred significantly more often in the postpartum period than during pregnancy (52 versus 23 percent of patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/2\">",
"     2",
"    </a>",
"    ]. In a second retrospective study, 20 gravid and 25 nongravid bipolar patients discontinued maintenance treatment and remained stable for 40 weeks; recurrence during weeks 41 to 64 occurred in significantly more postpartum patients than nongravid patients (70 versus 24 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12999023\">",
"    <span class=\"h2\">",
"     General population",
"    </span>",
"    &nbsp;&mdash;&nbsp;A study of nationwide Swedish birth and hospitalization registries found that the incidence of hospitalization for a postpartum bipolar mood episode was 0.03 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/10\">",
"     10",
"    </a>",
"    ]. However, this figure probably overestimates the incidence because it appears that the &ldquo;bipolar&rdquo; group included patients with unipolar depression [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12999031\">",
"    <span class=\"h2\">",
"     Clinical samples",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reviews of retrospective studies suggest that among bipolar patients, mood episodes occur after 25 to 50 percent of deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]; variations in rates between studies are probably due in part to differences in how episodes were defined, with lower rates observed in studies that included only more severe episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Factors associated with an increased risk of postpartum bipolar mood episodes include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lack of maintenance pharmacotherapy preceding or following delivery [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/5,17\">",
"       5,17",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prenatal mood symptoms and episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/2,10,18,19\">",
"       2,10,18,19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Younger age [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/12,20\">",
"       12,20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Unplanned pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/12\">",
"       12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Primiparity [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      History of previous postpartum mood episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Family history of mood disorder or postpartum psychosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/21-23\">",
"       21-23",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Onset of bipolar disorder may occur during the puerperium [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3376877\">",
"    <span class=\"h3\">",
"     Psychotic episodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar patients appear to be at increased risk for postpartum psychosis (eg, delusions and hallucinations) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/13,15,17,24\">",
"     13,15,17,24",
"    </a>",
"    ].While the estimated rate of puerperal psychosis in the general population is 1 to 2 per 1000 live births [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/25,26\">",
"     25,26",
"    </a>",
"    ], one study found the rate in bipolar women was 260 per 1000 deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/21\">",
"     21",
"    </a>",
"    ]. Other studies have found that psychosis occurs in approximately 10 to 50 percent of postpartum bipolar patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/27,28\">",
"     27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, many patients who present with postpartum psychosis are ultimately diagnosed with bipolar disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/15,24,28-30\">",
"     15,24,28-30",
"    </a>",
"    ]. As an example, two retrospective studies of patients admitted for postpartum psychosis (N = 119 and 50) found that the underlying diagnosis was bipolar disorder in 31 and 42 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Factors associated with an increased risk of postpartum psychosis in bipolar patients include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delivery complications (eg, breech presentation, fetal distress, and cord accidents) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prenatal mood episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prenatal obstetric complications (eg, hyperemesis, preeclampsia, and premature contractions) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Primiparity [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/33\">",
"       33",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      History of prior puerperal psychosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/13,34\">",
"       13,34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Early age of onset of bipolar disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Family history of bipolar disorder or postpartum psychosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/21,34,35\">",
"       21,34,35",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional information about postpartum psychosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17014?source=see_link\">",
"     \"Postpartum psychosis: Epidemiology, clinical manifestations, and assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=see_link\">",
"     \"Treatment of postpartum psychosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13589883\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The etiology of postpartum bipolar mood episodes is not known. Possible causes include decreases in estrogen and progesterone, decreased or erratic sleep, increased stress associated with caring for the newborn, and social issues (eg, relationship or financial problems) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/27,29,36-38\">",
"     27,29,36-38",
"    </a>",
"    ]. In addition, genetic effects may possibly render patients vulnerable to episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/20,39,40\">",
"     20,39,40",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A family study of bipolar disorder found that postpartum relapse occurred in significantly more patients with a positive family history of postpartum mania or psychosis (N = 27) compared with patients who had no such history (N = 125) (74 versus 30 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/21\">",
"       21",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A family study of bipolar disorder found that postpartum mood symptoms and episodes occurred in significantly more patients with a positive family history of postpartum symptoms (N = 69) compared with patients who had no such history (N = 234) (30 versus 15 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/41\">",
"       41",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      A genome-wide linkage study found an area on chromosome 16 associated with susceptibility to postpartum bipolar mood episodes [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/42\">",
"       42",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43784803\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar disorder is characterized by episodes of major depression (",
"    <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"     table 3",
"    </a>",
"    ), mania (",
"    <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"     table 1",
"    </a>",
"    ), and hypomania (",
"    <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"     table 2",
"    </a>",
"    ), as well as mixed episodes (major depression concurrent with mania or hypomania) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6\">",
"     6",
"    </a>",
"    ]. The most common psychopathology among postpartum bipolar patients is major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/18,43-45\">",
"     18,43-45",
"    </a>",
"    ]. A retrospective study of 1120 pregnancies in bipolar patients found the following rates of postpartum mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Major depression &ndash; 25 percent of pregnancies",
"     </li>",
"     <li>",
"      Mixed (depression concurrent with mania or hypomania) &ndash; 4 percent",
"     </li>",
"     <li>",
"      Mania &ndash; 3 percent",
"     </li>",
"     <li>",
"      Hypomania &ndash; 2 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings are consistent with observations that major depression is the predominant type of bipolar mood episode during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/46\">",
"     46",
"    </a>",
"    ], and in the general population of bipolar patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Comorbid anxiety disorders and substance use disorders are common among patients with postpartum bipolar depression [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/49\">",
"     49",
"    </a>",
"    ], which is also seen in the general population of bipolar patients [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/50,51\">",
"     50,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other symptoms commonly observed in postpartum bipolar mood episodes include mood lability and preoccupation with the newborn [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6,52\">",
"     6,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Onset of postpartum bipolar mood episodes appears to be greatest within the first few weeks after delivery, based upon retrospective studies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study of 630,373 primiparous pregnant women found that hospitalization for a postpartum bipolar episode was 23 times more likely within the first 30 days of delivery, compared with 11 to 12 months postpartum [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A study of 10,218 primiparous bipolar patients found that recurrent mood episodes occurred 37 times more often 10 to 19 days after delivery, compared with 6 to 11 months postpartum [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study of primiparous bipolar I mothers (N = 980) found that the median time to a mood episode was one week and for bipolar II mothers (N = 232), two to three weeks [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/53\">",
"       53",
"      </a>",
"      ]. A second study of 127 bipolar patients with postpartum mood episodes found that symptoms began on the day of delivery in 40 percent and within three days of parturition in 73 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postpartum bipolar mood episodes often progress rapidly [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/52\">",
"     52",
"    </a>",
"    ], and the mean duration of episodes varies from approximately one to three months [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/19,54\">",
"     19,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13589937\">",
"    <span class=\"h2\">",
"     Psychotic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Onset of postpartum psychosis in bipolar patients generally occurs within the first two to three weeks of parturition [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/13,24,52,55\">",
"     13,24,52,55",
"    </a>",
"    ]. The clinical features of postpartum bipolar psychosis can include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/13,26,36,56\">",
"     13,26,36,56",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Delusions",
"     </li>",
"     <li>",
"      Hallucinations",
"     </li>",
"     <li>",
"      Disorganized or bizarre behavior",
"     </li>",
"     <li>",
"      Disorganized thinking",
"     </li>",
"     <li>",
"      Cognitive impairment or confusion",
"     </li>",
"     <li>",
"      Impaired judgement",
"     </li>",
"     <li>",
"      Agitation",
"     </li>",
"     <li>",
"      Sleep disturbance",
"     </li>",
"     <li>",
"      Mood lability",
"     </li>",
"     <li>",
"      Impulsivity",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Postpartum bipolar patients with psychotic mood episodes may be at increased risk for suicide and infanticide [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional information about postpartum psychosis and the clinical features of psychosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17014?source=see_link\">",
"     \"Postpartum psychosis: Epidemiology, clinical manifestations, and assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of psychosis\", section on 'Psychosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H991133\">",
"    <span class=\"h1\">",
"     COURSE OF ILLNESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The course of illness in bipolar patients with a lifetime history of postpartum mood episodes and patients without this history does not appear to differ. A study prospectively followed bipolar patients with a history of postpartum mood episodes (N = 43) and without this history (N = 137) for up to 12 years, and found that the two groups did not differ significantly with regard to age of onset, bipolar subtype (bipolar I and bipolar II), comorbid psychopathology, number of recurrent episodes, occurrence of rapid cycling, number of suicide attempts, educational achievement, occupational functioning, and family psychiatric history [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the course of bipolar disorder may be more benign if the first lifetime mood episode (onset) occurs with a postpartum mood episode, rather than a nonpostpartum episode. A retrospective study of 123 female patients with bipolar disorder found that the number of recurrent mood episodes per year was significantly less among patients with postpartum onset, compared with nonpostpartum onset (0.5 versus 0.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H991140\">",
"    <span class=\"h2\">",
"     Subsequent mood episodes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum bipolar mood episodes are often followed by additional episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H991147\">",
"    <span class=\"h3\">",
"     Postpartum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many bipolar patients suffer multiple postpartum mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/13,18,34\">",
"     13,18,34",
"    </a>",
"    ]. A retrospective study of 54 bipolar patients with a postpartum episode and one subsequent delivery found that a second postpartum episode occurred in 57 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H991154\">",
"    <span class=\"h3\">",
"     Nonpostpartum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar patients who suffer a postpartum mood episode are at risk for subsequent nonpostpartum mood episodes [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/31,43,57\">",
"     31,43,57",
"    </a>",
"    ]. As an example, two retrospective studies of bipolar patients with a postpartum mood episode (N = 103 and 19) found that at least one subsequent episode occurred in 62 and 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/22,58\">",
"     22,58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H991161\">",
"    <span class=\"h2\">",
"     Suicide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bipolar patients with postpartum mood episodes may be at risk for suicide [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/59\">",
"     59",
"    </a>",
"    ]. A study of 1567 women who were admitted to a psychiatric hospital (diagnoses not specified) within one year of childbirth found that compared with the general population, completed suicide among admitted patients was 17 times higher [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H351628\">",
"    <span class=\"h1\">",
"     ASSESSMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial clinical evaluation of postpartum patients with a possible diagnosis of bipolar disorder includes a psychiatric and general medical history, mental status and physical examination, and focused laboratory tests [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. The psychiatric history and mental status examination should emphasize manic (",
"    <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"     table 1",
"    </a>",
"    ), hypomanic (",
"    <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"     table 2",
"    </a>",
"    ), depressive (",
"    <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"     table 3",
"    </a>",
"    ), and psychotic (eg, delusions and hallucinations) symptoms, especially thoughts of harming oneself or others (including the infant) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6\">",
"     6",
"    </a>",
"    ]. The clinical features of bipolar disorder and psychosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H4#H4\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Clinical manifestations and diagnostic criteria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of psychosis\", section on 'Psychosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postpartum bipolar patients often present with a depressive syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/45\">",
"     45",
"    </a>",
"    ], and a prior history of hypomania or hypomanic symptoms is easy to miss [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/63\">",
"     63",
"    </a>",
"    ], particularly in patients with bipolar II disorder or bipolar disorder not otherwise specified [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/20\">",
"     20",
"    </a>",
"    ]. As an example, a study evaluated the diagnosis of 56 patients referred by nurses, family physicians, psychiatrists, and obstetricians to a perinatal psychiatric clinic for treatment of postpartum unipolar major depression [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/49\">",
"     49",
"    </a>",
"    ]. The correct diagnosis was unipolar depression in 46 percent, bipolar disorder not otherwise specified in 29 percent, bipolar II disorder in 23 percent, and bipolar I disorder in 2 percent.",
"   </p>",
"   <p>",
"    Postpartum hypomania can be missed due to [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/64\">",
"     64",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient&rsquo;s lack of awareness of symptoms or poor insight &nbsp;",
"     </li>",
"     <li>",
"      Clinicians misconstruing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Excessive mood elevation as the normal elation of childbirth",
"     </li>",
"     <li>",
"      Decreased need for sleep as impaired or disrupted sleep",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H351797\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-report screening instruments can help make the diagnosis of bipolar disorder and save interviewer time, but are more likely to yield false positives than clinician-administered instruments. No screening instruments have been specifically developed for postpartum bipolar disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/65\">",
"     65",
"    </a>",
"    ]. However, self-report instruments that screen for mania, hypomania, and major depression and are easy to use include the:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mood Disorder Questionnaire &ndash; This 15-item instrument is the most widely used measure that screens for episodes of mania and hypomania, and has good psychometric properties (",
"      <a class=\"graphic graphic_table graphicRef53409 \" href=\"UTD.htm?19/63/20477\">",
"       table 4",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/65,66\">",
"       65,66",
"      </a>",
"      ]. A study of postpartum patients (57 with bipolar disorder and 68 with unipolar major depression, established by structured interview) found that the sensitivity was 75 percent and specificity 87 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/64\">",
"       64",
"      </a>",
"      ]; comparable results have been found in psychiatric [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/67\">",
"       67",
"      </a>",
"      ] and family medicine outpatients [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/68\">",
"       68",
"      </a>",
"      ]. The Mood Disorder Questionnaire does not generate a diagnosis of mania or hypomania; thus, patients who screen positive require a clinical interview to make the diagnosis.",
"     </li>",
"     <li>",
"      Patient Health Questionnaire - 9 Item (PHQ-9). This 9-item instrument screens for episodes of major depression, provides a diagnosis, and has good psychometric properties (",
"      <a class=\"graphic graphic_table graphicRef59307 \" href=\"UTD.htm?14/12/14541\">",
"       table 5",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/69\">",
"       69",
"      </a>",
"      ]. In addition, the PHQ-9 has been used as a screening tool for postpartum depression [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/70\">",
"       70",
"      </a>",
"      ]. The PHQ-9 is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4745?source=see_link&amp;anchor=H100014092#H100014092\">",
"       \"Using scales to monitor symptoms and treatment of depression (measurement based care)\", section on 'Patient Health Questionnaire - Nine Item'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several reasonable alternatives to the Mood Disorder Questionnaire are available [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/65\">",
"     65",
"    </a>",
"    ]. As an example, postpartum patients presenting with major depression can be screened for bipolar I disorder and bipolar II disorder by asking about a family history of bipolar disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/29,71\">",
"     29,71",
"    </a>",
"    ], or with the Screening Assessment of Depression-Polarity, which is a three item, clinician administered instrument [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/72\">",
"     72",
"    </a>",
"    ]. Patients who screen positive require a follow-up interview to establish the diagnosis of bipolar disorder.",
"   </p>",
"   <p>",
"    A reasonable alternative to the PHQ-9 is the Edinburgh Postnatal Depression Scale, which is a 10-item, self report instrument that screens for postnatal depression and is widely used (",
"    <a class=\"graphic graphic_figure graphicRef67741 graphicRef81407 \" href=\"UTD.htm?33/20/34115\">",
"     figure 1A-B",
"    </a>",
"    ). The original validation study found that the psychometric properties were good: sensitivity was 86 percent, specificity 78 percent, and positive predictive value 73 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/73\">",
"     73",
"    </a>",
"    ]. However, a systematic review of 37 studies found that sensitivity ranged from 34 to 100 percent and specificity from 44 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not known whether screening instruments improve outcome for postpartum bipolar patients. However, a randomized trial compared the Edinburgh Postnatal Depression Scale with clinical assessment in screening for postnatal unipolar major depression, and found that maternal mental health outcomes were significantly better among those screened with the Edinburgh Postnatal Depression Scale [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13590137\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are three subtypes of bipolar disorder that can be diagnosed, depending upon the mood symptoms and episodes that have occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27129/abstract/6\">",
"     6",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Bipolar I",
"     </li>",
"     <li>",
"      Bipolar II",
"     </li>",
"     <li>",
"      Bipolar disorder not otherwise specified",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnostic criteria for each subtype of bipolar disorder are identical for postpartum and nonpostpartum patients. Diagnosis of bipolar disorder is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H4#H4\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Clinical manifestations and diagnostic criteria'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13590145\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of bipolar disorder includes schizophrenia, schizoaffective disorder, unipolar major depression, and substance use disorder, and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H14#H14\">",
"     \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (See",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?4/5/4178?source=see_link\">",
"       \"Patient information: Bipolar disorder (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (The Basics)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Beyond the Basics topics (See",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/55/39796?source=see_link\">",
"       \"Patient information: Bipolar disorder (manic depression) (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=see_link\">",
"       \"Patient information: Reducing the costs of medicines (Beyond the Basics)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These educational materials can be used as part of psychoeducational psychotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=see_link&amp;anchor=H21#H21\">",
"     \"Bipolar disorder in adults: Maintenance treatment\", section on 'Psychoeducation'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    The National Institute of Mental Health also has educational material explaining the symptoms, course of illness, and treatment of bipolar disorder in a booklet entitled \"Bipolar Disorder,\" which is available online at the website",
"    <a class=\"external\" href=\"file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml\">",
"     file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml",
"    </a>",
"    or through a toll-free number, 866-615-6464. The web site also provides references, summaries of study results in language intended for the lay public, and information about clinical trials currently recruiting patients.",
"   </p>",
"   <p>",
"    More comprehensive information is provided in many books written for patients and family members, including The Bipolar Disorder Survival Guide: What You and Your Family Need to Know, written by David J. Miklowitz, PhD (published by The Guilford Press, 2002); An Unquiet Mind: A Memoir of Moods and Madness, written by Kay Jamison, PhD (published by Random House, 1995); and Treatment of Bipolar Illness: A Casebook for Clinicians and Patients, by RM Post, MD, and GS Leverich, LCSW (published by Norton Press, 2008).",
"   </p>",
"   <p>",
"    The Depression and Bipolar Support Alliance (",
"    <a class=\"external\" href=\"file://www.dbsalliance.org/\">",
"     file://www.dbsalliance.org",
"    </a>",
"    or 800-826-3632) is a national organization that educates members about bipolar disorder and how to cope with it. Other functions include increasing public awareness of the illness and advocating for more research and services. The organization is administered and maintained by patients and family members, and has local chapters.",
"   </p>",
"   <p>",
"    The National Alliance on Mental Illness (",
"    <a class=\"external\" href=\"file://www.nami.org/\">",
"     file://www.nami.org",
"    </a>",
"    or 800-950-6264) is a similarly structured organization devoted to education, support, and advocacy for patients with any mental illness. Bipolar disorder is one of their priorities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H86457796\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Onset of postpartum bipolar mood episodes occurs within a limited time period following birth of a live child; definitions of the puerperium range from the first 1 to 12 months following a live birth. (See",
"      <a class=\"local\" href=\"#H50297310\">",
"       'Definitions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of mood episodes in female bipolar patients may be greater during the puerperium than at other times, with episodes occurring after 25 to 50 percent of deliveries. (See",
"      <a class=\"local\" href=\"#H13183269\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The etiology of postpartum bipolar mood episodes is not known. Possible causes include decreases in serum estrogen and progesterone concentrations, disrupted sleep, increased stress, social issues, and genetic effects. (See",
"      <a class=\"local\" href=\"#H13589883\">",
"       'Pathogenesis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bipolar disorder is characterized by episodes of major depression (",
"      <a class=\"graphic graphic_table graphicRef70852 \" href=\"UTD.htm?17/21/17756\">",
"       table 3",
"      </a>",
"      ), mania (",
"      <a class=\"graphic graphic_table graphicRef81976 \" href=\"UTD.htm?3/53/3932\">",
"       table 1",
"      </a>",
"      ), and hypomania (",
"      <a class=\"graphic graphic_table graphicRef70757 \" href=\"UTD.htm?22/39/23164\">",
"       table 2",
"      </a>",
"      ), as well as mixed episodes (major depression concurrent with mania or hypomania). The most common type of postpartum episode is major depression, and psychotic features (eg, delusions and hallucinations) are frequently present. Most postpartum episodes occur during the first several (eg, four) weeks after delivery, and the mean duration of episodes varies from approximately one to three months. (See",
"      <a class=\"local\" href=\"#H43784803\">",
"       'Clinical manifestation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The course of illness in bipolar patients with a lifetime history of postpartum mood episodes and patients without this history does not appear to differ. Postpartum bipolar mood episodes are often followed by subsequent postpartum and nonpostpartum episodes. (See",
"      <a class=\"local\" href=\"#H991133\">",
"       'Course of illness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The assessment of postpartum patients with a possible diagnosis of bipolar disorder includes a psychiatric and general medical history, mental status and physical examination, and focused laboratory tests, with emphasis upon mood and psychotic symptoms, including thoughts of suicide and homicide. Postpartum hypomania and a prior history of hypomania are both easy to miss. (See",
"      <a class=\"local\" href=\"#H351628\">",
"       'Assessment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Self-report instruments that screen for mania, hypomania, and major depression, and are easy to use, include the Mood disorder Questionnaire (",
"      <a class=\"graphic graphic_table graphicRef53409 \" href=\"UTD.htm?19/63/20477\">",
"       table 4",
"      </a>",
"      ) and Patient Health Questionnaire - 9 Item (",
"      <a class=\"graphic graphic_table graphicRef59307 \" href=\"UTD.htm?14/12/14541\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H351797\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are three subtypes of bipolar disorder that can be diagnosed in postpartum patients: bipolar I disorder, bipolar II disorder, and bipolar disorder not otherwise specified. (See",
"      <a class=\"local\" href=\"#H13590137\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H4#H4\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Clinical manifestations and diagnostic criteria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The differential diagnosis of bipolar disorder includes schizophrenia, schizoaffective disorder, unipolar major depression, and substance use disorder, and is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=see_link&amp;anchor=H14#H14\">",
"       \"Bipolar disorder in adults: Epidemiology and diagnosis\", section on 'Differential diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/1\">",
"      Vesga-L&oacute;pez O, Blanco C, Keyes K, et al. Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 2008; 65:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/2\">",
"      Viguera AC, Tondo L, Koukopoulos AE, et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. Am J Psychiatry 2011; 168:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/3\">",
"      Bergink V, Bouvy PF, Vervoort JS, et al. Prevention of postpartum psychosis and mania in women at high risk. Am J Psychiatry 2012; 169:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/4\">",
"      Payne JL, Roy PS, Murphy-Eberenz K, et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 2007; 99:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/5\">",
"      Viguera AC, Nonacs R, Cohen LS, et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am J Psychiatry 2000; 157:179.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, American Psychiatric Association, Washington, DC, 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/7\">",
"      Wisner KL, Moses-Kolko EL, Sit DK. Postpartum depression: a disorder in search of a definition. Arch Womens Ment Health 2010; 13:37.",
"     </a>",
"    </li>",
"    <li>",
"     The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. file://www.who.int/classifications/icd/en/bluebook.pdf (Accessed on September 27, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/9\">",
"      Munk-Olsen T, Laursen TM, Pedersen CB, et al. New parents and mental disorders: a population-based register study. JAMA 2006; 296:2582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/10\">",
"      Harlow BL, Vitonis AF, Sparen P, et al. Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Arch Gen Psychiatry 2007; 64:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/11\">",
"      Jones I, Heron J, Blackmore ER, Craddock N. Incidence of hospitalization for postpartum psychotic and bipolar episodes. Arch Gen Psychiatry 2008; 65:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/12\">",
"      Doyle K, Heron J, Berrisford G, et al. The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse. Eur Psychiatry 2012; 27:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/13\">",
"      Cohen LS, Wang B, Nonacs R, et al. Treatment of mood disorders during pregnancy and postpartum. Psychiatr Clin North Am 2010; 33:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/14\">",
"      Yonkers KA, Wisner KL, Stowe Z, et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 2004; 161:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/15\">",
"      Chaudron LH, Pies RW. The relationship between postpartum psychosis and bipolar disorder: a review. J Clin Psychiatry 2003; 64:1284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/16\">",
"      Munk-Olsen T, Laursen TM, Mendelson T, et al. Risks and predictors of readmission for a mental disorder during the postpartum period. Arch Gen Psychiatry 2009; 66:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/17\">",
"      Burt VK, Rasgon N. Special considerations in treating bipolar disorder in women. Bipolar Disord 2004; 6:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/18\">",
"      Freeman MP, Smith KW, Freeman SA, et al. The impact of reproductive events on the course of bipolar disorder in women. J Clin Psychiatry 2002; 63:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/19\">",
"      Akdeniz F, Vahip S, Pirildar S, et al. Risk factors associated with childbearing-related episodes in women with bipolar disorder. Psychopathology 2003; 36:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/20\">",
"      Yonkers KA, Vigod S, Ross LE. Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstet Gynecol 2011; 117:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/21\">",
"      Jones I, Craddock N. Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 2001; 158:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/22\">",
"      Robertson E, Jones I, Haque S, et al. Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis. Br J Psychiatry 2005; 186:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/23\">",
"      Munk-Olsen T, Laursen TM, Pedersen CB, et al. Family and partner psychopathology and the risk of postpartum mental disorders. J Clin Psychiatry 2007; 68:1947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/24\">",
"      Bergink V, Lambregtse-van den Berg MP, Koorengevel KM, et al. First-onset psychosis occurring in the postpartum period: a prospective cohort study. J Clin Psychiatry 2011; 72:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/25\">",
"      Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM. Prophylactic lithium in puerperal psychosis. The experience of three centres. Br J Psychiatry 1991; 158:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/26\">",
"      Heron J, McGuinness M, Blackmore ER, et al. Early postpartum symptoms in puerperal psychosis. BJOG 2008; 115:348.",
"     </a>",
"    </li>",
"    <li>",
"     Frey BN, Macritchie KA, Soares CN, Steiner M. Bipolar disorder in women. In: Bipolar Disorder: Clinical and Neurobiological Foundations, Yatham LN, Maj M.  (Eds), Wiley-Blackwell, West Sussex 2010. p.463.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/28\">",
"      Doucet S, Jones I, Letourneau N, et al. Interventions for the prevention and treatment of postpartum psychosis: a systematic review. Arch Womens Ment Health 2011; 14:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/29\">",
"      Friedman SH. Postpartum mood disorders: genetic progress and treatment paradigms. Am J Psychiatry 2009; 166:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/30\">",
"      Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150:662.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/31\">",
"      Videbech P, Gouliaev G. First admission with puerperal psychosis: 7-14 years of follow-up. Acta Psychiatr Scand 1995; 91:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/32\">",
"      Sch&ouml;pf J, Rust B. Follow-up and family study of postpartum psychoses. Part I: Overview. Eur Arch Psychiatry Clin Neurosci 1994; 244:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/33\">",
"      Blackmore ER, Jones I, Doshi M, et al. Obstetric variables associated with bipolar affective puerperal psychosis. Br J Psychiatry 2006; 188:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/34\">",
"      Heron J, Robertson Blackmore E, McGuinness M, et al. No 'latent period' in the onset of bipolar affective puerperal psychosis. Arch Womens Ment Health 2007; 10:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/35\">",
"      Sharma V. Treatment of postpartum psychosis: challenges and opportunities. Curr Drug Saf 2008; 3:76.",
"     </a>",
"    </li>",
"    <li>",
"     Berga SL, Parry BL, Moses-Kolko EL. Psychiatry and reproductive medicine. In: Kaplan and Sadock's Comperhensive Textbook of Psychiatry, Ninth Edition, Sadock BJ, Sadock VA, Ruiz P.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2009. Vol II, p.2539.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/37\">",
"      Spinelli MG. Postpartum psychosis: detection of risk and management. Am J Psychiatry 2009; 166:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/38\">",
"      Packer S. Family planning for women with bipolar disorder. Hosp Community Psychiatry 1992; 43:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/39\">",
"      Mahon PB, Payne JL, MacKinnon DF, et al. Genome-wide linkage and follow-up association study of postpartum mood symptoms. Am J Psychiatry 2009; 166:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/40\">",
"      Kumar HB, Purushottam M, Kubendran S, et al. Serotonergic candidate genes and puerperal psychosis: an association study. Psychiatr Genet 2007; 17:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/41\">",
"      Payne JL, MacKinnon DF, Mondimore FM, et al. Familial aggregation of postpartum mood symptoms in bipolar disorder pedigrees. Bipolar Disord 2008; 10:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/42\">",
"      Jones I, Hamshere M, Nangle JM, et al. Bipolar affective puerperal psychosis: genome-wide significant evidence for linkage to chromosome 16. Am J Psychiatry 2007; 164:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/43\">",
"      Colom F, Cruz N, Pacchiarotti I, et al. Postpartum bipolar episodes are not distinct from spontaneous episodes: implications for DSM-V. J Affect Disord 2010; 126:61.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/44\">",
"      Mota N, Cox BJ, Enns MW, et al. The relationship between mental disorders, quality of life, and pregnancy: findings from a nationally representative sample. J Affect Disord 2008; 109:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/45\">",
"      Azorin JM, Angst J, Gamma A, et al. Identifying features of bipolarity in patients with first-episode postpartum depression: findings from the international BRIDGE study. J Affect Disord 2012; 136:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/46\">",
"      Viguera AC, Whitfield T, Baldessarini RJ, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007; 164:1817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/47\">",
"      Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/48\">",
"      Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/49\">",
"      Sharma V, Khan M, Corpse C, Sharma P. Missed bipolarity and psychiatric comorbidity in women with postpartum depression. Bipolar Disord 2008; 10:742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/50\">",
"      Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/51\">",
"      McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/52\">",
"      Jones I, Craddock N. Bipolar disorder and childbirth: the importance of recognising risk. Br J Psychiatry 2005; 186:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/53\">",
"      Di Florio A, Forty L, Gordon-Smith K, et al. Perinatal episodes across the mood disorder spectrum. JAMA Psychiatry 2013; 70:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/54\">",
"      Grof P, Robbins W, Alda M, et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. J Affect Disord 2000; 61:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/55\">",
"      Marangell LB. Current issues: women and bipolar disorder. Dialogues Clin Neurosci 2008; 10:229.",
"     </a>",
"    </li>",
"    <li>",
"     Burt VK, Stein K. Treatment of women. In: The American Psychiatric Publishing Textbook of Psychiatry, Fifth Edition, Hales RE, Yodofsky SC, Gabbard GO.  (Eds), American Psychiatric Publishing, Inc., Washington, DC 2008. p.1489.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/57\">",
"      Serretti A, Olgiati P, Colombo C. Influence of postpartum onset on the course of mood disorders. BMC Psychiatry 2006; 6:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/58\">",
"      Robling SA, Paykel ES, Dunn VJ, et al. Long-term outcome of severe puerperal psychiatric illness: a 23 year follow-up study. Psychol Med 2000; 30:1263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/59\">",
"      Oates M. Suicide: the leading cause of maternal death. Br J Psychiatry 2003; 183:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/60\">",
"      Appleby L, Mortensen PB, Faragher EB. Suicide and other causes of mortality after post-partum psychiatric admission. Br J Psychiatry 1998; 173:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/61\">",
"      Work Group on Psychiatric Evaluation, American Psychiatric Association Steering Committee on Practice Guidlines. Psychiatric evaluation of adults. Second edition. American Psychiatric Association. Am J Psychiatry 2006; 163:3.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association Practice Guideline for the Psychiatric Evaluation of Adults, Second Edition, 2006. file://www.psych.org/MainMenu/PsychiatricPractice/PracticeGuidelines_1.aspx (Accessed on July 18, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/63\">",
"      Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/64\">",
"      Sharma V, Xie B. Screening for postpartum bipolar disorder: validation of the Mood Disorder Questionnaire. J Affect Disord 2011; 131:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/65\">",
"      Chessick CA, Dimidjian S. Screening for bipolar disorder during pregnancy and the postpartum period. Arch Womens Ment Health 2010; 13:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/66\">",
"      Hirschfeld RM, Williams JB, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000; 157:1873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/67\">",
"      Hirschfeld RM. The mood disorder questionnaire: its impact on the field [corrected]. Depress Anxiety 2010; 27:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/68\">",
"      Hirschfeld RM, Cass AR, Holt DC, Carlson CA. Screening for bipolar disorder in patients treated for depression in a family medicine clinic. J Am Board Fam Pract 2005; 18:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/69\">",
"      Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001; 16:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/70\">",
"      Yawn BP, Pace W, Wollan PC, et al. Concordance of Edinburgh Postnatal Depression Scale (EPDS) and Patient Health Questionnaire (PHQ-9) to assess increased risk of depression among postpartum women. J Am Board Fam Med 2009; 22:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/71\">",
"      Sharma V, Burt VK, Ritchie HL. Bipolar II postpartum depression: Detection, diagnosis, and treatment. Am J Psychiatry 2009; 166:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/72\">",
"      Solomon DA, Leon AC, Maser JD, et al. Distinguishing bipolar major depression from unipolar major depression with the screening assessment of depression-polarity (SAD-P). J Clin Psychiatry 2006; 67:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/73\">",
"      Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/74\">",
"      Gibson J, McKenzie-McHarg K, Shakespeare J, et al. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand 2009; 119:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27129/abstract/75\">",
"      Leung SS, Leung C, Lam TH, et al. Outcome of a postnatal depression screening programme using the Edinburgh Postnatal Depression Scale: a randomized controlled trial. J Public Health (Oxf) 2011; 33:292.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14651 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6ED53622C5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27129=[""].join("\n");
var outline_f26_31_27129=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H86457796\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H50297302\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H50297310\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13183269\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12999023\">",
"      General population",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12999031\">",
"      Clinical samples",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3376877\">",
"      - Psychotic episodes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13589883\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H43784803\">",
"      CLINICAL MANIFESTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13589937\">",
"      Psychotic features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H991133\">",
"      COURSE OF ILLNESS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H991140\">",
"      Subsequent mood episodes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H991147\">",
"      - Postpartum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H991154\">",
"      - Nonpostpartum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H991161\">",
"      Suicide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H351628\">",
"      ASSESSMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H351797\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13590137\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13590145\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H86457796\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PSYCH/14651\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/14651|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/43/34495\" title=\"figure 1A\">",
"      Edinburgh depression scale 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/61/34783\" title=\"figure 1B\">",
"      Edinburgh depression scale 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PSYCH/14651|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/53/3932\" title=\"table 1\">",
"      DSM-IV-TR diagnostic criteria for mania",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/39/23164\" title=\"table 2\">",
"      DSM-IV-TR diagnostic criteria for hypomania",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/21/17756\" title=\"table 3\">",
"      DSM-IV-TR diagnostic criteria for major depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/63/20477\" title=\"table 4\">",
"      Mood disorder questionnaire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/12/14541\" title=\"table 5\">",
"      PHQ-9 questionnaire",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/11/19639?source=related_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/9/27802?source=related_link\">",
"      Bipolar disorder in adults: Maintenance treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/1/5146?source=related_link\">",
"      Bipolar disorder in postpartum women: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/58/28583?source=related_link\">",
"      Overview of psychosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?4/5/4178?source=related_link\">",
"      Patient information: Bipolar disorder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/55/39796?source=related_link\">",
"      Patient information: Bipolar disorder (manic depression) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/61/32726?source=related_link\">",
"      Patient information: Reducing the costs of medicines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/11/20666?source=related_link\">",
"      Postpartum blues and depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/39/17014?source=related_link\">",
"      Postpartum psychosis: Epidemiology, clinical manifestations, and assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/62/29670?source=related_link\">",
"      Treatment of postpartum psychosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/40/4745?source=related_link\">",
"      Using scales to monitor symptoms and treatment of depression (measurement based care)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27130="Differential diagnosis and evaluation of glomerular disease";
var content_f26_31_27130=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"8\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Differential diagnosis and evaluation of glomerular disease",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27130/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27130/contributors\">",
"     Lee A Hebert, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27130/contributors\">",
"     Samir V Parikh, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27130/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27130/contributors\">",
"     Richard J Glassock, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/31/27130/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/31/27130/contributors\">",
"     John P Forman, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/31/27130/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of some form of glomerular disease, as opposed to primary tubulointerstitial or vascular disease, is usually suspected from the history (including a family history of glomerular disease), physical examination (eg, edema), and from one or more of the following urinary findings: hematuria (particularly if the red cells have a dysmorphic appearance), red cell casts, lipiduria (since glomerular permeability must be increased to allow the filtration of large lipoproteins), and proteinuria, which may be in the nephrotic range (greater than 3.5",
"    <span class=\"nowrap\">",
"     g/day).",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link&amp;anchor=H10#H10\">",
"     \"Etiology and evaluation of hematuria in adults\", section on 'Glomerular versus nonglomerular bleeding'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=see_link&amp;anchor=H26#H26\">",
"     \"Urinalysis in the diagnosis of kidney disease\", section on 'The assessment of lipiduria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13914?source=see_link\">",
"     \"Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26262?source=see_link\">",
"     \"Evaluation of proteinuria in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these clues, the ability to distinguish glomerular disease from chronic tubulointerstitial disease may be difficult. Although tubulointerstitial disease does not directly increase protein excretion, nephron loss can induce secondary glomerulosclerosis leading to proteinuria that may reach the nephrotic range. Such patients may be erroneously considered to have a primary glomerular disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'Secondary FSGS'",
"    </a>",
"    .) Severe vascular diseases, such as malignant hypertension or a thrombotic microangiopathy, are other disorders that can be associated with hematuria and proteinuria and thus resemble primary glomerular disease.",
"   </p>",
"   <p>",
"    Establishing the correct diagnosis usually requires renal biopsy. This topic will review how the clinical features at presentation can allow the clinician to narrow the differential diagnosis prior to biopsy. The mechanisms of glomerular injury are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/30/18921?source=see_link\">",
"     \"Mechanisms of immune injury of the glomerulus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/27/43448?source=see_link\">",
"     \"Mechanisms of glomerular crescent formation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL PATTERNS OF GLOMERULAR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are many causes of glomerular disease, most patients present with one of two patterns, nephrotic or nephritic, that are based upon the urine sediment and the degree of proteinuria (",
"    <a class=\"graphic graphic_table graphicRef62131 \" href=\"UTD.htm?34/13/35036\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93802214\">",
"    <span class=\"h2\">",
"     Nephrotic pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nephrotic pattern is characterized by proteinuria that is usually above 3.5",
"    <span class=\"nowrap\">",
"     g/day",
"    </span>",
"    and lipiduria, but few cells or casts other than fatty casts (",
"    <a class=\"graphic graphic_picture graphicRef69603 graphicRef79604 \" href=\"UTD.htm?18/28/18883\">",
"     picture 1A-B",
"    </a>",
"    ). Patients who also have edema and hyperlipidemia (the full-blown nephrotic syndrome) tend to have a more marked glomerular leak than those with proteinuria alone. Some patients also have microscopic hematuria. Red cell casts are usually not seen and, when present, may result from a concurrent glomerulonephritis as has been described in diabetic nephropathy. (See",
"    <a class=\"local\" href=\"#H95232219\">",
"     'Limitations of this classification'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=see_link&amp;anchor=H95228685#H95228685\">",
"     \"Overview of diabetic nephropathy\", section on 'Hematuria'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Any of the conditions associated with a nephrotic pattern can produce a spectrum of disease ranging from asymptomatic proteinuria to full-blown nephrotic syndrome with marked edema. However, secondary focal segmental glomerulosclerosis (as with reflux nephropathy) is more likely in patients with nephrotic range proteinuria (more than 3.5",
"    <span class=\"nowrap\">",
"     g/day)",
"    </span>",
"    who have neither hypoalbuminemia nor edema [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'Secondary FSGS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients with proteinuria and a bland urine sediment have only mild proteinuria (eg, 1 to 3",
"    <span class=\"nowrap\">",
"     g/day).",
"    </span>",
"    Almost all of the causes of nephrotic syndrome can present with subnephrotic proteinuria with the exception of patients with minimal change disease and most patients with primary focal segmental glomerulosclerosis who typically present with the abrupt onset of the nephrotic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34601?source=see_link&amp;anchor=H18#H18\">",
"     \"Etiology, clinical features, and diagnosis of minimal change disease in adults\", section on 'General presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H12#H12\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'Clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The relatively bland sediment seen in the pure nephrotic disorders results from the lack of inflammatory cell infiltration in the glomeruli. This finding is in large part due to the absence of immune complex deposition in most of these disorders, such as minimal change disease, focal segmental glomerulosclerosis, diabetic nephropathy, and amyloidosis. Immune complexes are deposited in membranous nephropathy, but this occurs across the glomerular basement membrane in the subepithelial space. Thus, complement can be activated but the chemoattractants (C3a and C5a) are separated from the vascular space by the basement membrane and therefore do not have access to the circulating mononuclear cells and neutrophils [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/2\">",
"     2",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link&amp;anchor=H6#H6\">",
"     \"Causes and diagnosis of membranous nephropathy\", section on 'Animal models'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93802312\">",
"    <span class=\"h3\">",
"     Acute kidney injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the general lack of inflammation in patients with the nephrotic syndrome without a nephritic sediment (which is described in the next section), the serum creatinine concentration is usually normal or only slightly elevated at presentation. However, acute kidney injury (acute renal failure) can occur in a limited number of settings. This issue is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18598?source=see_link\">",
"     \"Acute kidney injury (acute renal failure) in minimal change disease and other forms of nephrotic syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, major causes of acute kidney injury in the nephrotic syndrome include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Concurrent acute tubular necrosis, usually in minimal change disease, and primarily in patients over 50 years of age. In children, acute kidney injury may result from reduced glomerular permeability. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18598?source=see_link\">",
"       \"Acute kidney injury (acute renal failure) in minimal change disease and other forms of nephrotic syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Tubular injury in collapsing focal segmental glomerulosclerosis, either idiopathic or associated with HIV infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/31/43512?source=see_link\">",
"       \"Collapsing focal segmental glomerulosclerosis not associated with HIV infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=see_link\">",
"       \"HIV-associated nephropathy (HIVAN)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Minimal change disease with acute interstitial nephritis induced by nonsteroidal antiinflammatory drugs. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24582?source=see_link\">",
"       \"NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Crescentic glomerulonephritis superimposed upon membranous nephropathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link&amp;anchor=H22#H22\">",
"       \"Causes and diagnosis of membranous nephropathy\", section on 'Crescentic glomerulonephritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nephrotic syndrome secondary to monoclonal immunoglobulin deposition disease may also be associated with myeloma cast nephropathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27400?source=see_link\">",
"       \"Types of renal disease in multiple myeloma\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93801583\">",
"    <span class=\"h2\">",
"     Nephritic pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;The nephritic urine sediment is characterized by the presence of red cells and occasionally white blood cells, with or without red cell or mixed cellular casts, and variable degrees of proteinuria, ranging from normal protein excretion to the nephrotic range (ie, both nephritic and nephrotic). Some of the red cells have a dysmorphic appearance and acanthocytes, which are best seen when the urine sediment is examined with phase contrast microscopy, are considered diagnostic of glomerular hematuria, particularly if they comprise 5 percent or more of urinary red cells (",
"    <a class=\"graphic graphic_picture graphicRef79440 \" href=\"UTD.htm?24/0/24591\">",
"     picture 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef62064 \" href=\"UTD.htm?13/47/14079\">",
"     picture 3",
"    </a>",
"    ). However, many clinicians do not have access to these microscopes or experience in accurately identifying acanthocytes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=see_link&amp;anchor=H1824471569#H1824471569\">",
"     \"Etiology and evaluation of hematuria in adults\", section on 'Acanthocytes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93802207\">",
"    <span class=\"h3\">",
"     Pathologic classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;On renal biopsy, glomerulonephritis has been described on",
"    <strong>",
"     light microscopy",
"    </strong>",
"    as being focal or diffuse. This terminology is most often used in lupus nephritis and has also been used in ANCA-positive vasculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H7#H7\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Classification'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link&amp;anchor=H377577#H377577\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\", section on 'Histopathologic classification'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, focal glomerulonephritis is characterized by inflammatory or vasculitic lesions in less than 50 percent of glomeruli on light microscopy and is most often segmental, involving less than 50 percent of the glomerular tuft. In diffuse glomerulonephritis, more than 50 percent of glomeruli (and often all or almost all glomeruli) have inflammatory lesions, which may be segmental or global. Focal glomerulonephritis generally has a less severe presentation typically characterized by hematuria, subnephrotic proteinuria, lack of edema, and no or only modest reductions in glomerular filtration rate. Nephrotic syndrome",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a substantially reduced glomerular filtration rate are primarily seen in diffuse disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95232219\">",
"    <span class=\"h2\">",
"     Limitations of this classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classification of glomerular disease into nephrotic and nephritic patterns allows the clinician to identify the most likely causes of the glomerular disease. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Causes of glomerular disease according to presentation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    However, there are limitations to this approach, which should",
"    <strong>",
"     not",
"    </strong>",
"    be considered an alternative to definitive diagnosis by renal biopsy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although patients with a nephrotic pattern can have some hematuria, red cell casts, which are suggestive of a nephritic pattern, can also occur. As an example, red cell casts have been reported in patients with diabetic nephropathy. In a study of eight such patients in whom renal biopsy was performed, five had only diabetic nephropathy and three had concurrent glomerulonephritis (postinfectious in two and IgA nephropathy in one) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=see_link&amp;anchor=H95228685#H95228685\">",
"       \"Overview of diabetic nephropathy\", section on 'Hematuria'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Occasional patients with glomerulonephritis on renal biopsy have no hematuria or proteinuria, including patients with crescentic glomerulonephritis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/4-6\">",
"       4-6",
"      </a>",
"      ]. \"Silent\" lupus nephritis has also been described in patients with no clinical evidence of renal disease in whom renal biopsy reveals focal or diffuse proliferative glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H17#H17\">",
"       \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Silent lupus nephritis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Nonspecific nature of the histologic patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to appreciate that most of the histologic patterns seen in glomerular disease have a number of causes. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Membranoproliferative glomerulonephritis can be a systemic immune complex disease (due, for example, to infective endocarditis, systemic lupus erythematosus, or hepatitis C virus), complement dysregulation, chronic thrombotic microangiopathy, or a monoclonal immunoglobulin deposition disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=see_link\">",
"       \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Membranous nephropathy can be induced by systemic lupus erythematosus, chronic hepatitis B virus infection, underlying malignancy and drugs (eg, gold,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/6/4200?source=see_link\">",
"       penicillamine",
"      </a>",
"      , mercury). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link\">",
"       \"Causes and diagnosis of membranous nephropathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Focal segmental glomerulosclerosis can be a primary condition that may be related pathogenetically to minimal change disease, or a secondary change induced by intraglomerular hypertension or healing of previous glomerular injury. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link\">",
"       \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96871475\">",
"    <span class=\"h2\">",
"     Concurrent glomerular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although uncommon, some patients have more than one cause of glomerular disease. At least two mechanisms may be involved: the chance occurrence of two independent renal diseases; or a single disease may initiate an immune response that mimics the presentation of another disease. The following examples of concurrent glomerular disease in patients with membranous nephropathy (MN) are illustrative of each of these mechanisms:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A study from a major renal pathology laboratory identified 14 patients with coexistent primary (or idiopathic) MN and ANCA-associated necrotizing and crescentic glomerulonephritis, with both conditions being diagnosed at the same time in most patients [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/7\">",
"       7",
"      </a>",
"      ]. Overall, there were 1149 patients with biopsies showing MN. Thus, the incidence of ANCA-associated crescentic glomerulonephritis in patients with MN was 1.2 percent.",
"      <br/>",
"      <br/>",
"      These data were derived from over 13,000 native kidney biopsies processed by this laboratory. MN not associated with lupus was present in 8.8 percent and ANCA-associated necrotizing and crescentic glomerulonephritis was present in 3.4 percent. Based upon these numbers, concurrent disease would have been expected",
"      <strong>",
"       by chance",
"      </strong>",
"      in 39 patients, well above the observed 14 cases. It was concluded that concurrent disease represented a chance occurrence of two",
"      <strong>",
"       unrelated",
"      </strong>",
"      disease processes. In addition to this association, there have been a smaller number of case reports of ANCA-associated crescentic glomerulonephritis in patients with membranous lupus nephropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/8\">",
"       8",
"      </a>",
"      ] and of ANCA-negative and anti-glomerular basement membrane (GBM) antibody-negative crescentic glomerulonephritis associated with idiopathic or secondary MN [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link&amp;anchor=H22#H22\">",
"       \"Causes and diagnosis of membranous nephropathy\", section on 'Crescentic glomerulonephritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In some patients with diabetes who develop MN, there may be a",
"      <strong>",
"       direct relation",
"      </strong>",
"      between the two diseases. This was demonstrated in a report of seven patients with diabetes who developed MN [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/10\">",
"       10",
"      </a>",
"      ]. Three of the patients had granular deposits of insulin along the glomerular capillary wall, as detected by anti-porcine insulin antibodies, along with IgG and complement. The nephrotic syndrome developed after the initiation of porcine insulin in all three patients and, in two of these patients, the use of human insulin rather than porcine insulin led to amelioration of the proteinuria. The other four patients had idiopathic MN.",
"      <br/>",
"      <br/>",
"      There are two major findings that suggest nondiabetic renal disease in diabetic patients with or without diabetic nephropathy: an acute increase in proteinuria",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the serum creatinine, since diabetic nephropathy is a slowly progressive disease over a period of years; and the development of an active urine sediment with red cells (particularly acanthocytes) and cellular casts, although these findings can also be seen with diabetic nephropathy alone. In addition, the onset of proteinuria less than five years from the documented onset of type 1 diabetes suggests a cause independent of diabetes, since the latent period for overt diabetic nephropathy is usually at least 10 to 15 years. These issues and the frequency of nondiabetic glomerular disease in patients with diabetes are discussed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=see_link&amp;anchor=H26#H26\">",
"       \"Overview of diabetic nephropathy\", section on 'Nondiabetic renal disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition to these examples, there are a number of other settings in which concurrent glomerular disease has been described. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      ANCA-associated and lupus nephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H573393#H573393\">",
"       \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Overlap of lupus and ANCA glomerulonephritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      ANCA-associated and anti-GBM antibody-associated glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9674?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical spectrum of antineutrophil cytoplasmic antibodies\", section on 'Anti-GBM antibody disease'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=see_link&amp;anchor=H11#H11\">",
"       \"Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease\", section on 'Antineutrophil cytoplasm antibodies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      IgA nephropathy with minimal change disease, membranous nephropathy, or ANCA-associated glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/19/1337?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical presentation and diagnosis of IgA nephropathy\", section on 'Clinical associations'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      ANCA-associated and bacterial infection-related glomerulonephritis (mostly poststreptococcal or Staphylococcus-associated) in adults.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CAUSES OF GLOMERULAR DISEASE ACCORDING TO PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;When approaching a patient with apparent glomerular disease, the urinalysis, the estimated glomerular filtration rate, the degree of proteinuria, and patient characteristics such as age, race, and, if present, family history of renal disease help to identify the most likely causes (",
"    <a class=\"graphic graphic_table graphicRef62131 \" href=\"UTD.htm?34/13/35036\">",
"     table 1",
"    </a>",
"    ). However, confirmation by renal biopsy is usually required.",
"   </p>",
"   <p>",
"    Although the following correlations may vary by geographic region, there are some general observations that appear to hold across widely disparate regions, particularly in developed countries. As an example, in a collection of studies based upon renal biopsy registries from multiple countries, the principal causes of acute glomerulonephritis (focal and diffuse disease) generally included IgA nephropathy, and endocapillary proliferative glomerulonephritis (often of a postinfectious nature) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/11-17\">",
"     11-17",
"    </a>",
"    ]. Rapidly progressive (crescentic) glomerulonephritis is not listed as a unique entity, since crescents can be induced by most of the causes of glomerulonephritis. In addition, minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy are among the most common causes of the nephrotic syndrome in adults in the developed world.",
"   </p>",
"   <p>",
"    The following is an approximate guide to the histologic lesions commonly seen in patients of varying ages in developed countries. This approach is",
"    <strong>",
"     not",
"    </strong>",
"    a substitute for renal biopsy, when indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=see_link&amp;anchor=H3#H3\">",
"     \"Indications for and complications of renal biopsy\", section on 'Indications and when biopsy may not be necessary'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As discussed below, serologic testing may point toward a specific diagnosis. (See",
"    <a class=\"local\" href=\"#H460668346\">",
"     'Laboratory testing in patients with suspected glomerular disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H93802546\">",
"    <span class=\"h2\">",
"     Nephrotic syndrome without a nephritic sediment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with nephrotic syndrome without a nephritic sediment do not have red cell casts but may have mild hematuria. (See",
"    <a class=\"local\" href=\"#H93802214\">",
"     'Nephrotic pattern'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Less than 15 years &mdash; Minimal change disease, focal segmental glomerulosclerosis, mesangial proliferative glomerulonephritis",
"     </li>",
"     <li>",
"      15 to 40 years &mdash; Focal segmental glomerulosclerosis, minimal change disease, membranous nephropathy (including lupus), diabetic nephropathy, preeclampsia, postinfectious glomerulonephritis (later stage)",
"     </li>",
"     <li>",
"      Greater than 40 years &mdash; Focal segmental glomerulosclerosis, membranous nephropathy, diabetic nephropathy, minimal change disease, IgA nephropathy, primary amyloidosis or the related disorder light chain deposition disease (which can account for 15 to 20 percent of cases in patients over the age of 60), benign nephrosclerosis, postinfectious glomerulonephritis (later stage).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mild glomerulonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mild glomerulonephritis is defined as a nephritic sediment in patients who have a normal or near normal estimated glomerular filtration rate and do not have the nephrotic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=see_link&amp;anchor=H20659769#H20659769\">",
"     \"Assessment of kidney function\", section on 'Estimation equations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Less than 15 years &mdash; Mild postinfectious glomerulonephritis, IgA nephropathy, thin basement membrane disease, hereditary nephritis, Henoch-Sch&ouml;nlein purpura (HSP, also termed IgA vasculitis [IgAV]), mesangial proliferative glomerulonephritis",
"     </li>",
"     <li>",
"      15 to 40 years &mdash; IgA nephropathy, thin basement membrane disease, lupus nephritis, hereditary nephritis, mesangial proliferative glomerulonephritis",
"     </li>",
"     <li>",
"      Greater than 40 years &mdash; IgA nephropathy",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Moderate to severe glomerulonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moderate to severe glomerulonephritis is defined as a nephritic sediment in patients who have a reduced estimated glomerular filtration rate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    nephrotic syndrome. Several of these disorders, such as postinfectious glomerulonephritis, lupus nephritis, membranoproliferative glomerulonephritis, and mixed cryoglobulinemia, are commonly associated with hypocomplementemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/11,18,19\">",
"     11,18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    They also may be associated with characteristic serologic findings, such as: antistreptococcal antibodies in poststreptococcal glomerulonephritis, antinuclear antibodies in lupus nephritis, anti-GBM antibodies in anti-GBM antibody disease, circulating cryoglobulins in mixed cryoglobulinemia, and antineutrophil cytoplasmic antibodies in granulomatosis with polyangiitis (Wegener's) and related diseases. (See",
"    <a class=\"local\" href=\"#H14578038\">",
"     'Hematuria following upper respiratory infection'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=see_link\">",
"     \"Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=see_link\">",
"     \"Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9674?source=see_link\">",
"     \"Clinical spectrum of antineutrophil cytoplasmic antibodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Less than 15 years &mdash; Postinfectious glomerulonephritis, membranoproliferative glomerulonephritis",
"     </li>",
"     <li>",
"      15 to 40 years &mdash; Postinfectious glomerulonephritis, lupus nephritis, rapidly progressive (crescentic) glomerulonephritis, IgA nephropathy, fibrillary glomerulonephritis, membranoproliferative glomerulonephritis",
"     </li>",
"     <li>",
"      Greater than 40 years &mdash; Rapidly progressive glomerulonephritis, vasculitis (including mixed cryoglobulinemia), IgA nephropathy, fibrillary glomerulonephritis, postinfectious glomerulonephritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49245340\">",
"    <span class=\"h2\">",
"     Effect of race",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of the different causes of glomerular disease varies with race as well as age. The potential magnitude of difference was illustrated in a review of 340 patients (mean age 43) over a 20 year period with nephrotic proteinuria in whom renal biopsy revealed primary glomerular disease (ie, not due to a known causes such postinfectious glomerulonephritis or lupus nephritis) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/20\">",
"     20",
"    </a>",
"    ]. The prevalence of the different causes of glomerular disease was different in black and white patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In black patients &mdash; Focal segmental glomerulosclerosis (57 percent), membranous nephropathy (24 percent) minimal change disease (14 percent) were the major causes. Membranoproliferative glomerulonephritis, IgA nephropathy, and immunotactoid nephropathy were each present in 1 to 2 percent.",
"     </li>",
"     <li>",
"      In white patients &mdash; Membranous nephropathy (36 percent), focal segmental glomerulosclerosis (23 percent), minimal change disease (20 percent), IgA nephropathy (8 percent), membranoproliferative glomerulonephritis (6 percent), and immunotactoid glomerulopathy (6 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The main difference was the marked increase in the proportion of cases due to focal segmental glomerulosclerosis (both idiopathic and that due to HIV infection) in blacks, which may be at least in part genetically mediated. The supportive data are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H9804961#H9804961\">",
"     \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'FSGS in African Americans'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=see_link&amp;anchor=H5577956#H5577956\">",
"     \"HIV-associated nephropathy (HIVAN)\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3936567\">",
"    <span class=\"h2\">",
"     Positive family history",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a variety of hereditary disorders that are associated with glomerular disease. Thin basement membrane nephropathy (benign familial hematuria), hereditary nephritis (Alport syndrome), and some causes of focal segmental glomerulosclerosis are examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thin basement membrane nephropathy is a common, often familial disorder with autosomal dominant inheritance. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12088?source=see_link&amp;anchor=H3#H3\">",
"       \"Thin basement membrane nephropathy (benign familial hematuria)\", section on 'Pathogenesis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      X-linked transmission accounts for approximately 80 percent of cases of hereditary nephritis. In such families, only males and affected and there is no father to son transmission. However, autosomal recessive and autosomal dominant variants also occur. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=see_link&amp;anchor=H2#H2\">",
"       \"Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)\", section on 'Genetics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Both autosomal dominant and autosomal recessive transmission occur in different genetic forms of focal segmental glomerulosclerosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=see_link&amp;anchor=H23#H23\">",
"       \"Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis\", section on 'Genetic disease'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14577549\">",
"    <span class=\"h2\">",
"     Systemic presentations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although many patients with glomerular disease have only renal involvement, systemic presentations are not uncommon, as frequently occurs in disorders such as systemic lupus erythematosus and vasculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=see_link\">",
"     \"Overview of the clinical manifestations of systemic lupus erythematosus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, some patients present with glomerular disease and one other important finding, such as pulmonary hemorrhage or hematuria following an upper respiratory infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14577579\">",
"    <span class=\"h3\">",
"     Acute glomerulonephritis and pulmonary hemorrhage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following disorders should be considered in patients presenting with acute glomerulonephritis and pulmonary hemorrhage (also called pulmonary-renal syndrome):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antineutrophil cytoplasmic antibody (ANCA)-positive vasculitis as seen in granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link&amp;anchor=H11698552#H11698552\">",
"       \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\", section on 'Pulmonary disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anti-glomerular basement membrane (GBM) antibody disease (Goodpasture's). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=see_link&amp;anchor=H5#H5\">",
"       \"Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease\", section on 'Clinical presentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pulmonary hemorrhage is a rare finding in lupus, HSP (IgAV), and infective endocarditis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/21,22\">",
"       21,22",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=see_link&amp;anchor=H27#H27\">",
"       \"Pulmonary manifestations of systemic lupus erythematosus in adults\", section on 'Pulmonary hemorrhage'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=see_link&amp;anchor=H37580720#H37580720\">",
"       \"Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\", section on 'Respiratory tract'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5556?source=see_link\">",
"       \"Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute glomerulonephritis complicated by pulmonary edema due to fluid overload, as can occur in poststreptococcal glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35304?source=see_link\">",
"       \"Poststreptococcal glomerulonephritis in children\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of studies have found that ANCA-positive vasculitis is the most common cause of glomerulonephritis and pulmonary hemorrhage followed by anti-GBM antibody disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. This was illustrated in a report of 88 patients in which 48 had ANCA antibodies alone, six had anti-GBM antibodies alone, and seven had both ANCA and anti-GBM antibodies [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/23\">",
"     23",
"    </a>",
"    ]. The remaining 27 patients had a variety of unrelated pulmonary diseases, such as pulmonary emboli and infection.",
"   </p>",
"   <p>",
"    Serologic testing for these disorders is discussed below. In patients who have purpuric lesions, skin biopsy may reveal leukocytoclastic vasculitis and IgA deposition, which is essentially diagnostic of HSP (IgAV). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=see_link&amp;anchor=H15#H15\">",
"     \"Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)\", section on 'Skin'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14578038\">",
"    <span class=\"h3\">",
"     Hematuria following upper respiratory infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of microscopic or gross (macroscopic) hematuria after an upper respiratory infection (URI) is most often associated with an immune complex mediated glomerulonephritis. A less common cause of hematuria after a URI is acute interstitial nephritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27209?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical manifestations and diagnosis of acute interstitial nephritis\", section on 'Infections'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The presence of renal involvement after a URI is usually discovered only if there is gross hematuria or the glomerulonephritis is severe enough to produce edema. Microscopic hematuria is much more common but is rarely detected. (See",
"    <a class=\"local\" href=\"#H662970\">",
"     'Microscopic hematuria alone'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H662940\">",
"    <span class=\"h4\">",
"     Clinically evident glomerulonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinically evident glomerulonephritis after a URI is most often due to IgA nephropathy or poststreptococcal glomerulonephritis (PSGN). Less common causes include Staphylococcus-related glomerulonephritis, C3 glomerulonephritis, and hereditary nephritis (Alport syndrome).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H660558\">",
"    <span class=\"h5\">",
"     IgA nephropathy versus PSGN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with IgA nephropathy, which is the most common cause in primary glomerulonephritis in many developed countries, often have one or recurrent episodes of gross hematuria, usually occurring one to three days after a URI due to either viral or bacterial infections. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/19/1337?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical presentation and diagnosis of IgA nephropathy\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Poststreptococcal glomerulonephritis (PSGN) is induced by pharyngeal or skin infection with specific nephritogenic strains of group A, beta-hemolytic streptococci. PSGN and IgA nephropathy can be distinguished by renal biopsy, but biopsy usually is not be performed if the clinical history is highly suggestive of PSGN and resolution begins within one to two weeks and usually not performed in IgA nephropathy for hematuria in the absence of findings suggestive of a worse prognosis such as proteinuria above 1000",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    or an elevated serum creatinine. The supportive data are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35304?source=see_link\">",
"     \"Poststreptococcal glomerulonephritis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/19/1337?source=see_link&amp;anchor=H12#H12\">",
"     \"Clinical presentation and diagnosis of IgA nephropathy\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42106?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and prognosis of IgA nephropathy\", section on 'Clinical predictors of progression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the absence of renal biopsy, the following features can help distinguish between PSGN and IgA nephropathy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The latent period from the onset of infection to the detection of hematuria is between",
"      <strong>",
"       one and three weeks",
"      </strong>",
"      with group A, beta-hemolytic streptococcal (GAS) pharyngitis (and between three and six weeks following streptococcal skin infection) compared with",
"      <strong>",
"       less than five days",
"      </strong>",
"      in IgA nephropathy after a bacterial or viral URI.",
"     </li>",
"     <li>",
"      Throat culture and laboratory tests for GAS (eg, streptozyme test) should be positive in PSGN following a URI but usually not in IgA nephropathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/38/5738?source=see_link&amp;anchor=H16#H16\">",
"       \"Evaluation of acute pharyngitis in adults\", section on 'Diagnostic tests'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Recurrent episodes of gross hematuria are common in IgA nephropathy but rare in PSGN since only certain streptococcal strains can cause renal disease and there is long-term persistence of antibodies against nephritis-associated streptococcal antigen, a leading candidate for the causative antigen [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      IgA nephropathy is typically a chronic disease and persistent microscopic hematuria is common after resolution of the URI. In contrast, PSGN gradually resolves after the infection has cleared. In children, a diuresis typically begins within one week, the serum creatinine returns to the previous baseline by three to four weeks, and hematuria resolves within three to six months [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/27\">",
"       27",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35304?source=see_link&amp;anchor=H19#H19\">",
"       \"Poststreptococcal glomerulonephritis in children\", section on 'Course'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, there are limitations to some of these distinctions in middle-aged and older adults. Staphylococcus appears to be as common as Streptococcus as a cause of postinfectious glomerulonephritis (PIGN) in adults and appears to be much more common than Streptococcus in elderly patients. Staphylococcus-related glomerulonephritis has some clinical features that differ from PSGN: the skin is a much more common site of infection than the upper respiratory tract, the latent period from the clinical onset of infection to the detection of glomerulonephritis may be shorter, and the onset of glomerulonephritis and the clinical recognition of infection can occur at the same time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H660574\">",
"    <span class=\"h5\">",
"     C3 glomerulonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;C3 glomerulonephritis is a form of membranoproliferative glomerulonephritis that is characterized by isolated C3 deposits. Affected patients may develop gross hematuria following an upper respiratory infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=see_link&amp;anchor=H455985668#H455985668\">",
"     \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\", section on 'C3 glomerulonephritis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118030821\">",
"    <span class=\"h5\">",
"     Hereditary nephritis (Alport syndrome)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodes of gross hematuria follow an upper respiratory infection are well described in hereditary nephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. In a study of 58 children with this disorder, episodes of gross hematuria often occurred after an upper respiratory infection at an interval of less than two days [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=see_link&amp;anchor=H3#H3\">",
"     \"Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)\", section on 'Clinical manifestations and course'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H118032056\">",
"    <span class=\"h5\">",
"     Thin basement membrane nephropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thin basement membrane nephropathy (benign familial hematuria) is a common often familial disorder with autosomal dominant inheritance that may have a frequency in the general population as high as 5 to 9 percent. Episodes of gross hematuria occur and may follow an upper respiratory infection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12088?source=see_link&amp;anchor=H4#H4\">",
"     \"Thin basement membrane nephropathy (benign familial hematuria)\", section on 'Clinical characteristics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H662970\">",
"    <span class=\"h4\">",
"     Microscopic hematuria alone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microscopic hematuria is much more common than macroscopic hematuria after a URI but these patients are not usually detected in clinical practice unless there are other manifestations of glomerular disease such as edema. The frequency of subclinical disease (also called",
"    <strong>",
"     asymptomatic or silent glomerulonephritis",
"    </strong>",
"    ) following a URI was evaluated in two prospective studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a prospective study of 240 previously healthy young men with a nonstreptococcal (mostly viral) URI, 9 (3.8 percent) had hematuria with red cell casts (patients with hematuria alone were excluded because it could reflect viral cystitis so the true incidence of hematuria was higher than 3.8 percent) and a modest reduction in creatinine clearance [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/31\">",
"       31",
"      </a>",
"      ]. Renal biopsy showed focal or diffuse mesangial proliferation, C3 deposition in five patients, and no or trace IgG or IgA deposition. Hypocomplementemia was present in four of the nine patients. These findings suggest in retrospect that some of these patients may have had a mild form of C3 glomerulonephritis, which had not yet been described. The pathologic changes (as determined by repeat biopsy in some patients) and decrease in creatinine clearance persisted for at least two to eight months. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=see_link&amp;anchor=H455985668#H455985668\">",
"       \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\", section on 'C3 glomerulonephritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A second prospective study included 248 children with group A streptococcal infection who had a normal urinalysis and total serum hemolytic complement (CH50) activity at presentation and were then evaluated weekly for at least six weeks in an attempt to detect subclinical glomerulonephritis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/32\">",
"       32",
"      </a>",
"      ]. A mild urinary abnormality, defined as hematuria",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      proteinuria, was found in 35 children (14.1 percent) and hypocomplementemia in 39, including 20 with mild urinary abnormalities. Renal biopsy in these 20 children revealed renal lesions ranging from a mild increase in mesangium and endothelial proliferation to the characteristic features of acute poststreptococcal glomerulonephritis (",
"      <a class=\"graphic graphic_picture graphicRef80304 \" href=\"UTD.htm?19/17/19734\">",
"       picture 4",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35304?source=see_link&amp;anchor=H9#H9\">",
"       \"Poststreptococcal glomerulonephritis in children\", section on 'Clinical manifestations'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H460668346\">",
"    <span class=\"h1\">",
"     LABORATORY TESTING IN PATIENTS WITH SUSPECTED GLOMERULAR DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Standard laboratory testing in patients with evidence of glomerular disease includes routine laboratory tests (eg, serum creatinine, serum albumin, complete blood count, and estimation of protein excretion in patients with proteinuria), serologic testing for disorders that cause glomerular disease, and measurement of serum complement levels to detect hypocomplementemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H49532891\">",
"    <span class=\"h2\">",
"     Serologic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing may be helpful in establishing a diagnosis in patients who present with a nephrotic or nephritic pattern as defined above. However, renal biopsy is usually performed even if serologic testing is positive for three reasons: the test itself may not be diagnostic; a positive test does not prove that that disease is responsible for the glomerular injury; and, in lupus nephritis, positive serology does not identify what type of lupus nephritis is present and patients with membranous lupus may be seronegative [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/33\">",
"     33",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Clinical patterns of glomerular disease'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The antinuclear antibody (ANA) test is a good example of these limitations. In a study of 87 adults with the nephrotic syndrome, 24 had a positive ANA, but only 15 had lupus [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/33\">",
"     33",
"    </a>",
"    ]. The combination of a high titer ANA and hypocomplementemia was virtually diagnostic of lupus. However, this information is still of limited utility, since a renal biopsy is usually indicated to determine the type of lupus nephritis that is present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link\">",
"     \"Diagnosis and classification of renal disease in systemic lupus erythematosus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite these limitations, there are certain serologic tests that are highly suggestive of a particular disorder. In addition, such testing may assist in interpretation of the renal biopsy. As an example, membranous nephropathy can be due to a variety of disorders including lupus, hepatitis B, or hepatitis C. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link&amp;anchor=H10#H10\">",
"     \"Causes and diagnosis of membranous nephropathy\", section on 'Etiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H460668475\">",
"    <span class=\"h3\">",
"     Patients with a nephrotic presentation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with the nephrotic syndrome with a nephrotic pattern in the urinalysis may have either primary renal disease (eg, minimal change disease, focal segmental glomerulosclerosis, or idiopathic membranous nephropathy) or a systemic disorder that affects the kidneys (eg, lupus, amyloidosis, hepatitis B or C virus infection, or HIV infection) (",
"    <a class=\"graphic graphic_table graphicRef62131 \" href=\"UTD.htm?34/13/35036\">",
"     table 1",
"    </a>",
"    ). Serologic testing is performed to help identify the systemic disorders. (See",
"    <a class=\"local\" href=\"#H93802214\">",
"     'Nephrotic pattern'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serologic findings suggestive of underlying systemic lupus erythematosus (SLE) include the presence of antinuclear antibodies (ANA), anti-double-stranded DNA antibodies and hypocomplementemia. However, membranous lupus, in which the urine has a nephrotic pattern, is the one form of lupus nephritis that may present with",
"      <strong>",
"       no other clinical or serologic manifestations of SLE",
"      </strong>",
"      (eg, complement levels may be normal and anti-DNA antibodies may not be detectable). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H12#H12\">",
"       \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Membranous lupus nephritis (class V)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3338?source=see_link&amp;anchor=H9#H9\">",
"       \"Diagnosis and differential diagnosis of systemic lupus erythematosus in adults\", section on 'Autoantibodies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Primary amyloidosis and light chain deposition disease are usually (80 to 90 percent) associated with a monoclonal gammopathy as detected by serum and urine immunofixation and serum free light chain ratio analysis. These disorders primarily occur in patients over the age of 40 [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/34\">",
"       34",
"      </a>",
"      ]. In addition, primary amyloidosis accounted for 10 percent of cases of nephrotic syndrome in patients over age 44 compared with only 1 percent in younger patients. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/29/13784?source=see_link&amp;anchor=H9#H9\">",
"       \"Renal amyloidosis\", section on 'Primary (AL) amyloidosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The value of hepatitis B virus (HBV) serology in a patient with the nephrotic syndrome has not been well defined. HBV most often induces membranous nephropathy. This disorder primarily occurs in children in whom the serum transaminases are mildly to moderately elevated [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/35\">",
"       35",
"      </a>",
"      ]. The serology is positive for surface (HBs) and e (HBe) antigens. An important limitation to serologic testing is that a positive result does not prove that the renal disease is due to HBV. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/28/44488?source=see_link&amp;anchor=H3#H3\">",
"       \"Renal disease associated with hepatitis B virus infection\", section on 'Membranous nephropathy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is a possible association between hepatitis C virus (HCV) infection and membranous nephropathy and, as mentioned in the next section, a clear association with membranoproliferative glomerulonephritis. Thus, HCV antibody testing is warranted in patients with a nephrotic pattern. However, as with HBV, positive serologic testing does not prove that the renal disease is due to HCV. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37353?source=see_link&amp;anchor=H4#H4\">",
"       \"Renal disease associated with hepatitis C virus infection\", section on 'Membranous nephropathy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Congenital and secondary syphilis have been associated with nephrotic syndrome due to membranous nephropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/36\">",
"       36",
"      </a>",
"      ]. In patients without a suggestive history of syphilis, serologic testing would generally not be performed until the renal biopsy results are known. Treponemal antigens have been identified in the glomeruli and effective treatment of syphilis can lead to resolution of the nephrotic syndrome. The supportive data are presented separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=see_link&amp;anchor=H4189223#H4189223\">",
"       \"Causes and diagnosis of membranous nephropathy\", section on 'Syphilis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=see_link&amp;anchor=H14#H14\">",
"       \"Diagnostic testing for syphilis\", section on 'Standard algorithms'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A collapsing form of focal segmental glomerulosclerosis (FSGS) is associated with HIV infection. Thus, HIV serologies are indicated prior to renal biopsy in patients with risk factors for HIV. However, nephrotic syndrome in such patients can also be due to membranous nephropathy induced by concurrent infection with hepatitis B, hepatitis C, or syphilis. In addition, HIV-infected patients can develop glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=see_link\">",
"       \"HIV-associated nephropathy (HIVAN)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=see_link\">",
"       \"Overview of kidney disease in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H460669045\">",
"    <span class=\"h3\">",
"     Patients with a nephritic pattern",
"    </span>",
"    &nbsp;&mdash;&nbsp;A nephritic pattern in the urinalysis with variable degrees of proteinuria can be caused by a variety of disorders (",
"    <a class=\"graphic graphic_table graphicRef62131 \" href=\"UTD.htm?34/13/35036\">",
"     table 1",
"    </a>",
"    ). Serologic testing can help identify the underlying disorder:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serologic findings suggestive of underlying systemic lupus erythematosus (SLE) include the presence of antinuclear antibodies (ANA), anti-double-stranded DNA antibodies, and hypocomplementemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=see_link&amp;anchor=H7#H7\">",
"       \"Diagnosis and classification of renal disease in systemic lupus erythematosus\", section on 'Classification'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3338?source=see_link&amp;anchor=H9#H9\">",
"       \"Diagnosis and differential diagnosis of systemic lupus erythematosus in adults\", section on 'Autoantibodies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antineutrophil cytoplasmic antibody (ANCA) titers should be performed to screen for a number of causes of vasculitis, such as granulomatosis with polyangiitis (Wegener's), microscopic polyangiitis, the Churg-Strauss syndrome, renal-limited vasculitis, and certain causes of drug-induced vasculitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9674?source=see_link&amp;anchor=H7#H7\">",
"       \"Clinical spectrum of antineutrophil cytoplasmic antibodies\", section on 'Disease associations'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link&amp;anchor=H11701485#H11701485\">",
"       \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Elevated titers of antistreptococcal antibodies following an episode of pharyngitis or impetigo is highly suggestive of poststreptococcal glomerulonephritis (PSGN). The streptozyme test, which measures five different streptococcal antibodies, is positive in more than 95 percent of patients with PSGN due to pharyngitis and about 80 percent of those with skin infections. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35304?source=see_link&amp;anchor=H14#H14\">",
"       \"Poststreptococcal glomerulonephritis in children\", section on 'Serology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Chronic bacterial (eg, endocarditis, shunt nephritis, abscesses), fungal, and, particularly in the developing world, parasitic infections can cause membranoproliferative glomerulonephritis. Blood cultures should be obtained when warranted. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=see_link&amp;anchor=H261825925#H261825925\">",
"       \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\", section on 'Infections'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Anti-glomerular basement membrane (GBM) disease should be considered in patients who also have pulmonary hemorrhage but can occur as an isolated renal disease. The diagnosis prior to renal biopsy can be made by serum assay for anti-GBM antibodies using a direct enzyme-linked immunoassay (ELISA). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease\", section on 'Serologic testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Testing for cryoglobulins may be warranted in patients who, in addition to the glomerulonephritis, have palpable purpura, systemic symptoms (eg, arthralgias),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hypocomplementemia [",
"      <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/37\">",
"       37",
"      </a>",
"      ]. Hepatitis C virus infection is present in the majority of patients with essential mixed cryoglobulinemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Both hepatitis B and hepatitis C virus have been associated with membranoproliferative glomerulonephritis. Serologic testing consists of circulating HBV surface and e antigens and anti-HCV antibodies. However, positive serologic testing for these infections does not prove that hepatitis virus is responsible for the glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/28/44488?source=see_link&amp;anchor=H4#H4\">",
"       \"Renal disease associated with hepatitis B virus infection\", section on 'Membranoproliferative glomerulonephritis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42279?source=see_link\">",
"       \"Serologic diagnosis of hepatitis B virus infection\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37353?source=see_link&amp;anchor=H3#H3\">",
"       \"Renal disease associated with hepatitis C virus infection\", section on 'Membranoproliferative glomerulonephritis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=see_link&amp;anchor=H8#H8\">",
"       \"Screening for and diagnosis of chronic hepatitis C virus infection\", section on 'Antibody testing'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In addition to the nephrotic syndrome described in the preceding section, HIV-infected patients can also develop glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=see_link\">",
"       \"Overview of kidney disease in HIV-infected patients\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8609515\">",
"    <span class=\"h2\">",
"     Hypocomplementemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocomplementemia is present in a variety of causes of glomerulonephritis, including lupus nephritis, postinfectious glomerulonephritis, membranoproliferative glomerulonephritis, and mixed cryoglobulinemia [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/18,38,39\">",
"     18,38,39",
"    </a>",
"    ]. Hypocomplementemia is usually detected by measuring serum C3 and C4.",
"   </p>",
"   <p>",
"    Hypocomplementemia is most often due to complement activation by immune deposits at a rate greater than that at which new complement proteins can be synthesized [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/40\">",
"     40",
"    </a>",
"    ]. In contrast, there is a lesser or slower rate of complement activation in IgA nephropathy, fibrillary glomerulonephritis, and membranous nephropathy. As a result, complement levels are usually normal in these disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/38\">",
"     38",
"    </a>",
"    ] with the exceptions of some patients with membranous nephropathy due to lupus or to hepatitis B virus infection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/41\">",
"     41",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/12/44233?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical features and therapy of membranous lupus nephritis\", section on 'Clinical presentation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/28/44488?source=see_link&amp;anchor=H3#H3\">",
"     \"Renal disease associated with hepatitis B virus infection\", section on 'Membranous nephropathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Complement levels are also generally normal or even elevated in anti-glomerular basement membrane antibody disease, granulomatosis with polyangiitis (Wegener's), polyarteritis nodosa, and Henoch-Sch&ouml;nlein purpura (HSP, also termed IgA vasculitis [IgAV]) [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/38\">",
"     38",
"    </a>",
"    ]. Although hypocomplementemia has been reported in a few patients with HSP (IgAV), most cases had associated evidence of streptococcal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/42,43\">",
"     42,43",
"    </a>",
"    ] (See appropriate topic reviews on the individual glomerular diseases).",
"   </p>",
"   <p>",
"    In addition to increased consumption, other mechanisms that can account for hypocomplementemia in glomerular disease include hereditary or acquired deficiency of complement components or its regulators, and the presence of circulating factors that promote complement activation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hereditary complement deficiencies predispose to the development of systemic lupus erythematosus. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42920?source=see_link&amp;anchor=H6#H6\">",
"       \"Inherited disorders of the complement system\", section on 'Specific disorders'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hereditary or acquired deficiency of the regulators of the alternative complement pathway are associated with certain types of MPGN, such as dense deposit disease and C3 glomerulonephritis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3498?source=see_link&amp;anchor=H2#H2\">",
"       \"Dense deposit disease (membranoproliferative glomerulonephritis type II)\", section on 'Pathogenesis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=see_link&amp;anchor=H12#H12\">",
"       \"Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis\", section on 'Complement-mediated MPGN'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hypocomplementemia can also occur in some non-immune complex-mediated renal diseases including atheroembolic renal disease, hemolytic-uremic syndrome and thrombotic thrombocytopenic purpura, rheumatoid vasculitis, and in a few patients with heavy chain deposition disease [",
"    <a class=\"abstract\" href=\"UTD.htm?26/31/27130/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. These disorders are not primary glomerular diseases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13528?source=see_link&amp;anchor=H6#H6\">",
"     \"Clinical presentation, evaluation, and treatment of renal atheroemboli\", section on 'Eosinophilia and hypocomplementemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29721?source=see_link&amp;anchor=H6#H6\">",
"     \"Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\", section on 'Renal disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43849?source=see_link&amp;anchor=H8#H8\">",
"     \"Atypical hemolytic uremic syndrome in children\", section on 'Complement dysregulation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical manifestations and diagnosis of rheumatoid vasculitis\", section on 'Hypocomplementemia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical manifestations and diagnosis of rheumatoid vasculitis\", section on 'Renal disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8609730\">",
"    <span class=\"h1\">",
"     WHEN RENAL BIOPSY MAY NOT BE NECESSARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The type and severity of glomerular disease is usually determined by renal biopsy, with performance of light, immunofluorescence, and electron microscopy. There are, however, a number of settings in which renal biopsy may not be necessary and the potential for complications such as bleeding avoided. These issues are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=see_link\">",
"     \"Indications for and complications of renal biopsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, \"The Basics\" and \"Beyond the Basics.\" The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on \"patient info\" and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=see_link\">",
"       \"Patient information: Glomerular disease overview (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?35/2/35875?source=see_link\">",
"       \"Patient information: The nephrotic syndrome (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3300458\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although there are many causes of glomerular disease, the characteristics of the urine sediment, the degree of proteinuria, and the patient's age often allow the differential diagnosis to be substantially narrowed prior to renal biopsy. In general, two different urinary patterns are seen: nephrotic and nephritic. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical patterns of glomerular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The nephrotic pattern is characterized by proteinuria that is usually above 3.5",
"      <span class=\"nowrap\">",
"       g/day",
"      </span>",
"      and lipiduria, but few cells or casts other than fatty casts. Some patients have microscopic hematuria but red cell casts are not seen. Patients who also have edema and hyperlipidemia (the full-blown nephrotic syndrome) tend to have a more marked glomerular leak than those with proteinuria alone. Almost all of the causes of nephrotic syndrome can present with subnephrotic proteinuria with the general exceptions of most patients with minimal change disease and some with primary focal segmental glomerulosclerosis who present with the abrupt onset of the nephrotic syndrome. Acute kidney injury (acute renal failure) can occur in a limited number of settings. (See",
"      <a class=\"local\" href=\"#H93802214\">",
"       'Nephrotic pattern'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The nephritic urine sediment is characterized by the presence of red cells and occasionally white blood cells with or without red cell or mixed cellular casts. Some of the red cells are acanthocytes, which are best seen when the urine sediment is examined with phase contrast microscopy. Acanthocytes are considered virtually diagnostic of glomerular hematuria but many clinicians have little experience in identifying these cells. Patients with glomerulonephritis have variable degrees of proteinuria, ranging from normal protein excretion to the nephrotic range. (See",
"      <a class=\"local\" href=\"#H93801583\">",
"       'Nephritic pattern'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some patients have the concurrent presence of two glomerular diseases, which may occur by chance or have a related pathogenesis. (See",
"      <a class=\"local\" href=\"#H96871475\">",
"       'Concurrent glomerular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When approaching a patient with apparent glomerular disease, the urinalysis, the estimated glomerular filtration rate, and patient age help to identify the most likely causes. Race and family history also may suggest particular etiologies. However, confirmation by renal biopsy is usually required. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Causes of glomerular disease according to presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Standard laboratory testing in patients with evidence of glomerular disease includes routine laboratory tests (eg, serum creatinine, serum albumin, estimation of protein excretion in patients with proteinuria) and serologic testing for disorders that cause glomerular disease. Although serologic testing may be helpful in establishing a diagnosis in some patients, a renal biopsy is usually performed even if serologic testing is positive for three reasons: the test itself may not be diagnostic; a positive test does not prove that that disease is responsible for the glomerular injury, and, in lupus nephritis, positive serology does not identify what type of lupus nephritis is present and patients with membranous lupus may be seronegative. However, serologic testing may assist in interpretation of the renal biopsy. (See",
"      <a class=\"local\" href=\"#H49532891\">",
"       'Serologic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Serologic tests for patients with a nephrotic pattern in the urinalysis may suggest a systemic disorder that affects the kidneys such as lupus, amyloidosis, hepatitis B (HBV) or hepatitis C (HCV) virus infection, or HIV infection. Serologic testing includes an antinuclear antibodies (ANA), anti-double-stranded DNA antibodies (dsDNA), C3, C4, anti-HIV antibody, and HCV and HBV serologies. Primary amyloidosis and light chain deposition disease may be suggested by serum and urine immunofixation and serum free light chain ratio analysis. (See",
"      <a class=\"local\" href=\"#H460668475\">",
"       'Patients with a nephrotic presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A nephritic pattern in the urinalysis with variable degrees of proteinuria can be causes by a variety of disorders. Laboratory testing includes C3, C4, ANA, dsDNA, antineutrophil cytoplasmic antibody (ANCA) titers, a streptozyme test, HBV and HCV serologies, and in some cases, blood cultures, anti-glomerular basement membrane (GBM) antibodies, and cryoglobulins. (See",
"      <a class=\"local\" href=\"#H460669045\">",
"       'Patients with a nephritic pattern'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hypocomplementemia, usually detected by measuring serum C3 and C4, is seen in a variety of causes of glomerulonephritis, including lupus nephritis, postinfectious glomerulonephritis, membranoproliferative glomerulonephritis, and mixed cryoglobulinemia. (See",
"      <a class=\"local\" href=\"#H8609515\">",
"       'Hypocomplementemia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/1\">",
"      Praga M, Borstein B, Andres A, et al. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis 1991; 17:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/2\">",
"      Fries JW, Mendrick DL, Rennke HG. Determinants of immune complex-mediated glomerulonephritis. Kidney Int 1988; 34:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/3\">",
"      O'Neill WM Jr, Wallin JD, Walker PD. Hematuria and red cell casts in typical diabetic nephropathy. Am J Med 1983; 74:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/4\">",
"      Goorno W, Ashworth CT, Carter NW. Acute glomerulonephritis with absence of abnormal urinary findings. Diagnosis by light and electron microscopy. Ann Intern Med 1967; 66:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/5\">",
"      Yata N, Ikeda M, Ishikura K, et al. Typical MPGN with few urinary abnormalities. Am J Kidney Dis 2004; 43:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/6\">",
"      Bruns FJ, Adler S, Fraley DS, Segel DP. Long-term follow-up of aggressively treated idiopathic rapidly progressive glomerulonephritis. Am J Med 1989; 86:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/7\">",
"      Nasr SH, Said SM, Valeri AM, et al. Membranous glomerulonephritis with ANCA-associated necrotizing and crescentic glomerulonephritis. Clin J Am Soc Nephrol 2009; 4:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/8\">",
"      Marshall S, Dressler R, D'Agati V. Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 1997; 29:119.",
"     </a>",
"    </li>",
"    <li>",
"     Rodriguez, EF, Nasr, SH, Sethi, S, et al. Membranous glomerulonephritis with crescents (abstract). Lab Invest 2011; 91 (suppl 1):350A.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/10\">",
"      Furuta T, Seino J, Saito T, et al. Insulin deposits in membranous nephropathy associated with diabetes mellitus. Clin Nephrol 1992; 37:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/11\">",
"      Rivera F, L&oacute;pez-G&oacute;mez JM, P&eacute;rez-Garc&iacute;a R, Spanish Registry of Glomerulonephritis. Clinicopathologic correlations of renal pathology in Spain. Kidney Int 2004; 66:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/12\">",
"      Iseki K, Miyasato F, Uehara H, et al. Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int 2004; 66:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/13\">",
"      Gesualdo L, Di Palma AM, Morrone LF, et al. The Italian experience of the national registry of renal biopsies. Kidney Int 2004; 66:890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/14\">",
"      Heaf J. The Danish Renal Biopsy Register. Kidney Int 2004; 66:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/15\">",
"      Simon P, Ramee MP, Boulahrouz R, et al. Epidemiologic data of primary glomerular diseases in western France. Kidney Int 2004; 66:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/16\">",
"      Nair R, Bell JM, Walker PD. Renal biopsy in patients aged 80 years and older. Am J Kidney Dis 2004; 44:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/17\">",
"      Bahiense-Oliveira M, Saldanha LB, Mota EL, et al. Primary glomerular diseases in Brazil (1979-1999): is the frequency of focal and segmental glomerulosclerosis increasing? Clin Nephrol 2004; 61:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/18\">",
"      Lewis EJ, Carpenter CB, Schur PH. Serum complement component levels in human glomerulonephritis. Ann Intern Med 1971; 75:555.",
"     </a>",
"    </li>",
"    <li>",
"     Rose, BD. Pathophysiology of Renal Disease, 2d ed, McGraw-Hill, New York, 1987, p. 166.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/20\">",
"      Korbet SM, Genchi RM, Borok RZ, Schwartz MM. The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 1996; 27:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/21\">",
"      Griffin KA, Schwartz MM, Korbet SM. Pulmonary-renal syndrome of bacterial endocarditis mimicking Goodpasture's syndrome. Am J Kidney Dis 1989; 14:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/22\">",
"      Wu HC, Wen YK, Chen ML, Fan CS. Pulmonary-renal syndrome in a patient with bacterial endocarditis. J Formos Med Assoc 2005; 104:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/23\">",
"      Niles JL, B&ouml;ttinger EP, Saurina GR, et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 1996; 156:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/24\">",
"      Boyce NW, Holdsworth SR. Pulmonary manifestations of the clinical syndrome of acute glomerulonephritis and lung hemorrhage. Am J Kidney Dis 1986; 8:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/25\">",
"      Gallagher H, Kwan JT, Jayne DR. Pulmonary renal syndrome: a 4-year, single-center experience. Am J Kidney Dis 2002; 39:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/26\">",
"      Yoshizawa N, Yamakami K, Fujino M, et al. Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol 2004; 15:1785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/27\">",
"      Lewy JE, Salinas-Madrigal L, Herdson PB, et al. Clinico-pathologic correlations in acute poststreptococcal glomerulonephritis. A correlation between renal functions, morphologic damage and clinical course of 46 children with acute poststreptococcal glomerulonephritis. Medicine (Baltimore) 1971; 50:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/28\">",
"      Gubler M, Levy M, Broyer M, et al. Alport's syndrome. A report of 58 cases and a review of the literature. Am J Med 1981; 70:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/29\">",
"      Kashtan CE. Alport syndrome and thin glomerular basement membrane disease. J Am Soc Nephrol 1998; 9:1736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/30\">",
"      Aarons I, Smith PS, Davies RA, et al. Thin membrane nephropathy: a clinico-pathological study. Clin Nephrol 1989; 32:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/31\">",
"      Smith MC, Cooke JH, Zimmerman DM, et al. Asymptomatic glomerulonephritis after nonstreptococcal upper respiratory infections. Ann Intern Med 1979; 91:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/32\">",
"      Sagel I, Treser G, Ty A, et al. Occurrence and nature of glomerular lesions after group A streptococci infections in children. Ann Intern Med 1973; 79:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/33\">",
"      Howard AD, Moore J Jr, Gouge SF, et al. Routine serologic tests in the differential diagnosis of the adult nephrotic syndrome. Am J Kidney Dis 1990; 15:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/34\">",
"      Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 1997; 30:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/35\">",
"      Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int 1990; 37:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/36\">",
"      O'Regan S, Fong JS, de Chadar&eacute;vian JP, et al. Treponemal antigens in congenital and acquired syphilitic nephritis: demonstration by immunofluorescence studies. Ann Intern Med 1976; 85:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/37\">",
"      D'Amico G, Colasanti G, Ferrario F, Sinico RA. Renal involvement in essential mixed cryoglobulinemia. Kidney Int 1989; 35:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/38\">",
"      Hebert LA, Cosio FG, Neff JC. Diagnostic significance of hypocomplementemia. Kidney Int 1991; 39:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/39\">",
"      Hepburn NJ, Ruseva MM, Harris CL, Morgan BP. Complement, roles in renal disease and modulation for therapy. Clin Nephrol 2008; 70:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/40\">",
"      Quigg RJ. Complement and the kidney. J Immunol 2003; 171:3319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/41\">",
"      Yoshikawa N, Ito H, Yamada Y, et al. Membranous glomerulonephritis associated with hepatitis B antigen in children: a comparison with idiopathic membranous glomerulonephritis. Clin Nephrol 1985; 23:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/42\">",
"      Motoyama O, Iitaka K. Henoch-Schonlein purpura with hypocomplementemia in children. Pediatr Int 2005; 47:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/43\">",
"      Kikuchi Y, Yoshizawa N, Oda T, et al. Streptococcal origin of a case of Henoch-Schoenlein purpura nephritis. Clin Nephrol 2006; 65:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/44\">",
"      Soma J, Sato K, Sakuma T, et al. Immunoglobulin gamma3-heavy-chain deposition disease: report of a case and relationship with hypocomplementemia. Am J Kidney Dis 2004; 43:E10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/31/27130/abstract/45\">",
"      Kambham N, Markowitz GS, Appel GB, et al. Heavy chain deposition disease: the disease spectrum. Am J Kidney Dis 1999; 33:954.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3041 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-07BE0D3610-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27130=[""].join("\n");
var outline_f26_31_27130=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3300458\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL PATTERNS OF GLOMERULAR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93802214\">",
"      Nephrotic pattern",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H93802312\">",
"      - Acute kidney injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93801583\">",
"      Nephritic pattern",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H93802207\">",
"      - Pathologic classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H95232219\">",
"      Limitations of this classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Nonspecific nature of the histologic patterns",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96871475\">",
"      Concurrent glomerular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CAUSES OF GLOMERULAR DISEASE ACCORDING TO PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H93802546\">",
"      Nephrotic syndrome without a nephritic sediment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mild glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Moderate to severe glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49245340\">",
"      Effect of race",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3936567\">",
"      Positive family history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14577549\">",
"      Systemic presentations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14577579\">",
"      - Acute glomerulonephritis and pulmonary hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14578038\">",
"      - Hematuria following upper respiratory infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H662940\">",
"      Clinically evident glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H660558\">",
"      - IgA nephropathy versus PSGN",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H660574\">",
"      - C3 glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H118030821\">",
"      - Hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H118032056\">",
"      - Thin basement membrane nephropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H662970\">",
"      Microscopic hematuria alone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H460668346\">",
"      LABORATORY TESTING IN PATIENTS WITH SUSPECTED GLOMERULAR DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H49532891\">",
"      Serologic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H460668475\">",
"      - Patients with a nephrotic presentation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H460669045\">",
"      - Patients with a nephritic pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8609515\">",
"      Hypocomplementemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8609730\">",
"      WHEN RENAL BIOPSY MAY NOT BE NECESSARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3300458\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/3041\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3041|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?29/6/29792\" title=\"picture 1A\">",
"      Fatty cast",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/0/31758\" title=\"picture 1B\">",
"      Fatty cast polarized",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?24/0/24591\" title=\"picture 2\">",
"      Phase contrast micrograph showing dysmorphic red cells in urine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?13/47/14079\" title=\"picture 3\">",
"      Scanning electron micrograph showing dysmorphic red cells",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?19/17/19734\" title=\"picture 4\">",
"      Postinfectious GN Light Low",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/3041|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/13/35036\" title=\"table 1\">",
"      Differential glomerular disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18598?source=related_link\">",
"      Acute kidney injury (acute renal failure) in minimal change disease and other forms of nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/45/36570?source=related_link\">",
"      Assessment of kidney function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/37/13914?source=related_link\">",
"      Assessment of urinary protein excretion and evaluation of isolated non-nephrotic proteinuria in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43849?source=related_link\">",
"      Atypical hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/54/19306?source=related_link\">",
"      Causes and diagnosis of membranous nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/12/44233?source=related_link\">",
"      Clinical features and therapy of membranous lupus nephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/49/40729?source=related_link\">",
"      Clinical manifestations and diagnosis of Henoch-Sch&ouml;nlein purpura (IgA vasculitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/36/27209?source=related_link\">",
"      Clinical manifestations and diagnosis of acute interstitial nephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/13/20697?source=related_link\">",
"      Clinical manifestations and diagnosis of rheumatoid vasculitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=related_link\">",
"      Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/33/36377?source=related_link\">",
"      Clinical manifestations, diagnosis and treatment of hereditary nephritis (Alport syndrome)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/19/1337?source=related_link\">",
"      Clinical presentation and diagnosis of IgA nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43833?source=related_link\">",
"      Clinical presentation, classification, and causes of membranoproliferative glomerulonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/13/13528?source=related_link\">",
"      Clinical presentation, evaluation, and treatment of renal atheroemboli",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/15/7418?source=related_link\">",
"      Clinical presentation, laboratory manifestations, and diagnosis of immunoglobulin light chain (AL) amyloidosis (primary amyloidosis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/28/9674?source=related_link\">",
"      Clinical spectrum of antineutrophil cytoplasmic antibodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/31/43512?source=related_link\">",
"      Collapsing focal segmental glomerulosclerosis not associated with HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/26/3498?source=related_link\">",
"      Dense deposit disease (membranoproliferative glomerulonephritis type II)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27706?source=related_link\">",
"      Diagnosis and classification of renal disease in systemic lupus erythematosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/16/3338?source=related_link\">",
"      Diagnosis and differential diagnosis of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/1/29721?source=related_link\">",
"      Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/44/39624?source=related_link\">",
"      Diagnostic testing for syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/6/41066?source=related_link\">",
"      Epidemiology, classification, and pathogenesis of focal segmental glomerulosclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/59/34746?source=related_link\">",
"      Etiology and evaluation of hematuria in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34601?source=related_link\">",
"      Etiology, clinical features, and diagnosis of minimal change disease in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/38/5738?source=related_link\">",
"      Evaluation of acute pharyngitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26262?source=related_link\">",
"      Evaluation of proteinuria in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/3/2104?source=related_link\">",
"      HIV-associated nephropathy (HIVAN)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/11/21690?source=related_link\">",
"      Indications for and complications of renal biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/58/42920?source=related_link\">",
"      Inherited disorders of the complement system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/27/43448?source=related_link\">",
"      Mechanisms of glomerular crescent formation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/30/18921?source=related_link\">",
"      Mechanisms of immune injury of the glomerulus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/0/24582?source=related_link\">",
"      NSAIDs: Acute kidney injury (acute renal failure) and nephrotic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/63/30714?source=related_link\">",
"      Overview of diabetic nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4168?source=related_link\">",
"      Overview of kidney disease in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/31/41464?source=related_link\">",
"      Overview of the clinical manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/19/4409?source=related_link\">",
"      Pathogenesis and diagnosis of anti-GBM antibody (Goodpasture's) disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/35/37426?source=related_link\">",
"      Patient information: Glomerular disease overview (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?35/2/35875?source=related_link\">",
"      Patient information: The nephrotic syndrome (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/30/35304?source=related_link\">",
"      Poststreptococcal glomerulonephritis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/60/11210?source=related_link\">",
"      Pulmonary manifestations of systemic lupus erythematosus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/29/13784?source=related_link\">",
"      Renal amyloidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/28/44488?source=related_link\">",
"      Renal disease associated with hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/30/37353?source=related_link\">",
"      Renal disease associated with hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/27/5556?source=related_link\">",
"      Renal disease in the setting of infective endocarditis or an infected ventriculoatrial shunt",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41849?source=related_link\">",
"      Screening for and diagnosis of chronic hepatitis C virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/18/42279?source=related_link\">",
"      Serologic diagnosis of hepatitis B virus infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/51/12088?source=related_link\">",
"      Thin basement membrane nephropathy (benign familial hematuria)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42106?source=related_link\">",
"      Treatment and prognosis of IgA nephropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27400?source=related_link\">",
"      Types of renal disease in multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=related_link\">",
"      Urinalysis in the diagnosis of kidney disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_31_27131="Anal outcome hist AJCC";
var content_f26_31_27131=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F52279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F52279&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Outcome of anal cancer stratified by AJCC stage group and tumor histology (squamous vs. nonsquamous types)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\" rowspan=\"2\">",
"       Stage group",
"      </td>",
"      <td class=\"subtitle1\" colspan=\"3\">",
"       5-year survival rate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2\">",
"       Squamous",
"      </td>",
"      <td class=\"subtitle2\">",
"       Nonsquamous",
"      </td>",
"      <td class=\"subtitle2\">",
"       p value",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       I",
"      </td>",
"      <td>",
"       71.4",
"      </td>",
"      <td>",
"       59.1",
"      </td>",
"      <td>",
"       0.003",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       II",
"      </td>",
"      <td>",
"       63.5",
"      </td>",
"      <td>",
"       52.9",
"      </td>",
"      <td>",
"       0.001",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IIIA",
"      </td>",
"      <td>",
"       48.1",
"      </td>",
"      <td>",
"       37.7",
"      </td>",
"      <td>",
"       0.085",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IIIB",
"      </td>",
"      <td>",
"       43.2",
"      </td>",
"      <td>",
"       24.4",
"      </td>",
"      <td>",
"       0.003",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       IV",
"      </td>",
"      <td>",
"       20.9",
"      </td>",
"      <td>",
"       7.4",
"      </td>",
"      <td>",
"       0.002",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Source: National Cancer Database: Cases diagnosed 1998-1999: n = 3598.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27131=[""].join("\n");
var outline_f26_31_27131=null;
var title_f26_31_27132="ACR fibromyalgia classification";
var content_f26_31_27132=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79179&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    The American College of Rheumatology 1990 criteria for the classification of fibromyalgia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        1. History of widespread pain.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Definition.",
"        </strong>",
"        Pain is considered widespread when all of the following are present: pain in the left side of the body,",
"pain in the right side of the body, pain above the waist, and pain",
"below the waist. In addition, axial skeletal pain (cervical spine or",
"anterior chest or thoracic spine or low back) must be present. In this",
"definition, shoulder and buttock pain is considered as pain for each",
"involving side. \"Low back\" pain is considered lower segment pain.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        2. Pain in 11 of 18 tender point sites on digital palpation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Definition.",
"        </strong>",
"        Pain, on digital palpation, must be present in at least 11 of the following 18 tender point sites:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Occiput: bilateral, at the suboccipital muscle insertions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Low cervical: bilateral, at the anterior aspects of the intertransverse spaces at C5-C7.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trapezius: bilateral, at the midpoint of the upper border.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Supraspinatus: bilateral, at origins, above the scapula spine near the medial border.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Second rib: bilateral, at the second costochondral junctions, just lateral to the junctions on upper surfaces.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lateral epicondyle: bilateral, 2 cm distal to the epicondyles.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Gluteal: bilateral, in upper outer quadrants of buttocks in anterior fold of muscle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Greater trochanter: bilateral, posterior to the trochanteric prominence.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Knee: bilateral, at the medial fat pad proximal to the joint line.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Digital palpation should be performed with an approximate",
"force of 4 kg. For tender point to be considered \"positive\" the subject",
"must state the palpation was painful. \"Tender\" is not to be considered",
"\"painful.\"",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * For classification purposes, patients will be said to have fibromyalgia if both criteria are satisfied. Widespread pain must have been present for at least three months. The presence of a second clinical disorder does not exclude the diagnosis of fibromyalgia.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Wolfe, F, Smythe, HA, Yunus, MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33:160. Copyright &copy; 1990 John Wiley &amp; Sons.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27132=[""].join("\n");
var outline_f26_31_27132=null;
var title_f26_31_27133="Spitz tumors histo differential";
var content_f26_31_27133=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85847&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Histopathologic criteria for conventional Spitz nevi, atypical Spitz tumors, and melanoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Conventional Spitz tumors",
"       </td>",
"       <td class=\"subtitle1\">",
"        Atypical Spitz tumors",
"       </td>",
"       <td class=\"subtitle1\">",
"        Melanoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Architecture",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diameter",
"       </td>",
"       <td>",
"        &lt;5 to 6 mm",
"       </td>",
"       <td>",
"        &ge;5 to 6 mm",
"       </td>",
"       <td>",
"        &ge;10 mm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Outline",
"       </td>",
"       <td>",
"        Symmetric (wedge-shaped)",
"       </td>",
"       <td>",
"        Asymmetric",
"       </td>",
"       <td>",
"        Asymmetric",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Circumscription",
"       </td>",
"       <td>",
"        Sharp lateral circumscription",
"       </td>",
"       <td>",
"        Often poor circumscription",
"       </td>",
"       <td>",
"        Poor circumscription",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Epidermal hyperplasia",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Effacement of the epidermis may be present",
"       </td>",
"       <td>",
"        Absent, or effacement of the epidermis may be present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Maturation with dermal depth",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Possibly diminished or lack of zonation and maturation",
"       </td>",
"       <td>",
"        Lack of zonation and maturation often present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Eosinophilic hyaline globules (Kamino bodies)",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"       <td>",
"        Absent or few",
"       </td>",
"       <td>",
"        Typically absent",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Cellular density",
"       </td>",
"       <td>",
"        Orderly nondisruptive infiltration of collagen by melanocytes",
"       </td>",
"       <td>",
"        High cellular density",
"       </td>",
"       <td>",
"        High cellular density",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Cytology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cellular population",
"       </td>",
"       <td>",
"        Uniform spindle and/or epithelioid",
"       </td>",
"       <td>",
"        Spindle and/or epithelioid cells showing increasing cytological atypia",
"       </td>",
"       <td>",
"        Spindle and/or epithelioid cells showing increasing cytological atypia and pleomorphism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cytoplasm",
"       </td>",
"       <td>",
"        Opaque or ground glass cytoplasm",
"       </td>",
"       <td>",
"        Granular versus ground glass cytoplasm",
"       </td>",
"       <td>",
"        Granular or mixed cytoplasm",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nuclear to cytoplasmic ratio",
"       </td>",
"       <td>",
"        Low nuclear to cytoplasmic ratio",
"       </td>",
"       <td>",
"        Increasingly high nuclear to cytoplasmic ratio",
"       </td>",
"       <td>",
"        High nuclear to cytoplasmic ratio",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chromatin pattern",
"       </td>",
"       <td>",
"        Nuclei with open, delicate chromatin pattern",
"       </td>",
"       <td>",
"        Loss of delicate or dispersed chromatin pattern",
"       </td>",
"       <td>",
"        Loss of delicate or dispersed chromatin pattern",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nucleoli",
"       </td>",
"       <td>",
"        Uniform nucleoli",
"       </td>",
"       <td>",
"        Increasingly prominent nucleoli",
"       </td>",
"       <td>",
"        Large nucleoli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pleomorphism",
"       </td>",
"       <td>",
"        Rare",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"       <td>",
"        Usually present",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Hyperchromatism",
"       </td>",
"       <td>",
"        Absent",
"       </td>",
"       <td>",
"        May be present",
"       </td>",
"       <td>",
"        Present",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Proliferation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mitotic rate",
"       </td>",
"       <td>",
"        &lt;2/mm",
"        <sup>",
"         2",
"        </sup>",
"        <br/>",
"        Absent or rare mitoses in deep dermis",
"        <br/>",
"        Lack of atypical mitoses",
"       </td>",
"       <td>",
"        <p>",
"         2 to 6/mm",
"         <sup>",
"          2",
"         </sup>",
"         (particularly &gt;6/mm",
"         <sup>",
"          2)",
"         </sup>",
"        </p>",
"        <p>",
"         Deep or marginal dermal mitoses may be present",
"        </p>",
"        <br/>",
"       </td>",
"       <td>",
"        <p>",
"         2 to 6/mm",
"         <sup>",
"          2",
"         </sup>",
"         (particularly &gt;6/mm",
"         <sup>",
"          2",
"         </sup>",
"         )",
"        </p>",
"        <p>",
"         Deep or marginal dermal mitoses frequently present",
"        </p>",
"        <br/>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Proliferative index (Ki-67 expression)",
"       </td>",
"       <td>",
"        &nbsp;&lt;2 percent",
"       </td>",
"       <td>",
"        <p>",
"         2 to &gt;10 percent",
"        </p>",
"       </td>",
"       <td>",
"        Often &gt;15 to 30 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Barnhill RL. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment. Mod Pathol 2006; 19 Suppl 2:S21.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27133=[""].join("\n");
var outline_f26_31_27133=null;
var title_f26_31_27134="Electrolyte patterns EGD PFT";
var content_f26_31_27134=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F66606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F66606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 567px\">",
"   <div class=\"ttl\">",
"    Median electrolyte concentrations versus time in secretin-stimulated duodenal aspirates obtained through an endoscope",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 547px; height: 378px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Concentration patterns simulate the traditional secretory curves observed with traditional pancreatic function testing using gastroduodenal collection tubes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cleveland Clinic Foundation.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27134=[""].join("\n");
var outline_f26_31_27134=null;
var title_f26_31_27135="EUS lymph node FNA";
var content_f26_31_27135=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of a 1 cm posterior mediastinal lymph node",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Fine needle aspiration&nbsp;of a 1 cm lymph node. B) Non-small cell (60X magnification).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_31_27135=[""].join("\n");
var outline_f26_31_27135=null;
